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The generation of reactive oxygen species (ROS) by UVA radiation (320-380 nm) is 
responsible for damage to intracellular biological macromolecules, cytotoxicity and many 
other effects. Both the endogenous chromophore protoporphyrin IX (PPIX) and ‘free’ 
iron are potentially important sources of ROS after UVA irradiation in human cells. The 
aim of this study was to determine the importance of PPIX in the inactivation of human 
cells after UVA irradiation, and to determine what effect UVA irradiation had on 
intracellular ‘free’ iron levels.
By modulating levels of the intracellular chromophore PPIX in human cells by 
exogenous administration of the haem precursor S-aminolevulinic acid (ALA) and 
irradiating these cells with graded doses of UVA, it was determined that the basal content 
of PPIX in TK6 human lymphoblastoid cells is insufficient to make a significant 
contribution to the UVA-mediated inactivation of these cells. The basal content of PPIX 
was however found to make a significant contribution to UVA-mediated inactivation of 
the primary human fibroblast cell line, FEK4, which implicates PPIX as a critical UVA 
chromophore in this cell line.
We document in this study the development of a flow cytometry-based fluorescence 
assay system that is capable of determining membrane damage and changes in 
intracellular ‘free’ iron levels. By using this assay and the cytoplasmic aconitase assay, 
we have confirmed that UVA irradiation of human skin cells results in an increase in 
intracellular ‘free’ iron levels. We also demonstrate that while administration of ALA to 
FEK4 cells does lower the intracellular ‘free’ iron levels, this type of treatment strongly 
exacerbates the increase in ‘free’ iron levels observed after UVA irradiation.
The effects of ALA treatment and UVA irradiation on ferritin levels in FEK4 cells was 
also determined in this study using a polyclonal (anti-ferritin) antibody enzyme-linked 
immunosorbent assay. We demonstrate in this study that UVA irradiation of cells, and to 
a much greater extent, UVA irradiation of cells treated with ALA, results in the
IV
degradation of ferritin. This provides strong evidence for ferritin being a major source of 
the increase in intracellular ‘free’ iron levels observed after such treatments.
It is hoped that data obtained from this study will contribute to an advancement in the 
understanding of the intracellular effects of UVA irradiation and that this may help in the 
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Chapter 1: Introduction
1. Introduction
1.1 Physiology o f the Human Skin
The skin is the largest organ of the human body and it has many functions, the most 
important of which is to keep internal systems intact and to protect the body from 
harmful external factors such as chemical agents, physical agents (e.g. ultraviolet light), 
and microorganisms. Amongst other functions, the skin is also important in preventing 
the loss of body fluids, regulating temperature, vitamin D production and immune 
surveillance. The skin is composed of three layers: the epidermis, the dermis and the 
hypodermis. The epidermis is mainly composed of keratinocytes, Langerhans cells and 
melanocytes. Keratinocytes produce the protein keratin, which provides a strength and 
flexibility to the epidermis. Langerhans cells are antigen-presenting cells, and 
melanocytes synthesise melanin and re-distribute it to surrounding keratinocytes by via 
dendritic processes. Melanins act as UV radiation absorbers and scatterers as well as free 
radical scavengers (Chedekel and Zeise, 1997). Melanin granules form a protective cap 
over the outer part of the keratinocyte nuclei in the inner layers of the epidermis. In the 
stratum comeum (the outermost layer of the epidermis), they are uniformly distributed to 
form an UV-absorbing dispersion, which reduces the amount of radiation that can 
penetrate the skin. The dermis is a tough and supportive connective tissue matrix that is 
connected to the epidermis. The thin upper part of the dermis is known as the papillary 
dermis because it has small fingerlike projections (papillae) containing capillaries, which 
nourish the epidermis. The papillary dermis is composed of loosely interwoven collagen. 
The coarse and horizontally running bundles of collagen are found in the thicker, lower
1
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part of the dermis, known as the reticular dermis. Collagen fibres constitute the major 
structural protein of the dermis and they provide strength and resilience. Elastin fibres 
are also found in the dermis and provide elasticity to the skin. The ground substance of 
the dermis is a semi-solid matrix of glycosaminoglycans (GAG) that provides viscosity 
and hydration, and allows dermal structures limited movement. GAGs exist as high 
molecular weight polymers with a protein core, these are known as proteoglycans. 
Embedded in the reticular layer are many blood and lymphatic vessels, nerves and nerve 
endings, oil glands and hair roots. The dermis consists of a number of different cell 
types, particularly fibroblasts (which synthesise collagen, elastin and GAG). Other cells 
found in the dermis include fat (adipose) cells and immunological cell types such as 
dermal dendrocytes, mast cells, macrophages and lymphocytes. The deepest part of the 
skin is the subcutaneous layer or hypodermis. It consists of mainly fibrous, loose 
connective tissue such as adipose tissue. This layer is richly supplied with lymphatic 
vessels, blood vessels, and nerves. The coiled ducts of sweat glands, and bases of hair 
follicles are also found in the hypodermis.
2
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1.2 Electromagnetic Radiation and the Laws o f Photochemistry
Electromagnetic radiation exhibits wave-particle duality, which means it possesses 
characteristics of both particles and waves. It is transmitted as discrete units known as 
either quanta or photons. The magnitude of the energy of a photon is governed by the 
following relationship:
E = hv
Where E = energy (in J), h = Planck’s constant (6.626 x 10'34 J-s), and v = frequency (in 
Hz or cycles per sec). An important physical relationship that governs the properties of 
electromagnetic waves, is described by the following equation:
v = c/X
where c = speed of light (3 x 108 m/s) and X = wavelength (m). By substituting the 
second equation into the first, we get the following equation that describes the energy of 
electromagnetic radiation at a defined wavelength:
E = hc/X
From this equation it can be seen that energy and wavelength have a reciprocal 
relationship. As the wavelength decreases, the energy associated with it increases and 
vice-versa. The effect electromagnetic radiation has on a biomolecule depends on two
3
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factors: the energy of the incident photons and the wavelength of electromagnetic 
radiation (rays) absorbed by a molecule. The latter constitutes the absorption spectrum of 
the molecule (and is determined by its molecular structure). Less energetic wavelengths, 
such as infrared, when absorbed by a molecule, result in both an increase in rotational 
energy, and an increase in the energy of vibration of the constituent atoms relative to each 
other (i.e. bending and stretching of bonds). As the incident wavelength becomes more 
energetic (e.g. UV and visible rays), electronic transitions may occur where an electron 
may pass from its ground state orbital to an excited energy state. Excited molecules show 
a greater probability of undergoing chemical reactions and it is this photon-induced 
chemistry that eventually gives rise to photobiological effects. At very short, energetic 
wavelengths, such as x-rays and y-rays, the predominant chemical effects are bond 
breakage and ionisation (loss of an orbital electron from the target molecule).
The Gotthus Draper law is the primary law of photochemistry (and photobiology). This 
law states that light radiation must be absorbed by a molecule to induce a photochemical 
reaction, and in turn, photobiological reaction. It is not correct to consider that all light 
absorbed results in a chemical change as some of the light may be emitted as 
fluorescence or heat. The second law of photochemistry (the Stark-Einstein Law) states 
that light absorbed does not necessarily need to result in a photochemical reaction, but 
that if it does, only one photon is required for each molecule affected. This suggests, in 
general, that a photochemical change will not be induced by every photon absorbed by a 
molecule, but that the efficiency of producing a photochemical reaction (the quantum 
yield of a molecule, O) is of importance.
4
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Quantum yield is defined by:
0 =  Number of molecules reacting chemically 
Number of photons absorbed
The greater the quantum yield of a molecule, the more efficient that molecule is at 
inducing a photochemical reaction after absorbing a photon.
1.2.1 The Solar Spectrum
The solar electromagnetic spectrum includes wavelengths that range from very short, 
high-energy cosmic rays (1 O’ m), to longer, less energetic radiowaves (10 m). Around 
30-40% of total solar radiation, including most of the harmful wavelengths (wavelengths 
below 290 nm), is absorbed and filtered out by the ozone layer and molecular oxygen of 
the stratosphere. Wavelengths below 190 nm such as vacuum UV, gamma rays, x-rays 
and cosmic rays are high-energy wavelengths that are able to displace electrons from 
incident molecules to form ions. These wavelengths are known as ionising radiation. 
Wavelengths above 190 nm are unable to do this, because they lack the energy, and are 
known nonionising radiation.
The ultraviolet wavelengths of the solar electromagnetic spectrum stretch from 10 nm to 
380 nm. The UV spectrum is divided into to different bands based on its biological 
effects, and also for convenience. The shortest, hence the most harmful wavelengths of
5
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the UV spectrum are those below 290 nm and are termed vacuum UV (10-190 nm) and 
UVC (190-290 nm). These wavelengths (and shorter wavelengths) do not reach the 
earth’s surface as they are absorbed and filtered out by ozone, molecular oxygen and 
other molecules in the stratosphere. The radiation that does penetrate through the 
stratosphere and thus reaches the earth’s surface is summarised in Table 1.1. This is 
composed of approximately 10% UV, 50% visible, and 40% infrared (IR).







The UV that reaches the earth’s surface is composed of approximately 10% UVB and 
90% UVA at midday. UVB intensity declines from the noontime apex, but UVA 
intensity usually remains relatively constant. The biological consequences of these two 
bands of the UV spectrum are discussed below.
6
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1.3 Deleterious Biological Events Induced by Solar UV Radiation
This section discusses some of the biological consequences of exposure to either UVB 
(290-320 nm) or UVA radiation (320-380 nm), as these are the most harmful solar 
wavelengths that reach the earth’s surface. UVB radiation is discussed very briefly, 
outlining mainly its pathological consequences. UVA radiation, on the other hand, is 
discussed in much greater detail because the investigation of certain molecular and 
cellular effects of UVA irradiation provides the basis of this project. Firstly, the 
generation of reactive oxygen species by UVA is discussed, followed by UVA-induced 
damage to particular biomolecules. The pathological consequences of UVA irradiation 
are also covered.
1.3.1 Pathological Consequences o f UVB Radiation (290-320 nm)
UVB radiation is also known as erythemal UV because of its ability to induce erythema. 
There is evidence to suggest that UVB is responsible for the induction of non-melanoma 
skin cancer in man (Fitzpatrick and Sober, 1985; Brash et al., 1991). UVB induced 
photocarcinogenesis appears to be affected directly by genetic mutation, and indirectly by 
the impairment of the immune response (discussed below). UVB is absorbed by most 
biological macromolecules (such as lipids, proteins and nucleic acids), DNA in particular, 
is one of the most prominent UVB absorbing chromophores. The most frequent 
photoproducts formed after UVB exposure are cyclobutane-type pyrimidine dimers and 
(6-4) photoproducts (Freeman et al., 1986; Freeman et al., 1989; Olsen et al., 1989). 
UVB has been found to cause a limited number of strand breaks and there is also 
evidence that it can induce 8-hydroxy-2’-deoxyguanosine formation in primary murine
7
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keratinocytes (Stewart et al., 1994). UVB is known to effect the immune system. 
Langerhans cells, for example, which are recognised as major antigen-presenting cells of 
the epidermis, have been shown using a mouse model, to have their antigen-presenting 
function impaired after UVB irradiation (Greene, 1979). UVB exposure has also been 
found to significantly deplete Langerhans cells in humans (Cooper et al., 1992). 
Tumours implanted into mice that had been UVB irradiated prior to implant, grew rapidly 
rather than being rejected, as was observed in non-irradiated mice (Kripke, 1974). This 
suggested that UVB exposure could result in immunosuppression. Within the past 25 
years, UV-induced immunosuppression has been the subject of intense investigation 
(reviewed by Beissert and Granstein, 1995). Several factors have been identified as 
being responsible for UVB induced immunosuppression. One such factor was the 
development of suppressor T lymphocytes in mice after UVB irradiation, which was 
followed by the appearance of skin cancers. Transfer of these suppressor cells to non- 
irradiated recipients resulted in the inhibition of tumour rejection (Fisher and Kripke, 
1982). In others studies, local and systemic immunosuppression has been demonstrated 
using contact hypersensitivity (CHS) in murine models after UVB exposure (reviewed by 
Ullrich, 1995). Urocanic acid (UCA), a molecule found in the stratum comeum, was 
found to absorb UV light in a similar range to DNA. Subsequent investigations on the 
action spectrum of UCA on the immune system revealed that UVB exerted an inhibitory 
effect, which occurred as a result of isomerisation of the molecule (reviewed by Norval et 
al., 1995, Noonan et al., 1988). It has also been observed that UVB contributes to 
photoaging. In experiments using hairless mice, UVB was shown to induce severe 
dermal elastosis (Kligman and Sayre, 1991), cause changes in collagen (an initial
8
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increase followed by a decrease after prolonged exposure), and an increases in GAG and 
proteoglycans (Kligman and Kligman, 1997).
1.3.2 UVA-induced Oxidative Stress - Formation o f ROS
Many biological macromolecules absorb UVA, which can invariably result in the 
generation of reaction oxygen species (ROS), reviewed by Tyrrell (1991). For example, 
two studies showed (Czochralska et al., 1984; Cunningham et al., 1985) that irradiation 
of an aqueous solution of NADH (or NADPH) with UVA resulted in the formation of 
both superoxide anion (O2*”) and hydrogen peroxide (H2O2). McCormick and co­
workers (1976) demonstrated that irradiation of an oxygenated solution of tryptophan 
with wavelengths between 300 and 400 nm resulted in the photochemical oxidation of 
typtophan, yielding the formation of H2O2 and V-formyl kynurenin (a typtophan 
product). Subsequent irradiation of TV-formyl kynurenin photoproduct with UVA 
irradiation was shown also to generate of H2O2 (Andley and Clark, 1989). H2O2 
generation, after irradiation of either typtophan or V-formyl kynurenin, was postulated to 
occur via intermediate production of the (V - (Andley and Clark, 1989). The production 
of these ROS in biological systems could potentially be very crucial, because in the 
presence of redox-active cations, such as iron, the highly reactive hydroxyl radical may 
be formed by Fenton and Haber Weiss chemistry (reviewed in Halliwell and Gutteridge, 
1999). Various aspects of intracellular iron and its significance in relation to UVA 




Another major source of photochemical generation of ROS during UVA irradiation is 
that of endogenous photosensitisers. Absorption of a photon by a photosensitiser, at a 
defined wavelength, results in the excitation of the sensitiser to its singlet state. The 
excited singlet state can return to its ground state (accompanied by the emission of 
fluorescence) or it undergo a process known as intersystem crossing along with spin 
inversion, producing the longer lived, less energetic triplet state. The triplet state can 
react in one of three competitive mechanisms: a Type I photodynamic mechanism, which 
involves the interaction of the triplet state photosensitiser with another photosensitiser 
(involving energy transfer) or an organic substrate, producing free radical intermediates. 
Alternatively, a Type II mechanism may occur, which normally results in a direct energy 
transfer to ground state molecular oxygen. This produces either singlet oxygen ( ^ 2), or 
O2*”, and a ground state photosensitiser (less than 1% of Type II reactions result in O2*- 
formation (Foote, 1991). The third mechanism, by which a triplet state sensitiser may 
respond, is by relaxation back to its ground state resulting in concomitant 
phosphorescence emission. The mechanism that is favoured, and the products formed, 
are usually dependent on the environment of the reaction and the biochemical nature of 
the photosensitiser. For example, if the photosensitiser is bound to a substrate then a 
Type I mechanism might be favoured. Under aerobic conditions a Type II mechanism 
might be favoured. Another factor that influences the fate of the mechanism is the 
quantum yield and triplet lifetime of the photosensitiser. Photosensitisers with high 
quantum yields and longer triplet lifetimes have an increased chance of reacting with 
molecular oxygen, thus producing 1C>2 . Photosensitisers that lack these properties tend to 
favour fluorescence and are rather inefficient as a photosensitiser (reviewed by Ryter and
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Tyrrell, 1997). Molecules such as porphyrins (in particular protoporphyrin IX (PPIX) 
which is discussed in detail in Chapter 2), and flavins and quinones have all been 
postulated as being potential endogenous photosensitisers responsible for detrimental 
effects observed by UVA radiation.
1.3.3 UVA-induced DNA Damage
There are a number of different biological macromolecules that are affected as a result of 
exposure to UVA radiation (reviewed by Tyrrell, 1991, 1994). Despite DNA being a 
poor chromophore for the absorption of UVA radiation, various types of DNA damage 
have been observed. Damage to DNA after UVA irradiation is thought to occur 
primarily through the actions of sensitiser radicals and ROS. In particular, one DNA 
lesion that has been observed after UVA irradiation and highly documented in recent 
years is 7,8-dihydro-8-oxo-2’deoxyguanosine (also written as 8-oxo-dG, 8-hydroxy-2’- 
deoxyguanosine and 8-OHdG). UVA radiation dose-dependent increases in this lesion 
have been previously reported in cultured cells (Rosen et al., 1996;Kvam and Tyrrell 
(1997). An increase in 8-oxo-dG lesions was also observed after pre-treatment of cells 
with riboflavin or 5-aminolevulinic acid (ALA) followed by exposure to visible light 
(Pflaum et al., 1998). Singlet oxygen has been shown to mediate the formation of 8-oxo- 
dG resulting in strand breaks (Devasgayam et al., 1991), though the rate of induction of 
this lesion by UVA in mammalian cells has been reported to be 10-fold higher than single 
strand breaks (Pflaum et al., 1994). This lesion was first shown to be mutagenic by 
Kuchino and co-workers (1987) as it led to the misreading of DNA templates, both at the 
8-oxo-dG site and at adjacent residues in vitro. Further studies have indicated that DNA
11
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Fig. 1.1. Formation of 8-oxo-dG by oxidation at C8 of dG (deoxyguanine) causes structural and 
conformational alterations at dG that can result in mispairing of 8-oxo-dG with A (adenine), see text for 
details (source: Guyton and Kensler, 1993).




|  C (anti)\ H deoxyribose
|  G (anti)\
Oxidation at C8 of G
H deoxyribose
J *  8-hydroxy-G (anti)]
I
H deoxyribose







|  8-oxo-G (syn)\
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polymerases selectively incorporate dC (deoxycytosine) and dA (deoxyadenine) opposite 
8-oxo-dG (Shibutanti et al., 1991). Chain extension past the dA 8-oxo-dG pair proceeded 
more efficiently compared to its dC counterpart indicating that once misincorporation 
occurs the stable G-A mispair is not recognised by proofreading and will persist. If the 8- 
oxo-dG lesion is not excised (e.g. by formamidopyrimidine glycosylase, also known as 
FAPyG) before DNA replication proceeds, or if dATP or 8-oxo-dGTP is mistakenly 
incorporated at the apurinic site that results from excision of the modified base, the 
mutation resulting from the 8-oxo-dG mispairing will be a G:C to T:A transversion (see 
Fig.l.1). Since a high frequency of G:C to T:A mutations in the ras oncogene have been 
observed in tumours of sun exposed skin, it has been postulated that 8-oxo-dG formation 
may contribute to some of these mutations and thus may be carcinogenic (Hattori- 
Nakakuki et al., 1994).
Pyrimidine photoproducts have been reported following UVA irradiation of E.Coli, but a 
6-fold greater energy input is required at 365 nm compared to 254 nm in order to achieve 
the same order of magnitude of lesions (Tyrrell, 1973). Pyrimidine dimer formation in 
keratinocytes has also been reported after irradiation with visible light between the 
wavelengths of 400 and 500 nm (Pflaum et al., 1998), these lesions were postulated to 
occur by direct absorption of light, rather than through other intermediates. Peak et al. 
(1987a, b) demonstrated the induction of DNA single strand breaks (SSBs) in human 
cells in vitro by UVA exposure.
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UVA irradiation of cells in a deuterium oxide (D2O) environment enhanced these SSBs. 
It is possible therefore, that singlet oxygen might be a mediator of these breaks as the 
decay of this ROS is slowed down by an order of magnitude compared with H2O. Roza 
and collegues (1985) also observed UVA-induced SSBs after irradiating human 
fibroblasts with UVA. However, it was shown that by adding catalase before irradiation, 
almost all of these breaks were eradicated, indicating that H2O2 is produced, and may be 
responsible for the induction of these lesions. The hydroxyl radical has also been 
implicated in the production of SSBs in isolated Bacillus subtilis DNA after 365 nm 
UVA irradiation (Peak and Peak, 1990), as hydroxyl radical quenchers such as acetate, 
mannitol, formate, and azide were shown to protect against these breaks. Finally, the 
requirement for oxygen in the light-mediated (380-490 nm) induction of DNA-protein 
cross-links (DPCs) was demonstrated in studies by Gantt et al. (1979). Peak et al. (1985) 
subsequently demonstrated that production of these DPCs by radiation at 405 nm could 
either be enhanced or reduced by irradiating in either D2O or hypoxic conditions 
respectively. DPC can result in the interference of chromatin unfolding, DNA repair, 
replication and transcription.
1.3.4 Lipid Peroxidation and UVA-induced Damage to Biological Membranes 
Lipid peroxidation is the oxidative deterioration of polyunsaturated lipids (reviewed by 
Bucala, 1996). Polyunsaturated fatty acids (PUFAs) contain two or more carbon-carbon 
double bonds. The major constituents of biological membranes (organelle and plasma 
membranes) are lipids and proteins, thus during lipid peroxidation it is possible that 
membrane proteins may also get damaged. Cell and organelle membranes tend to be
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(amphipathic) lipid bilayers with proteins inserted within them. The fluidity of a 
membrane is known to be essential for its proper functioning and usually it is determined 
by its unsaturated and PUFA side chains. These side chains lower the melting point of 
the interior of the membrane thus damage to PUFAs can result in a compromise of 
membrane function.
Any species that is sufficiently reactive to abstract a hydrogen atom (H) from a 
methylene (-CH2-) group of an unsaturated or PUFA can cause initiation of lipid 
peroxidation (Fig. 1.2). The more double bonds present in a fatty acid, the more prone 
that fatty acid is to H atom abstraction. The hydroxyl radical (OH*) can readily initiate 
lipid peroxidation and travel into the interiors of membranes producing a carbon radical 
(-C*H-) and H2O. Superoxide on the other hand is insufficiently reactive to abstract H 
atoms from PUFAs. The carbon radical formed by H atom abstraction is stabilised to 
form a conjugated diene and there are different reactions that can proceed. For example, 
if two carbon radicals collide, the side chains of fatty acids can become cross-linked. 
Under aerobic conditions the most likely fate of a carbon radical is it will combine with 
O2 to give a peroxyl radical (LOO*). This reaction is particularly favoured because O2 is 
a hydrophobic molecule that can concentrate in the interior of membranes. However, 
under low oxygen concentrations, alternative pathways may be favoured, such as reaction 
with protein thiols (-SH groups). The next stage of lipid peroxidation is called the 
propagation stage. This is where a peroxyl radical abstracts an H atom from another lipid 
molecule thus producing a lipid hydroperoxide (LOOH) and another carbon radical, thus 
allowing the chain of lipid peroxidation to continue.
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Fig. 1.2. The top part o f this diagram represents a lipid bilayer made up of phospholipids (grey cirlcles with 
black tails). Inserted in this bilayer is cholesterol (white circular structures) which is mostly found in the 
plasma membrane, and in and around the bilayer are proteins (spotted oblong structures). The dark grey 
structure is an a-tocopherol molecule. The schematic below the lipid bilayer picture shows an idealised 
representation of the initiation and propagation of lipid peroxidation of a fatty acid with three double bonds 
(source: Halliwell and Gutteridge, 1999).
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Iron plays a detrimental role in the process of lipid peroxidation. Not only can Fe 
catalyse the formation of the hydroxyl radical, it can also catalyse the decomposition of 
lipid hydroperoxides (LOOH) to produce the alkoxyl radical (LO#). Alkoxyl radicals are 
capable of abstracting H atoms from PUFAs and lipid hydroperoxides producing carbon 
radicals and peroxyl radicals, which can continue to propagate lipid peroxidation. 
Alternatively, Fe3+ can decompose peroxides to peroxyl radicals, which also can continue 
the propagation of lipid peroxidation. There are quite a number of iron chelates that can 
stimulate lipid peroxidation, some of which include simple chelates (e.g. Fe -ADP) and 
haemproteins (e.g. cytochromes) (Halliwell and Gutteridge 1999).
Singlet oxygen is capable of causing rapid lipid peroxidation, and the production of 
peroxides occurs via the reaction of singlet oxygen directly with carbon-carbon double 
bonds. This is known as an ene reaction. Within the hydrophobic interior of lipid 
membranes the lifetime of singlet oxygen is much greater than if it was in an aqueous 
solution. Production of singlet oxygen by excitation of photosensitisers, such as 
porphyrins, has been shown to induce rapid peroxide formation (reviewed by Girotti,
1990). Singlet oxygen can also be formed during lipid peroxidation e.g. by the reaction 
of two peroxyl radicals to form a cyclic intermediate, which subsequently decomposes to 
give singlet oxygen. This, itself, could form more lipid peroxides. There are a number of 
different peroxide decomposition products including epoxides, aldehydes, ketones and 
hydrocarbons. One of the more common products is malondialdehyde (MDA), which 
can attack proteins and introduce mutagenic lesions in DNA. 4-Hydoxy-2-£ra«5-nonenal 
(4-HNE) is another common product, which can inhibit DNA and protein synthesis. At
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high enough concentrations it can cause membrane blebbing followed by cell lysis (see 
Halliwell and Gutteridge, 1999, and references cited therein).
UVA has been shown to induce lipid peroxidation in a number of studies (reviewed by 
Tyrrell, 1994). UVA (365 nm) radiation was shown to lyse the membranes of isolated rat 
liver lysosomes, this was measured by protein release from these organelles (Desai, 
1964). Using an enzymatic assay with yeast, cell membrane damage was shown to occur 
after UVA irradiation (Ito and Ito, 1983). More recently, lipid peroxidation and 
membrane damage has been shown to occur in a number of cultured human cell lines 
such as fibroblasts and keratinocytes after UVA treatment (Morliere et al., 1991; Moysan 
et al., 1993; Gaboriau et al., 1993; Vile and Tyrrell, 1995; Applegate et al., 1995). Lipid 
peroxidation was determined from the level of thiobarbituric acid-reactive species 
(TBARS) and membrane damage was evaluated using the lactate dehydrogenase (LDH) 
leakage assay. In one of the studies (Gabroriau et al., 1993), fluorescence anisotropy of a 
membrane-bound probe demonstrated reductions in cell membrane fluidity as a function 
of UVA irradiation.
1.3.5 UVA Radiation and Oxidative Protein Damage
Oxidative damage to proteins can occur directly by ROS or indirectly by end products of 
lipid peroxidation such as MDA and HNE. Hydrogen peroxide and superoxide, at 
physiological levels, tend to have little or no direct affect on proteins. The hydroxyl 
radical and singlet oxygen, on the other hand, can generate a wide range of end-products 
upon attack of proteins, some examples of which are briefly discussed below (Halliwell
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and Gutteridge, 1999). Thiol groups of cysteine and methionine are easily oxidised by 
many ROS to form either thiyl radicals or disulphides. Methionine is readily oxidised to 
methionine sulphoxide. Oxidation of histidine can often cause inactivation of enzyme 
active sites, which appears to be important in protein cross-linking as well as ‘marking’ 
proteins for proteolysis. Tryptophan residues are powerful singlet oxygen scavengers and 
are sensitive to hydroxyl radical attack forming fluorescent products such as N- 
formylkynurenine. Tyrosine residues in proteins can be attacked by the hydroxyl radical 
to form dihydroxyphenylalanine (DOPA), this forms a part of melanin synthesis. 
Tyrosine radicals can end up crosslinking with one another to form bityrosine, which 
conceivably could inhibit signal transduction by blocking tyrosine phosphorylation. It is 
well known that damaged proteins become ‘marked’ for proteolytic degradation and the 
destruction of these unwanted proteins, in eukaryotes, mostly occurs in proteosomes 
which are multicatalytic protease complexes (some proteins are also degraded in 
lysosomes).
Relatively little attention has been paid to protein damage caused by UVA irradiation. 
This may be because proteins are readily re-cycled through degradation and synthesis. 
However, just from irradiating cultured cells with UVA and measuring protein content by 
the Bradford procedure (1976), it is clear that there is significant protein degradation 
occurring in a dose-dependent manner (R.D. Watkin, unpublished observation). There 
have been studies showing that UVA radiation is capable of inactivating certain enzymes, 
including catalase, pepsin, amylase and tyrosinase, in an oxygen dependent manner 
(reviewed by Tyrrell, 1991). Haem-containing antioxidant enzymes, such as catalase and
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peroxidases, are UVA absorbing chromophores (the absorption maximum of catalase is 
in the UVA range). Catalase was shown to be directly destroyed by solar simulated 
radiation in human fibroblasts (Shindo et al., 1994). Kramer and Ames (1987) showed 
that catalase is rapidly inactivated by UVA radiation in Salmonella typhimurium. They 
also showed that certain strains of this bacterium, which constitutively overexpress 
certain proteins such as catalase and alkyl hydroperoxide reductase (a flavin-containing 
protein that is a bifunctional catalase-peroxidase), are significantly more sensitive to 
UVA-induced cell killing compared to the wild type. In addition, an Escherichia coli 
strain that overexpresses catalase, by virtue of a kat G plasmid, is considerably more 
sensitive to UVA killing than the strain not carrying the plasmid, despite being more 
resistant to H2O2 (Eisenstark and Perrot, 1987). These studies suggest that catalase (and 
other UVA absorbing enzymes) may not only be inactivated by UVA radiation, but might 
also act as endogenous photosensitisers (reviewed by Tyrrell, 1991). More recently it 
was shown that UVA caused a dose-dependent oxidation of sulphydryl groups of bovine 
serum albumin and human y-globulin in vitro, and of proteins in primary human 
fibroblasts (Vile and Tyrrell, 1995). The in vitro studies showed that the UVA-mediated 
protein oxidation was iron-dependent and involved singlet oxygen and hydrogen 




1.3.6 Patholgical Consequences of UVA Radiation (320-380 nm)
Until recently (the past 15 years), very little attention was paid to the harmful affects of 
UVA radiation (320-380 nm), which is very abundant in natural sunlight. In fact, UVA 
was considered to be innocuous and of little or no concern to dermatologists, because of 
its relative inability to cause noticeable effects such as erythema. In 1974, the 
development of a treatment that used psoralens plus UVA (PUVA) for the 
photochemotherapy of psoriasis and other skin diseases led to an increased interest in 
UVA radiation. The availability of high intensity UVA-emitting systems for use in 
PUVA treatment contributed to growth of the tanning industry. The industry blossomed 
throughout the Western world from the mid-1970s and early 80s, and it became 
increasingly evident that through recreational and cosmetic purposes, people were 
exposing themselves to much greater amounts of UVA radiation, without realising its 
potentially acute and chronic harmful effects. In the past 15 years, the understanding of 
the effects of UVA has increased rapidly, and it now evident that UVA is not safe and 
can produce many of the harmful effects that are produced by UVB. Ironically, UVA 
exposure has increased with the use of sunscreens. This is because some sunscreens are 
designed to reduce erythema (sunburn) essentially blocking out UVB, but not UVA to 
allow melanogenesis (tanning) to occur. People spend longer times in the sun because 
the discomfort of sunburn is no longer there as a deterrent. Additionally, most UVA 
sunscreens have complications making them unsuitable. This is because they are either 




The amount of solar UVA radiation that reaches the earth’s surface is significantly 
greater than that of UVB throughout the year. This is because, unlike UVB, UVA is not 
filtered or attenuated by stratospheric ozone, and is less affected by the solar zenith angle 
and seasonal variation. Of the total solar irradiance at sea level, approximately 5-7% is 
UV and greater than 90% of this is UVA (Pathak, 1997). Transmission of UVA into the 
dermis is much greater than UVB because it is absorbed less by biological 
macromolecules in the epidermis. UVA radiation can penetrate deep in to the skin to a 
depth of 160-250 pm, compared to UVB radiation that can only penetrate to a depth of 
17-49 pm (Pathak, 1997). In untanned, fair-skined people, approximately 50% of UVA 
rays reach the dermis. In pigmented people (people with darker skin), the amount of 
UVA rays that reach the dermis is less, but is still a significant amount (approximately 
30-35%). Physiologically, this means that UVB can induce structural and functional 
changes only as deep as the superficial papillary dermis, whereas UVA can exert its 
effects throughout the skin, deep into the reticular dermis. Therefore epidermal 
keratinocytes, melanocytes and Langerhans cells are affected by UVA, along with dermal 
components such as fibroblasts, structural fibres (collagen and elastin), lymph and blood 
vessels (and cells within them) and nerves (Kumakiri et al., 1977; Beitner, 1986; Lavker 
et al., 1995).
Some of the harmful, damaging effects observed after UVA exposure are similar to those 
observed after UVB exposure. UVA has been found to be photocarinogenic. In 
experiments using hairless mice, UVA radiation was shown to induce non-melanoma 
skin tumours (Sterenborg et al., 1990; Kelfkens et al., 1992; Bech-Thomsen and Wulf,
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1995; de Laat et al., 1997). It was hypothesised recently (Moan et al., 1999) that UVA 
may be also be responsible for melanoma induction in humans as it has been shown in the 
Xiphophorus fish (Setlow and Woodhead, 1994). There are lines of evidence that 
suggest that UVA radiation can be either immunosuppressive or immunoprotective 
(depending on irradiation conditions). In mice irradiated with chronic low-dose UVA, 
Bestak and Halliday (1996) showed that local suppression of contact hypersensitivity 
CHS, Langerhans cell depletion and T suppressor cell activation occurred. It has also 
been demonstrated, however, that UVA can be photoprotective at physiologically 
relevant doses. In experiments with mice, it was shown that UVA abrogated the 
immunosuppressive effects of UVB and UCA (Reeve and Tyrrell, 1999).
UVA radiation has been strongly implicated as a cause of photoaging. In a study by 
Kligman and collegues (1985), hairless mice irradiated with UVA over a 34-week period 
developed a significant degree of elastosis. Although the deposition of elastic fibres was 
less dense than that produced by UVB, the elastosis not surprisingly extended much 
deeper into the dermis. UVA irradiation with a light source that only emitted 
wavelengths between 340 and 380 nm (UVA I) failed to cause significant elastosis, even 
after huge doses. This suggests that it is the wavelengths of 320-340nm (UVA II) that 
are mainly responsible for this UVA-induced photodamage. In experiments with human 
models, irradiation of skin with UVA resulted in a decrease in elastic tissue whereas solar 
simulated UV (UVA and UVB) produced a slight increase (Lowe et al., 1995). In a study 
using hairless mice, Menter and colleagues (1996) showed that narrow-band UVA (320- 
355 nm) caused marked dermal collagen damage (but only moderate elastosis) and
23
Chapter 1: Introduction
broadband UVA has been found to stimulate collagenase synthesis in human dermal 
fibroblasts (Petersen et al., 1992).
1.4 Defence Against UVA-induced Oxidative Stress
There are a number of different ways a cell is protected against oxidative stress. These 
include, antioxidant molecules, antioxidant enzymes, metal sequestering proteins and 
inducible responses such as haem oxygenase induction. In this section, some of the 
important components of cutaneous antioxidant defence will be briefly discussed.
1.4.1 Antioxidant Molecules
Glutathione (GSH), is an endogenous tripeptide that is the most abundant thiol found in 
most tissues. It plays an extremely important role in the cellular defence against 
oxidative damage and GSH depletion by D, L-buthionine-(S, 7?)-sulfoximine (BSO) 
treatment strongly sensitises cells to the lethal action of UVA and UVB radiations 
(Tyrrell and Pidoux, 1986). GSH is a powerful free radical scavenger and quenches 
radicals by hydrogen atom donation resulting in the formation of GSH disulphide (GSSG 
or oxidised glutathione), and is regenerated by glutathione reductase with NADPH acting 
as a hydrogen donor. GSH also functions as a hydrogen donor for several other 
antioxidants such as ascorbate, which in turn regenerates a-tocopherol (Shindo et al., 
1994). GSH has also been shown to protect calf thymus DNA and Chinese hamster ovary 
cells (CHO) against 8-OHdG formation after UVA exposure (Fischer-Neilsen et al., 
1992; Fischer-Neilsen et al., 1993).
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a-Tocopherol (vitamin E) is a lipophilic endogenous antioxidant that provides protection 
against UV-induced oxidative membrane damage. a-Tocopherol functions as a chain 
breaking antioxidant, is a scavenger of lipid peroxide radicals (see Halliwell and 
Gutteridge, 1999), and has been shown to protect against UVA-induced lipid 
peroxidation in cultured human fibroblasts (Morliere et al., 1990; Gaboriau et al., 1993) 
and keratinocytes (Djavaheri-Mergny et al., 1996). a-Tocopherol has also been shown to 
be a physical quencher and chemical scavenger of singlet oxygen, with the irreversible 
oxidation of a-tocopherol to its a-tocopheryl quinone (reviewed by Fryer, 1993).
Ascorbate (vitamin C) has been shown to protect against 8-OHdG formation in either, 
CHO cells after UVA irradiation (Fischer-Neilsen et al., 1992), or mouse keratinocytes 
after UVB irradiation (Stewart et al., 1996). The mechanism of ascorbate protection is 
thought to be two-fold. Either ascorbate directly quenches or reacts with singlet oxygen, 
hydroxyl radicals and superoxide anions (Njus and Kelley, 1991; Darr et al., 1992) or it 
restores the antioxidant properties of oxidised a-tocopherol by regenerating tocopheroxyl 
radicals (Leung et al., 1981; Njus and Kelley, 1991).
/2-carotene is a precursor for vitamin A and is a member of the carotenoid family of 
antioxidants. It is capable of quenching excited triplet states and singlet oxygen, and 
scavenging peroxide radicals (Krinsky et al., 1982). There are contrasting views on the 
effectiveness of /2-carotene as a photoprotectant. It would appear from most of the 
studies to date, that /2-carotene itself is limited in its protective effects, unless in the 
presence of other antioxidants (reviewed by Edge, 1998). In the presence of antioxidants
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(such as a-tocopherol, ascorbate and GSH), /^-carotene appears to reduce the induction of 
cancer development as determined by in vitro and in vivo studies (reviewed by Toma et 
al., 1995). There are many other antioxidants that have been shown to be 
photoprotective, including the endogenous molecule ubiquinol (coenzyme Q) and certain 
exogenous flavenoids, these however are not discussed here.
1.4.2 Antioxidant Defence Enzymes
In addition to antioxidants, the cell is also protected from oxidative stress by enzymatic 
antioxidants, some of which are briefly discussed. Glutathione peroxidase (GPX) is a 
selenium dependent enzyme that is active against H2O2 and lipid hydroperoxides by 
coupling the reduction of these compounds with the oxidation of reduced glutathione 
(GSH), forming water and an alcohol respectively. GPX is dependent on the presence of 
selenium in each of the four subunits of the enzyme a sufficient supply of GSH, which is 
the unique hydrogen donor for this enzyme. Selenium deficiency was found to cause a 
decrease in GPX activity and increased lipid peroxidation in cultured human fibroblasts 
after UVA exposure (Moysan et al., 1995). In human skin fibroblasts, Leccia and 
colleagues (1993) showed that incubation with selenium increased GPX and decreased 
UVA-induced lipid peroxidation. As mentioned above, glutathione reductase reduces 
oxidised glutathione (GSSG) back to GSH using NADPH, thus recycling GSH that is 
oxidised by GPX activity.
Catalase is another enzyme that scavenges H2O2 in the skin, but unlike other peroxidases, 
catalase catalyses the direct decomposition of H2O2 to ground state oxygen and water,
26
Chapter 1: Introduction
without the use of another substrate. As discussed previously in this chapter, catalase 
activity is strongly reduced after UVA exposure, probably due to oxidative damage to the 
enzyme. Compared to GPX, catalase is thought to be less important as an antioxidant 
enzyme because fibroblasts deficient in catalase activity did not show decreased survival 
after a single dose of solar simulated UV (Shindo et al., 1994). However, catalase was 
found to reduce damage to other antioxidant enzymes (GPX and superoxide dismutase) 
and thus maintain their activity during chronic UV exposure (Shindo et al., 1994).
Superoxide dismutases (SODs) all essentially catalyse the same reaction, which is the 
reduction of superoxide anion to less reactive H2O2 . In the skin, the enzyme is present in 
forms such as Cu-Zn-SOD and Mn-SOD. SOD activity has been found to be reduced by 
solar simulated UV irradiation in human skin fibroblasts (Shindo et al., 1994) and by 
UVA irradiation in human keratinocytes (Punnonen et al., 1991). However, inactivation 
of this enzyme is thought to occur indirectly by ROS rather then directly as was found 
with catalase (Shindo et al., 1994). Zinc addition (one of the metals in the active site of 
Cu-Zn-SOD) to cultured human fibroblasts resulted in a reduction in lipid peroxidation 
and an increase in survival, yet no increasee in Zn-SOD activity was observed (Leccia et 
al., 1993). Similarly, Parat and colleagues (1995) found that addition of manganese (the 
metal in the active site of Mn-SOD) to cultured human fibroblasts protected these cells 
from oxidative injury by UVA irradiation; but this was not accompanied by an increase in 
Mn-SOD activity. In contrast to this however, it has recently been shown that cultured 
fibroblasts repetitively exposed to UVA radiation (200 kJ/m2 per day for three days) 
actually developed an adaptive response, marked by an increase in Mn-SOD mRNA
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levels and Mn-SOD activity after the third exposure (Poswig et al., 1999). Since the 
product of SOD activity is H2O2 (which is toxic), increases in SOD activity are ideally 
accompanied an increases in catalase and/or GPX (Amstad et al., 1991; Yohn et al.,
1991). However, if SOD activity exceeds that of H2 O2 scavengers, it has been shown that 
the toxicity of superoxide increases due to an accumulation of H2O2 formed by SOD 
activity (Amstad et al., 1991).
Haem oxygenase, the principal mammalian enzyme responsible for haem catabolism, is 
an enzyme that can either be inducible (HO-1) or constitutive (HO-2). The enzyme is 
involved in the breakdown of haem to biliverdin, which is then converted to bilirubin by 
biliverdin reductase, both of which are antioxidants (Stocker et al., 1987). UVA 
irradiation (and treatment with other agents that induce oxidative stress such as H2O2 or 
sodium arsenite) of cultured human fibroblasts and keratinocytes leads to induction of 
HO-1 activity (Keyes and Tyrrell, 1987,1989; Appelgate et al., 1991) suggesting that HO 
has some role in the protection of cells. Under conditions where the levels of cellular 
antioxidant systems are inadequate to cope with oxidative stress the levels of HO-1 are 
induced. For example, the depletion of GSH levels correlated with an increase in both 
the constitutive and oxidant-inducible accumulation of HO mRNA levels (Lautier et al.,
1992). The induction of HO-1 activity by UVA irradiation was linked to the induction of 
the iron storage protein ferritin (Vile and Tyrrell, 1993). Addition of the HO inhibitor 
tin-protoporphyrin IX prior to UVA irradiation prevented an increase in ferritin levels 
suggesting a HO-dependent mechanism. More recently, Kvam et al. (1999) showed that 
UVA irradiation resulted in the release of ‘free’ haem intracellularly and Pourzand et al.
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(1999) also showed that the levels of ‘free’ iron also increased immediately after UVA 
irradiation. The increase in free haem would explain HO-1 induction, and both free haem 
and free iron would account for an increase in ferritin to sequester potentially toxic ‘free’ 
iron in a relatively inert form, thus preventing the formation of the highly toxic hydroxyl 
radical (see Chapter 5). Sequestration of redox active metals is another line of 
antioxidant defence and other proteins that can bind potentially oxidant metals, such as 
transferrin and metallothioneins may also be considered to have antioxidant properties. 
After chronic UV exposure, the level of non-haem iron of skin has been found to be 
elevated (Bissert et al., 1991), an increase in ferritin might help reduce the potential 
toxicity of this iron increase. Ferris et al. (1999) showed that in murine cells either 
overexpressing HO-1 or that were HO-1 deficient, HO-1 activity regulated iron 
accumulation and efflux. In experiments where 55Fe was added to cells overexpressing 
HO-1 activity, iron uptake was reduced and iron efflux was increased compared to 




1.5 Objectives o f this Project
The objectives of each individual study are presented at the end of each chapter 
introduction (Chapters 2-5) so they will not be discussed in detail here. The overall aims 
and scope of this project are twofold. Firstly, to investigate the importance of 
protoporphyrin IX as an endogenous chromophore in the UVA-mediated inactivation of 
human cells. Identification of UVA absorbing chromphores that account for the radiation 
wavelength dependence of deleterious effects in the skin remains elusive. Several have 
been postulated, including porphyrins, flavins and quinones, though none have been 
proven to be the chromophore that is responsible for UVA-mediated damage.
It was recently demonstrated in our laboratories that exposure of cultured human 
fibroblasts to UVA radiation resulted in an increase in intracellular ‘free’ iron levels 
(Pourzand et al., 1999). In light of this, the second part of this project concentrated on 
gaining a better understanding into the changes in iron levels as a result of UVA 
irradiation, and to further investigate the source of iron release. Included in the iron 
studies was also the investigation into what effect UVA irradiation of cells with altered 
PPIX levels had on changes in intracellular ‘free’ iron. The purpose of this was to 
determine if PPIX was effective in promoting iron release in UVA irradiated cells.
Overall, the intention of this project was to enhance the current understanding and 
knowledge of the effects of UVA radiation. By achieving this, it is hoped that some 
contribution may be made, at least in the long term, to the prevention of the pathological 
consequences of UVA radiation such as photocarcinogenesis and photo-induced ageing.
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2. Study of the relationship between endogenous protoporphyrin IX 
concentration in human cells and inactivation by UVA radiation
2.1 Introduction
2.1.1. PPIX Biosynthesis and Cellular Distribution
Protoporphyrin IX (PPIX) is the immediate precursor of haem in the haem 
biosynthetic pathway (Fig. 2.1). In the first, and rate limiting, step of this pathway, 6- 
aminolevulinic acid (ALA) is formed from glycine and succinyl CoA by the pyridoxyl 
phosphate-requiring enzyme ALA synthase (ALAS). The last step in the formation of 
haem is the incorporation of iron into PPIX and it takes place in the mitochondria 
under the action of the enzyme, ferrochelatase. Administration of exogenous ALA 
effectively bypasses the rate limiting ALA synthesis step in this pathway in 
mammalian cells leading to the accumulation of the endogenous chromophore PPEX. 
PPEX also accumulates because of the limited capacity of ferrochelatase. The 
intracellular distribution (Peng et al., 1997 and references cited therein) of PPIX after 
ALA stimulation tends to follow a general pattern as a function of time, with an initial 
localisation in the mitochondria where it is formed. PPIX gradually migrates to other 
subcellular compartments and their membranes (including the perinulcear region, 
endoplasmic reticulum, and lysosomes) over time, eventually localising in the plasma 
membrane. There are a variety of factors that determine and affect the affinity of 
porphyrins for biological membranes and intracellular compartments. These factors 
include the hydrophobicity of the molecule, charge and aggregation state, pH, and the 
physicochemical properties of the microenvironment the porphyrin is in (Riccheli, 
1995, and references cited therein).
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Fig. 2.1. The haem biosynthetic pathway. The synthesis occurs partly in the mitochondria (as indicated 
on the left side of the figure) and partly in the cytoplasm. B6, pyridoxyl-5’-phosphate; ALA, a- 
aminolevulinic acid; PGB, porphobilinogen; URO’GEN, uroporphyrinogen; COPRO’GEN, 
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2.1.2 Intracellular Effects o f UVA Irradiation
UVA radiation (320-380nm) generates reactive oxygen species (ROS) by 
photochemical reactions which cause lipid peroxidation, DNA damage, protein 
oxidation and inactivation of enzymes, and cell death (Tyrrell, 1991 and references 
cited therein; Vile et al., 1995). UVA is also known to induce several genes in a 
variety of different cell types (reviewed by Tyrrell, 1994, 1996), in particular, the 
major stress protein HO-1 in human skin fibroblasts (Keyse and Tyrrell, 1987).
2.1.3 Intracellular Effects o f ALA-PDT
ALA based photodynamic therapy (ALA-PDT) is a clinical cancer treatment that is 
based on the administration of ALA to tumour tissues in order to generate 
photosensitising concentrations of PPIX. Activation of PPIX by light of an 
appropriate wavelength induces a photochemical reaction that is intended to destroy 
tumour cells and tissues (Kennedy and Pottier, 1992). It is generally accepted that the 
main activated oxygen species produced during PPIX photosensitisation is *02, 
though other ROS may also be involved (He et al., 1995). Singlet oxygen has only a 
limited range of action 0.01-0.02 pm because of a short lifetime of 0.01-0.04 ps 
(Moan and Berg, 1991), therefore initial sites of damage are generally restricted to the 
immediate locality of the photosensitiser that generates it (e.g. PPIX). PPIX is 
produced mitochondrially so it is not unexpected that mitochondria have been shown 
to be damaged after ALA-PDT. Some forms of damage that have been documented 
include swelling of the mitochondria (Iinuma et al, 1996); morphological alterations, 
decreases in cellular ATP levels, and disruption to various mitochondrial enzymes and 
functions (Salet and Moreno, 1990); inactivation of mitochondrial ferrochelatase (He 
et al., 1995); and reduced oxygen consumption (Shevchuk et al., 1996). Owing to
33
Chapter 2: Study o f the relationship between endogenous protoporphyrin IX concentration in human
cells and inactivation by UVA radiation
PPIX localisation, ALA-PDT has been shown to damage other cellular compartments. 
Uberriegler and colleagues (1995) described endoplasmic reticulum decomposition, 
production of large cytoplasmic vacuoles, and the nucleus breaking down into several, 
partially compartmentalised smaller masses. Damage to lysosomes and release of 
acidic hydrolases induced by exogenous addition of PPIX and subsequent 
photosensitisation has been documented in mouse fibroblasts along with lipofuscin 
formation (Morliere et al., 1987). Gaullier et al. (1995) showed lysosomal damage, 
lipofuscin formation, and membrane blebbing in keratinocytes and fibroblasts that had 
been treated with ALA followed by exposure to targeted light. It was recently 
demonstrated that increasing the intracellular PPIX content of human skin fibroblasts 
by incubation with ALA significantly lowers the threshold for induction of HO-1 gene 
activation by UVA radiation (Ryter and Tyrrell, 1998). Neutrophils exposed to PPIX 
and UVA irradiation have exhibited inactivation of various soluble cytosolic enzymes 
and also exhibited leakage of potassium ions (K) and lactate dehydrogenase as a result 
of plasma membrane damage (Sandberg et al., 1981). Ionic alterations involving K 
leakage accompanied by Na, Cl, and Ca influx have also been observed in melanoma 
cells (Schoenfeld et al., 1995). Finally ALA-PDT has been also observed to cause 
cell inactivation by both apoptosis and necrosis and the type of death process depends 
on cell type (Noodt et al., 1996; Webber et al., 1996).
2.1.4 UVA Absorbing Chromophores and the Objectives o f this Study 
Identification of UVA absorbing chromophores that account for the radiation 
wavelength dependence of deleterious effects in the skin remains elusive. Riboflavin 
has been implicated as a critical chromophore by Sato and coworkers (1995; Minami 
et al., 1999). They have shown that addition of riboflavin (vitamin B2) to normal
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human fibroblasts significantly increases their sensitivity to UVA and the cytotoxic 
action of riboflavin is exerted primarily through the generation of H2O2 upon and after 
UVA irradiation. It is noteworthy however, that the concentration of riboflavin used 
in these studies was 100 pg/ml which is considerably higher than the level of 0.2 
jug/ml which they document has been measured in normal human whole blood (Sato 
et al., 1995). The same group has also investigated UVA-induced pyridoxine 
(vitamin Be) photosensitisation (Sato et al., 1993). This study showed that whilst a 
high concentration was used (100 pg/ml), the addition of pyridoxine also markedly 
enhanced the photosensitivity of normal human fibroblasts to UVA radiation. The 
mode of cytotoxicy of pyridoxine was reported to occur through photoproducts of this 
compound rather than through an intermediate such as H2O2 .
In our study we have tested the hypothesis that PPEX may be a critical chromophore 
in the UVA inactivation of the human lymphoblastoid cell line, TK6 and the primary 
human fibroblast, FEK4. To achieve this objective it was necessary to determine the 
rate of cell inactivation by UVA as a function of intracellular PPEX concentration. 
PPEX was extracted by a method of acid extraction (Schoenfeld et al., 1995) and the 
concentration determined by spectrofluorimetry. Inactivation of TK6 cells was 
measured by assaying for clone forming ability 14 days post-irradiation (Tyrrell et al., 
1984). Inactivation of FEK4 cells was measured by microscopically counting 
surviving populations 24 h post-irradiation (see methods), described by Gibson et al. 
(1997).
35
Chapter 2: Study o f the relationship between endogenous protoporphyrin IX concentration in human
cells and inactivation by UVA radiation
The rate of inactivation was derived from the slope of the dose response curve. Since 
cell inactivation was close to exponential it can be expressed by the mathematical 
relationship:
N/N0 = e w
Where N/No is the surviving fraction after dose D, and k is the slope of the curve. The 
k value in this study is referred to as the inactivation rate constant.
2.1.5 The MTS Assay
The MTS (3-(4, 5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4- 
sulphophenyl)-2H-tetrazolium, inner salt) assay was investigated as a possible method 
for determining ALA-induced phototoxicity. This particular method is more 
advanced, but effectively based on the same principle as the MTT assay, an assay that 
has and is being widely used to investigate the number of viable cells in proliferation 
or cytotoxicity assays. Mosman (1983) initially developed the MTT assay, based on 
the reduction of the tetrazolium salt, MTT (3-(4,5-dimethylthiazol-2-yl)-2,5- 
diphenyltetrazolium bromide) by actively growing cells to produce a blue formazan 
product. Despite its acceptance, the actual biochemical mechanisms or subcellular 
localisation of MTT reduction were actually unknown. For a period it was accepted 
that the cellular reduction of the MTT occurred in the mitochondria, the inner 
membrane mitochondrial enzyme succinate dehydrogenase being mostly responsible. 
In contrast to this, data produced more recently (Berridge and Tan, 1993) suggested 
most cellular MTT reduction occurred outside the inner mitochondrial membrane and 
involved pyridine nucleotide cofactors NADH and NADPH-dependent mechanisms,
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possibly occurring in microsomes and on the outer mitochondrial membrane. The 
MTS assay works on a similar principle to that of the MTT assay, but is more 
advanced. The MTS tetrazolium compound, when used with an electron transfer 
reagent such as phenazine methosulphate (PMS), has the advantage of producing a 
soluble coloured formazan compound when bioreduced by viable cells (Fig. 2.2). The 
corresponding MTT formazan product, on the other hand, is insoluble and requires an 
additional solubilisation step, which can be particularly inconvenient when using 
suspension cell lines. The solubilisation step involves removing the original reagent, 
washing the cells, then adding an organic solvent such as dimethyl sulphoxide to 
solubilise the insoluble MTT formazan crystals, before adding the solution to a 96- 
well plate for reading. The convenience of using the MTS reagent is that the cells and 
the reagents are placed in a 96-well plate and can be recorded directly on a plate 
reader after a specified period. Fig 2.2 shows the schematic of the metabolism of 
MTS to its chracteristic coloured formazan product.
Fig. 2.2. Reduction of MTS to its formazan product by metabolically active cells. Dehydrogenase 
enzymes are thought to generate reducing equivalents such as NADH and NADPH which can transfer 
their electrons to the electron transfer reagent (ETR) phenazine methosulphate (PMS). The reduced 
PMS, in turn can directly interact with and reduce the MTS tetrazolium compound producing the 
coloured formazan product detectable at 490 nm (source: Promega technical bulletin #TB169, 1996).







Chapter 2: Study o f the relationship between endogenous protoporphyrin EX concentration in human
cells and inactivation by UVA radiation
After testing the MTS method for suitability as a phototoxicity assay in response to 
UVA radiation, we became concerned that this type of assay might not be suitable for 
ALA-induced photosensitisation studies. This was because of a chemical reaction 
that occurs between ALA and MTT resulting in a characteristic blue formazan 
product (Campbell et al., 1996). In our study, we test for a similar reaction between 
ALA and MTS to determine if this assay is suitable for evaluating ALA-induced 
phototoxicity.
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2.2 Methods
2.2.1 Chemicals
All chemicals were from Sigma Chemical Co. (UK) unless stated otherwise. Cell 
culture materials were from Gibco (UK), except foetal calf serum (FCS) which was 
from PAA Laboratories (Australia) and isotonic phosphate-buffered saline (PBS) 
which was from Oxoid (UK).
2.2.2 Cell Culture
The human lymphoblastoid cell line TK6 (Thilly, 1979) was cultured in RPMI 1640 
supplemented with 10% FCS, L-glutamine, sodium bicarbonate, penicillin and 
streptomycin. Under these conditions the cells doubled approximately every 18-20h. 
Cultures were grown at 37°C in a 5% CO2 incubator and were maintained in 
exponential growth phase by diluting to 2 x 105 cells/ml every 1 or 2 days. For all 
experiments, TK6 cells were diluted to 2 x 105 cells/ml and grown for 24h. The 
primary human skin fibroblast cell line FEK4 (Tyrrell and Pidoux, 1986) was cultured 
in Earle’s modified minimal essential medium (EMEM) supplemented with 15% 
FCS, L-glutamine, sodium bicarbonate, penicillin and streptomycin. Cells were 
passaged by trypsinisation once a week and were used for experiments between 
passages 9 and 15. For all experiments, FEK4 cells were seeded into plastic culture 
dishes and grown for 3 days to approximately 80% confluency.
2.2.3 Induction o f PPIX Synthesis
PPIX levels in TK6 and FEK4 cells were modulated by addition of ALA to the 
culture media in concentrations up to 400 pM and 200 pM respectively, for 4 and 18 
hours in the dark. Subsequent handling of cells was performed under low light.
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2.2.4 Extraction o f Porphyrins
After ALA incubation, porphyrins were extracted according to the method described 
by Schoenfeld et al. (1994) as follows: Approximately 1 x 107 cells were collected 
and centrifuged for 5 min at 1000 rpm. TK6 could be directly spun from their culture 
media, but FEK4 needed to be washed with PBS and trypsinised from the plates 
before being collected. After spinning down, cells were washed with PBS, 
centrifuged again, then re-suspended in 0.75 ml of glacial acetic acid. This 
suspension was briefly sonicated, after which 2.25 ml of ethyl acetate was added. The 
mixture was vortexed, centrifuged at 2500 rpm for 5 min and the supematent 
collected. PPIX was back extracted into 1ml of 1.5M HC1 by vortexing the 
supematent with the HC1 and centrifuging as before. The organic phase (top) was 
aspirated and the acid phase (bottom) containing the porphyrins was retained for 
spectrofluorimetric measurement.
2.2.5 Fluorimetric Determination o f Porphyrin Levels in the Extract
A commercial PPIX standard (Sigma Chemical Co., UK) was prepared for a 
calibration curve, which was measured using a spectrofluorimeter (Kontron SFM25, 
Switzerland). The PPIX (MW 606.6) was initially dissolved in DMSO at a 
concentration of 10 pg/ml and subsequently serially diluted in 1.5 M HC1 for 
calibration standards. Fluorescence of the extracts was measured at an excitation of 
404 nm and emission of 604 nm (maxima were determined by doing a wavelength 
scan of the excitation and emission spectra of the commercial PPIX standard, Fig. 
2.5). PPEX concentration of the extracts was determined in relation to the 
fluorescence of the PPIX standard.
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2.2.6 UVA Source and Irradiation Conditions fo r  TK6 and FEK4 Cells 
Irradiation was performed at a temperature between 20 and 24°C using a broad 
spectrum Sellas 4 kW UVA lamp (Germany), the spectral output of this lamp is 
shown in Fig. 2.3. The UVA dose rate was measured using an ELI700 radiometer 
(International Light, USA). TK6 cell suspensions were irradiated at a density of 5 x 
105 cells/ml in PBS supplemented with 0.01% Ca2+ and Mg2+(Keyse and Tyrrell, 
1989). Cells were irradiated in quartz vessels (Scientific Laboratory Supplies Ltd, 
England) that were agitated using a mixing platform (IKA Laboratechnik,Germany). 
Sham- irradiated cells were treated in the same manner. 80% confluent FEK4 cells 
were irradiated in the dishes they were cultured in. Prior to irradiation, media was 
removed and cells were washed with isotonic phosphate-buffered saline (PBS). Cells 
were then covered in PBS supplemented with 0.01% Ca2+ and Mg2+ and irradiated. 
Sham-irradiated cells were treated in the same manner.
Fig. 2.3. UVA lamp profile. The spectral output of the UVA Sellas lamp is divided in to two parts, 
200-400 nm (below) and 400-700 nm (p. 42). Note the relative emission intensity (y-axis) is in much 
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Fig. 2.3. continued.
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2.2.7 Determination o f Phototoxicity in TK6 Cells as a Result o f UVA Irradiation as 
Determined by the CellTiter 96® AQueous One Solution Cell Proliferation Assay 
The CellTiter 96® AQueous One Solution Cell Proliferation Assay (Promega, UK) 
was optimised for TK6 cells (data not shown) so that phototoxic effects of UVA could 
be investigated (the principle of this assay is described in section 2.1.5). A solution 
was made up in Milli-Q water (Millipore, UK) containing MTS tetrazolium 
compound at a concentration of 133 pg/ml and 25 pM phenazine methosulphate 
(PMS). The MTS/PMS solution was distributed in a 96-well plate (Helena 
Bioscience, UK), 20 pi per well. After irradiation (up to 500 kJ/m2 UVA), the TK6 
cells were collected, centrifuged for 5 min at 1000 rpm, then re-suspended at a density 
of 1 xlO6 cells/ml in serum free medium. 100 pi of this cell suspension was added to 
each well of the 96-well plate containing the MTS/PMS solution. The 96-well plate 
was then incubated for two hours at 37°C to allow formation of the soluble MTS
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formazan product. The reaction was stopped by adding 25 pi of 10% SDS to each 
well. Absorbance was recorded at 490 nm using a microplate reader and corrected 
using a blank (reagents minus cells). There was a linear response between number of 
viable cells and the amount of MTS formazan compound produced at 490 nm (Fig 
2.4). Absorbance of UVA irradiated cells was compared to those of sham-irradiated 
cells and expressed as percentage of viable cells.
Fig. 2.4. The effect o f cell number on absorbance at 490 nm using the CellTiter 96® AQueous One 
Solution Assay. Various numbers of TK6 human lymphoblastoid cells in 100 pi of RPM3 were added 
to wells of a 96-well plate each containing 20 pi o f the MTS/PMS solution (see text). After 2 h at 37°C 
in a humidified 5% C02 atmosphere, the absorbance was recorded at 490 nm using an ELISA plate 
reader. Each point represents the mean ± S.D. of 4 independent experiments. The correlation 
coefficient was 0.99938, indicating that there was a linear response between viable cell number and 
absorbance at 490 nm. The background absorbance for blank and cell number and was corrected for.
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2.2 8 Investigation o f the Interaction Between ALA and M TS
This investigation was performed using the method described in section 2.2.7. 
Instead of measuring absorbance of the MTS formazan produced by cells, absorbance 
of the MTS formazan produced as a result of interaction between the MTS 
tetrazolium salt and ALA was measured, as a function of ALA concentration. Results 
were displayed as fold increase in absorbance over control. The control used v/as 
reagents minus ALA. ALA was prepared in serum free media in concentrations up to 
120 pM.
2.2.9 Determination o f Phototoxicity in TK6 Cells Using the Cloning Assay 
The cloning assay was performed according to Tyrrell et al., (1984). TK6 cell 
suspensions were diluted in fresh complete media to a concentration of 10 cells per ml 
and were distributed in 96-well microtiter plates at a volume of 200 pi per well (i.e. 2 
cells/well). Cells were incubated at 37°C in a humidified 5% CO2 atmosphere and 
after a minimum of 14 days, colonies were scored microscopically. The original 
cloning efficiency was calculated assuming poisson distribution of the clone forming 
units over the wells using the formula:
Cloning efficiency = -lnPo/w
Where Pq is the fraction of wells with no clone present and n is the average number of 
cells originally distributed per well. Under our conditions, the cloning efficiency of 
TK6 human lymphoblastoid cells on the plastic microtiter plates was approximately 
70-80%. ALA-treated and UVA-irradiated cells as described above, and surviving 
fractions were calculated with reference to the sham-irradiated controls.
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2.2.10 Determination o f Phototoxicity in FEK4 Cells
Phototoxicity was determined in FEK4 cells according to a method described by 
(Gibson et al., (1997). After irradiation, the buffer was removed and conditioned 
media added to the plates. Cells were incubated for 24 h after which the conditioned 
media was removed and the plates washed with PBS. Cells were trypsinized and re­
suspended in 1 ml of complete media. Cell counts were performed microscopically; 
ALA-treated and UVA-irradiated surviving fractions were determined relative to the 
sham-irradiated levels.
2.2.11 Determination o f the Inactivation Rate Constant, k
The inactivation rate constant was determined as described in section 2.1.4.
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2.3 Results
2.3.1 PPIX Calibration fo r Spectrofluorimetry
The excitation and emission maxima were determined by running the appropriate 
wavelength scans of the commercial PPIX standard (Fig. 2.5a). These maxima were 
then used to measure the fluorescence of the serially diluted PPIX standard in order to 
construct the calibration curve (2.5b). The concentration of PPEX in prepared extracts 
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Fig. 2.5. (a) Excitation and emission spectra of PPIX in HC1. (b) A typical calibration curve of a PPIX 
standard, measured using spectrofluorimetry.
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2.3.2 PPIX Biosynthesis in TK6 Human Lymphoblastoid Cells 
Porphyrin synthesis was stimulated by ALA treatment of the cells at concentrations 
between 100 and 400 pM for 4 and 18 hours (Fig. 2.6). No ALA dark toxicity was 
observed using these conditions (data not shown). PPIX was extracted from the cells 
and measured using spectrofluorimetry. The porphyrin accumulation in these cells 
appeared to be ALA dose dependent. Both incubation periods yielded similar 
quantities of intracellular PPIX with the range of ALA concentrations used. When 
porphyrin synthesis was stimulated (with ALA concentrations ranging from 100 to 
1000 pM) up to 18 hours and PPIX extracted at different times during this period, 
total intracellular PPEX content appeared to reach a maximum at approximately 8 h 
(Fig.2.7). Between 8 and 18 hours, total intracellular content of PPIX decreased due 
to efflux of the molecule from the cell.
48
Chapter 2: Study o f the relationship between endogenous protoporphyrin DC concentration in human
cells and inactivation, by UVA radiation
Fig. 2.6. Biosynthesis o f PPDC by TK6 cells as a function of ALA concentration in the culture 
medium. The graph shows the amount of PPDC in the cells after 4 ( • )  and 18 hours incubation (0) 
with ALA. Data represent the mean of 3-5 independent experiments (± S.D.).
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Fig. 2.7. Biosynthesis o f PPIX by TK6 cells as a function of incubation time and ALA concentration 
in the culture medium. The graph shows the amount of PPEX in the cells over time after incubation 
with either no ALA (T), lOOpM (V), 400pM ( • ) ,  or lOOOfiM (O) ALA. Data represent the mean of 3- 
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2.3.3 PPIX Biosynthesis in FEK4 Primary Human Skin Fibroblasts 
Porphyrin synthesis was stimulated by ALA treatment of the fibroblasts at 
concentrations between 50 and 200 pM for 4 and 18 hours (Fig. 2.8). No ALA dark 
toxicity was observed using these conditions (data not shown). The porphyrin 
accumulation in these cells also appeared to be ALA dose dependent. Unlike TK6, 
the 18 h incubation yielded significantly higher intracellular PPIX concentrations 
compared to 4 h with the range of ALA concentrations used. As ALA dose increased, 
the PPIX ratio between the two incubations also increased. Incubation with ALA for 
18 h at a concentration of 50 pM produced a 1.765-fold higher intracellular PPEX 
concentration compared to the 4 h incubation, whereas 200 pM ALA produced a 
4.778-fold higher PPIX level after 18 h than after 4 h.
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Fig. 2.8. Biosynthesis of PPIX by FEK4 cells as a function of ALA concentration in the culture 
medium. The graph shows the amount of PPIX in the cells after 4 ( • )  and 18 hours incubation (O) 
with ALA. Data represent the mean of 3-4 independent experiments (± S.D.).
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2.3.4 M TS - A  Viability Marker to Quantify UVA-induced Phototoxicity 
TK6 cells were irradiated with UVA doses up to 500 kJ/m and then incubated with 
the MTS tetrazolium salt. Production of the soluble coloured MTS formazan product 
(as a result of bioreduction of the tetrazolium salt by viable cells), as measured at 490 
nm, is directly proportional to the number of living cells in culture (Fig.2.4) so this 
assay was employed to evaluate UVA-induced phototoxicity. Fig 2.9 shows the UVA 
dose response observed using this assay.
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Fig. 2.9. Percentage of viable cells at a series of UVA doses as estimated using the MTS assay. 
Following irradiation, 1 x 105 cells (were incubated for 2h at 37°C in (100 pi of) serum free media 
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2.3.5 M TS Tetrazolium Salt and its Interaction with ALA
It was previously reported (Campbell et al., 1996) that the value of the colourimetric 
MTT (methyl-thiazol-tetrazolium) assay for use in evaluating phototoxicity as a result 
of ALA-induced photosenstisation was limited due to a chemical reaction between 
ALA and MTT resulting in a blue formazan product. The MTS and MTT are very 
similar reagents so the interaction of AL A and MTS was investigated to determine if 
this assay could be used for further phototoxic investigations involving cells treated 
with ALA. Fig. 2.10 shows the fold increases in absorbance over control (at 490 nm) 
as a result of an interaction between MTS and ALA as a function of ALA 
concentration in a cell-free system. From this graph, it is clear that somewhere 
between 7.5 and 15 juM ALA there is a sharp increase in the absorbance measured at 
490 nm.
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Fig. 2.10. Changes in absorbency measured at 490 nm as a result of the interaction between ALA and 
MTS formazan salt after 2h incubation at 37°C. The reaction was performed in a cell-free, serum-free 
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2.3.6 UVA-induced Porphyrin Toxicity in TK6 Human Lymphoblastoid Cells 
Figs. 2.11 and 2.12 display the UVA dose response curves for TK6 cells with various 
intracellular PPIX concentrations. Cells were stimulated with ALA for 4 (Fig. 2.11) 
and 18 hours (Fig.2.12) then exposed to graded doses of UVA. Following irradiation, 
cells were assayed for colony forming ability (see methods). This data clearly shows 
that the degree of UVA-induced toxicity increases as a function of intracellular PPIX 
content in these cells. However, there is no simple correlation between total 
intracellular PPIX concentration and the rate of UVA-induced cell inactivation. The 
relative rates of cell inactivation appears to be more efficient after the 4 h ALA 
incubation than after 18 h (see Fig.2.16).
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Fig. 2.11. UVA dose-dependent inactivation of clone-forming ability of TK6 cells with ALA-induced 
PPDC. Cells were incubated with ALA for 4h followed by UVA irradiation, then assayed for clone- 
forming ability. The legend indicates the intracellular PPDC concentration as a result o f ALA 
treatment. Data represent the mean of 3-4 independent experiments (± S.D.).
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Fig. 2.12. UVA dose-dependent inactivation of clone-forming ability of TK6 cells with ALA-induced 
PPIX. Cells were incubated with ALA for 18h followed by UVA irradiation, then assayed for clone- 
forming ability. The legend indicates the intracellular PPEX concentration as a result o f ALA 
treatment. Data represent the mean of 3-4 independent experiments (± S.D.).
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2.3.7 UVA-induced Porphyrin Toxicity in FEK4 Primary Human Skin Fibroblasts 
Fig. 2.13 shows the dose response of 80% confluent untreated FEK4 cells to UVA 
after doses up to 500 kJ/m . As the graph shows, the highest UVA dose in this study 
resulted in a 50% survival 24 h post-irradiation. Figs. 2.14 (4 h ALA) and 2.15 (18 h 
ALA) display the UVA dose response curves for FEK4 cells with various intracellular 
PPIX concentrations. Cells were stimulated with ALA for 4 and 18 hours then 
exposed to graded doses of UVA. Following irradiation, cell survival was measured 
24 h later (see methods). Similar to TK6, this data shows that the degree of UVA- 
induced toxicity increases as a function of intracellular PPIX content in these cells. 
However, also like the TK6, there is no simple correlation between total intracellular 
PPIX concentration and the rate of UVA-induced cell inactivation (see Fig. 2.17).
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Fig. 2.13. UVA dose-dependent cell killing of FEK4 fibroblasts. Cells were grown to approximately 
80% confluency followed by UVA irradiation; survival was determined after 24 h. Data represent the 







0 100 200 300 400 500
UVA (kJ/m )
61
Chapter 2: Study o f the relationship between endogenous protoporphyrin DC concentration in human
cells and inactivationby UVA radiation
Fig. 2.14. UVA dose-dependent cell killing of FEK4 fibroblasts with ALA-induced PPDC. Cells were 
incubated with ALA for 4h followed by UVA irradiation; survival was determined after 24h. The 
legend indicates the intracellular PPDC concentration as a result o f ALA treatment. Data represent the 
mean of 4 independent experiments (± S.D.).
0.01
0 20 40 60 80 100
UVA dose (kJ/m2)
4.925 pmoles PPIX/107cells 
7.6325 pmoles PPIX/107cells 
19.55 pmoles PPIX/107cells 
28.665 pmoles PPIX/107cells 
43.85pmoles PPIX/107cells
62
Chapter 2: Study o f  the relationship between endogenous protoporphyrin IX concentration in human
cells and inactivation by UVA radiation
Fig. 2.15. UVA dose-dependent cell killing of FEK4 fibroblasts with ALA-induced PPIX. Cells were 
incubated with ALA for 18h followed by UVA irradiation; survival was determined after 24h. The 
legend indicates the intracellular PPIX concentration as a result of ALA treatment. Data represent the 
mean o f 4 independent experiments (± S.D.)
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2.3.8 Inactivation o f TK6 Cell Populations by UVA as a Function o f PPIX  
Concentration
Fig. 2.16 depicts the rate of inactivation of TK6 cell populations plotted as a function 
of intracellular PPIX concentration. This data shows that the rate of inactivation of 
these cells with modulated PPIX levels is generally higher after 4 h ALA incubation 
than it is after 18 h. By examining the relationship between the inactivation rate 
constants at different intracellular PPIX concentrations, an estimate of the basal 
content of PPEX that would be necessary to lead to significant cell death following 
UVA irradiation can be derived by back extrapolating the linear portion of the curve 
to the abscissa. The estimate of the appropriate concentration of PPIX after 4 and 18 
hours ALA incubation was approximately 20 and 40-45 pmoles/107 cells respectively. 
The estimated basal content of PPIX in the TK6 cells varied between 5.5 and 7 
pmoles/107 cells (see discussion).
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Fig. 2.16. Rates o f inactivation of TK6 cells by UVA radiation as a function of intracellular PPIX 
concentration. The graph shows the inactivation rate constants (k) o f cells incubated for 4 ( • )  and 18 
hours (O) with ALA followed by UVA irradiation, verses intracellular PPDC concentration. Data 
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2.3.9 Inactivation o f FEK4 Cell Populations by UVA as a Function o f PPIX  
Concentration
Fig. 2.17 depicts the rate of inactivation of FEK4 cell populations plotted as a 
function of intracellular PPIX concentration. This data shows that the rate of 
inactivation of cells is greater as a function of intracellular PPIX concentration after 4 
h ALA incubation compared with 18 h incubation. Estimation of the basal content of 
PPIX that would be necessary to lead to significant cell death following UVA 
irradiation in FEK4 cells was performed in the same manner as it was for TK6 (see 
section 2.3.8). The estimate after 18 hours ALA incubation was approximately 10-20 
pmoles/107 cells. In contrast to the 18 h incubation (and to the TK6 data), the 
estimate for 4 h ALA incubation was within the linear portion of the curve. The 
measured basal content of PPIX in the FEK4 cells varied between 4.925 and 5.176
•j
pmoles/10 cells (see discussion).
66
Chapter 2: Study o f  the relationship between endogenous protoporphyrin IX concentration in human
cells and inactivatiorLby UVA radiation
Fig. 2.17. Rates of inactivation of FEK4 cells by UVA radiation as a function o f intracellular PPIX 
concentration. The graph shows the inactivation rate constants (&) of cells incubated for 4 ( • )  and 18 
hours (O) with ALA followed by UVA irradiation, verses intracellular PPEX concentration. Data 
represent the mean o f 3-4 independent experiments (± S.D.).
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2.4 Discussion
To determine if PPEX is a crucial chromophore in UVA-mediated inactivation of the 
human lymphoblastoid cell line TK6 and the primary human skin fibroblast cell line 
FEK4, we have studied how the rate of cellular inactivation by UVA radiation varies 
as a function of intracellular PPIX concentration. In TK6, although incubation with 
ALA for 18 h of ALA would be expected to yield higher cellular porphyrin content 
than incubation for 4 h, Fig. 2.6 shows that the two ALA incubation periods result in 
similar intracellular PPIX concentrations. This is probably explained by the efflux of 
PPIX from the cells which occurs through diffusion and is influenced by the level of 
serum protein in the culture medium (Iinuma et al., 1994), in particular albumin 
(Steinbach at al., 1995). With this cell line (under the conditions detailed in the 
methods section, which involves culturing the cells for 24 h in medium containing 
10% FCS, then adding ALA) we have demonstrated that total intracellular PPIX 
reaches a maximum after about 8 h (possibly indicating saturation) and then decreases 
between 8 and 18 hours (Fig. 2.4). This decrease suggests that between 8 and 18 
hours, the rate of porphyrin synthesis in TK6 may be lower than the rate of efflux. It 
was reported that mammalian epithelial cells which were cultured in media containing 
a high serum content (10% FCS), when stimulated with ALA, showed a considerably 
higher release of porphyrins into the medium compared with cells cultured in media 
containing a low serum content (1% FCS) (Fukuda et al., 1993). A similar result was 
observed using the same cell line, but comparing PPIX efflux from cells cultured in 
media containing 10% FCS with cells cultured in media that was serum-free 
(Washbrook et al., 1997). These two reports do however differ with regard to the rate 
of tetrapyrrole synthesis as a function of serum content in the culture medium. 
Fukuda and collegues (1993) showed that the rate of porphrin synthesis, with 10%
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FCS in the culture medium, was over twice that which occurred when the serum 
content was 1% serum after incubation with 0.6 mM ALA for 6 h. Reasons for this 
are not clear, but they suggest either stimulation of enzymes in tetrapyrrole synthesis 
or a transport mechanism (presumably involving ALA) playing a role. In contrast, 
Washbrook and collegues (1997) showed that the rate of porphyrin synthesis was 
approximately 30% lower in 10% culture media compared to that of serum free 
medium. They argue that serum in the medium decreases ALA uptake by either 
inhibiting influx of ALA or increasing its efflux.
Unlike TK6, incubation of FEK4 with ALA for 18 h leads to a considerably higher 
content of intracellular PPIX compared with incubation with ALA for 4 h (Fig. 2.8). 
The reason for the discrepancy between the two cell lines is probably explained by the 
large volume of the fibroblast compared with the lymphoblastoid cell, which would 
permit a larger amount of intracellular PPIX to accumulate after the longer incubation 
period. When comparing the two cell lines after 4 h ALA incubation, the intracellular 
content of PPIX appears similar in both cell types (under the 100 and 200 fiM 
conditions). This comparison can only be made loosely though, as the serum content 
may be different in the media when the cells were drugged with ALA. The study 
undertaken here was aimed at looking at intracellular PPIX content after ALA 
stimulus and not extracellular porphyin levels as a result of efflux. However, in 
retrospect, studying porphyrin efflux would have been useful to ascertain and 
compare the rate of porphyrin production in the two cell lines.
MTS was initially investigated to use a simple but rapid assay for obtaining 
phototoxicity data to compliment the clonogenic assay. The MTS technique was
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optimised for the lymphoblastoid cells and then used to obtain dose response data for 
irradiation with UVA up to 500 kJ/m2 (Fig. 2.9). It was then intended to use this 
assay to investigate the response of cells that had different porphyrin levels to 
irradiation with UVA radiation. However, in a previous study, Campbell and 
colleagues (1996) reported that the MTT tetrazolium salt could interact with ALA to 
produce a characteristic blue formazan product. Based on this observation, a cell free 
system was devised to investigate the reaction, if any, MTS had with ALA. Fig.2.10 
clearly shows that at low ALA concentrations a formazan product is produced, which 
is detectable at 490 nm. This suggests that ALA leads to the reduction of the MTS 
tetrazolium salt. It has been demonstrated in vitro that ALA can cause iron release 
from ferritin (Otieza et al., 1995). In the presence of iron and under aerobic 
conditions, ALA can be oxidised to 4,5-dioxovaleric acid (DOVA) (Carvalho et al., 
1997). This reaction may be responsible for the MTS reduction. In conclusion, 
neither MTS tetrazolium salt or the MTT tetrazolium salt would appear to be suitable 
for use in determining ALA-induced photosensitisation effects because of the 
coloured formazan compound produced as a result of the interaction between the 
tetrazolium salt and ALA.
Fig. 2.13 illustrates the dose response of untreated FEK4 cells to UVA radiation after 
doses up to 500 kJ/m . This particular method of determining phototoxicity (Gibson 
et al., 1997) had not been previously investigated in our laboratories, so this 
preliminary study was carried out to test the sensitivity of this technique. From this 
result, it was concluded that this method was suitable to carry out further 
phototoxicity studies.
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Figs. 2.11-2.12 and 2.14 -  2.15 show that while an increase in intracellular PPIX 
concentration does increase the sensitivity of the TK6 and FEK4 cell lines to UVA- 
induced phototoxicity, there is no absolute correlation between intracellular PPIX 
content and UVA inactivation. This observation is consistent with data produced by 
other groups (Iinuma et al., 1994; Gibson et al., 1997). Despite this, Iinuma and 
colleagues (1994) concluded that there might be a threshold of intracellular PPIX 
necessary before ALA-induced phototoxicity was observed. The 4 h ALA incubation 
in our study resulted in a greater efficiency of cell killing by UVA radiation compared 
to that with 18 h incubation in both cell lines (Figs.2.11-2.12 and 2.14-2.15). This 
observation may have implications for the optimisation of ALA-PDT, but why should 
this shorter incubation lead to greater phototoxicity? Malik et al. (1996) have 
demonstrated using fluorescence and spectral imaging and mapping that after 
incubation with ALA, the monomeric fraction of PPIX was primarily in the plasma 
membrane and the membranes of cytoplasmic organelles. On the other hand, 
aggregated species of PPIX were located in the cytoplasm and vesicular 
compartments including the mitochondria and endoplasmic reticulum. It was also 
shown that dimerisation may be induced after excess PPIX is produced by ALA 
induction. In another study, it has been shown that compared with longer incubation 
periods, shorter incubation times with exogenously added PPIX produce a larger 
fraction of the rapidly bleached monomeric form of PPIX, as measured by 
fluorescence decay measurements (Strauss et al., 1998). A concomitant dramatic 
effect on cellular phototoxicity was also observed using these shorter incubations. 
Bezdetnaya and colleagues (1996) demonstrated that photobleaching of monomers is 
more likely to occur compared with the aggregated species when solutions of both 
PPIX and HpD are irradiated. In the aggregated species fluorescence and intersystem
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crossing is reduced due to an increased internal conversion, which is the nonradiative 
pathways of energy loss within a molecule. This appears consistent with the 
observation that the fluorescence and triplet state yields are much reduced in the 
aggregated form of Hp compared to the monomeric component (Smith, 1985). 
Finally, aggregation of the photosensitiser Hp has been found to reduce the singlet 
oxygen yield and thus, essentially it’s phototoxic capacity (Tanelian and Heinrich, 
1995).
One other factor that may play a role in the ability of PPIX to inactivate cells is its 
localisation after ALA treatment. There are several studies that have used 
fluorescence microscopy to monitor PPIX localisation ALA treatment (reviewed by 
Peng et al., 1997, and refs, cited therein), and it would appear that the localisation 
pattern is primarily affected by the time that cells are incubated with ALA. The 
majority of these studies document a similar pattern that changes with time, which is 
the initial appearance of PPIX in the mitochondria (where it is formed), followed by 
its localisation in the membranes of organelles and eventually the plasma membrane. 
Some groups have also observed PPIX staining in the cytoplasm (Gaullier et al, 1995; 
Uberriegler et al., 1995). Thus, the primary sites of PPIX photosensitisation may be 
restricted by the pattern of PPIX localisation and accumulation, which in turn may 
affect the inactivation of cells. In conclusion, distribution of the porphyrin, 
concentration, and aggregation state may all have crucial effects on the ability of 
PPIX to sensitise cells to UVA.
Finally, an estimation of the basal content of PPIX necessary to mediate significant 
cell killing by UVA was made from the relationship between the inactivation rate
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constants and the intracellular PPIX concentration in both cell lines (Figs. 2.16 and 
2.17). The method used to estimate the basal content necessary to contribute to 
significant cellular inactivation is derived by back extrapolating the linear portion of 
the curve, which is produced by plotting inactivation rate constants against PPIX 
concentration, back to the abscissa. The estimated value essentially indicates a 
threshold of intracellular PPIX required, after a particular incubation, before a 
significant contribution is made to UVA-induced cell killing. This threshold does not 
necessarily indicate the total concentration of intracellular PPIX, but rather a 
concentration of PPIX species (monomeric, dimeric and aggregated forms) that are 
able to generate a sufficient amount of ROS in order to result in significant cell 
inactivation after UVA irradiation. The slow rate of increase in inactivation over the 
non-linear part of the curve (Figs. 2.16 and 2.17) shows that an increase in PPIX 
concentration is not accompanied by a significant relative increase in the rate of 
inactivation. This suggests that, either insufficient ROS species are generated because 
of a lack of total PPIX, insufficient quantities of an efficient photosensitising fraction 
of PPDC (i.e. monomers) to generate these ROS, or that the antioxidant capacity is 
sufficient to protect the cell. When this threshold is reached, the rate of inactivation 
increases in a linear manner and at a much greater rate. This is because whatever 
limiting factor or factors were effective before the threshold was reached, are no 
longer inhibiting the increase in rate of inactivation, as a function of PPDC 
concentration.
Under our conditions, it was determined that the basal content of PPDC is insufficient 
to make a significant contribution to UVA-mediated inactivation of the human 
lymphoblastoid cell line TK6 and therefore it is unlikely to be a critical UVA
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chromophore in this cell line under normal conditions (Fig. 2.16). Whilst incubation 
of FEK4 cells with ALA for 18 h cells would appear to give a similar result as that for 
TK6 cells, the incubation of FEK4 with ALA for 4 h appears to produce quite a 
different outcome (Fig. 2.17). The basal content of these cells lies within the back 
extrapolate of the linear portion of this curve, suggesting that it is sufficient to make a 
significant contribution to UVA-mediated cell inactivation. We conclude from this 
study that the basal content of PPIX in FEK4 fibroblasts appears to implicate this 
molecule as a critical chromophore in the UVA-mediated inactivation of this cell line.
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Chapter 3. Study of the effects of 5-aminolevulinic acid-induced protoporphyrin IX 
and UVA irradiation on the cytoplasmic aconitase activity of iron regulatory 
protein-1 in human skin cells
3.1 Introduction
3.1.1 Iron Homeostasis
Iron is an essential nutrient and is important for a variety of cellular processes including 
respiration and cell division. Despite iron playing a critical role in such processes, when 
in excess, it is potentially highly toxic because it can catalyse the formation of free 
radicals through mechanisms such as the Fenton and Haber Weiss reactions (Halliwell 
and Gutteridge, 1999). In mammalian cellular systems, there is a tightly regulated system 
that is responsible for acquisition, utilisation, and storage of iron. The genes that 
comprise this system are themselves modulated by levels of intracellular iron.
Cellular iron homeostasis in non-erythroid mammalian cells is maintained primarily 
through the co-ordinated regulation of the synthesis of the two proteins, transferrin 
receptor (TfR) and ferritin. Iron acquisition (reviewed by Richardson and Ponka, 1997) 
occurs through the binding of di-ferric transferrin (Tf) to the cell-surface transferrin 
receptor (TfR). This complex is internalised within enclosed endocytic vesicles. 
Acidification of the endosome results in release of the Tf bound iron; the apo-Tf/TfR 
complex is returned to the cell surface where it dissociates for recycling of the same 
process. This released iron is subsequently exported to the cytoplasm where it is either 
incorporated into a number of iron-containing/requiring proteins, transported to the
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mitochondria for haem synthesis, or stored in the cytoplasmic iron storage protein 
ferritin. Ferritin is composed of 24 subunits encoded by two highly homologous genes, 
in which up to 4500 iron atoms can be stored in the Fe form (reviewed by Bridges, 
1990; Harrision and Arosio, 1996; see Chapter 5).
Two cytoplasmic RNA-binding proteins known as iron regulatory protein-1 and -2 (ERP- 
1 and IRP-2) control the rate of ferritin and TfR synthesis through the regulation of 
translation, and through the stabilisation of their mRNAs (Henderson and Kuhn, 1995). 
Under conditions of iron deprivation the IRPs are capable of binding to stem-loop 
structures, known as iron-responsive elements (IREs), in the 5’-untranslated region (5’- 
UTR) of the ferritin mRNA and in the 3’-untranslated region (3’-UTR) of the TfR 
mRNA. Binding of the IRPs to the 5’-UTR of the ferritin mRNA results in repression of 
translation of the ferritin protein (Gray and Hentze, 1994). In contrast, binding of the 
IRPs to the 3’-UTR of the TfR mRNA results in its stabilisation, thus allowing translation 
to proceed (Casey et al., 1989). When iron supply to cells is increased IRP-1 becomes 
post-transcriptionally inactivated and IRP-2 is degraded. Intracellular iron levels affect 
the rate of synthesis of both IRPs, through the activity of IRP-1 and through the stability 
of IRP-2. Thus, when the intracellular iron level is low, the production of ferritin is low 
while the production of TfR is high. On the other hand, when the intracellular iron level 
is high the production ferritin is high, whilst the production of TfR is low (reviewed by 
Hentze and Kuhn, 1996; Haile, 1999). Purification of the human IRP-1 protein led to the 
discovery that it displays a marked homology with mitochondrial aconitase (Rouault et 
al, 1991; Hentze and Argos, 1991). Mitochondrial aconitase is an iron sulphur protein
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that catalyses the reversible isomerisation of citrate to isocitrate via czs-aconitate in the 
citric acid cycle. A cubane sulphur-cluster ([4Fe-4S]), like that of the mitochondrial 
aconitase, was found in the IRP-1 (Kennedy et al., 1992) and analysis of recombinant 
IRP-1 led to the observation that the protein functioned as a cytosolic aconitase in iron- 
replete cells (holoprotein), inactive in IRE-binding. In iron-deficient cells however, the 
apoprotein (without the cluster) accumulates and binds to IREs exhibiting no aconitase 
activity. Thus, IRP-1 is a bifunctional regulator possessing the two mutually exclusive 
functions, RNA-binding and aconitase activity, depending on the levels of intracellular 
iron (Henderson and Kuhn, 1995). An IRE element has been also been identified in the 
5’-UTR of mammalian mitochondrial aconitase (Kim et al., 1996). The level of 
translation of this protein has been shown to be regulated by ERP/IRE-binding so that iron 
levels may regulate mitochondrial aconitase, and hence the function of the citric acid 
cycle.
3.1.2 What is the Function o f Cytoplasmic Aconitase Activity?
While the role of the mitochondrial aconitase (m-aconitase) functioning as one of the 
enzymes of the Kreb’s cycle is well characterised and understood, the role of the of the 
cytoplasmic aconitase (c-aconitase) in the metabolism of cytoplasmic citrate remains 
largely unclear. Philpott and colleagues (1994) confirmed that the enzymatic activity is 
not necessary for cluster assembly/disassembly or regulated RNA binding as previously 
suggested by Klausner and colleagues (1993). Philpott and colleagues suggested that the 
cytoplasmic aconitase function and concomitant citrate metabolism are directly regulated 
by iron. Hence, the role of citrate (and its metabolism) in intracellular iron trafficking
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may provide the key to the cytoplasmic aconitase function. Paraskeva and Hentze (1996) 
also postulate a relationship between citrate and iron transport. They suggest that a co- 
regulatory function of both the mitochondrial and cytoplasmic aconitases in response to 
iron levels may exist, and that iron level may affect the catalytic turnover of citrate. 
Since citrate can bind iron and might serve as intracellular iron transporter, both the 
RNA-binding and the enzymatic activity of IRP-1 may collaborate in the regulation of 
intracellular iron transport. Gray and colleagues (1993) discussed the possibility of a link 
between the two aconitases, again with reference to citrate. They speculate that in iron 
starved cells repression of both aconitases may lead to preservation of citrate which is an 
intracellular carrier of iron to the mitochondria (Frausto da Silva, 1991). This may also 
aid the liberation of iron stored within cells (O’Connell et al., 1989). Alternatively, iron 
overload in cells may be aided by reduction in citrate levels from increased aconitase 
activity, thus reducing iron mobilisation from iron stores. Clearly the elucidation of the 
role of cytoplasmic aconitase requires further experimental investigation.
3.1.3 Response o f IRPs to Oxidative Stress
In the attempt to understand how the iron-sulphur-cluster may function as a sensor of 
intracellular iron levels, the influence of oxidants on the iron-sulphur cluster of IRP-1 
assembly, as well as iron availability, must also be understood. The iron-sulphur cluster 
of IRP-1 is positioned in a solvent filled cleft where it may be susceptible to oxidant 
destabilisation. The nature of the nitric oxide (NO) interaction with aconitase is 
controversial, some groups suggest peroxynitrite is the reactive species (Hausladen and 
Fridovich, 1994; Castro et al, 1994), whereas others have suggested that NO itself is
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sufficient to destabilise the cluster (Kennedy et al., 1997; Gardner et al., 1997; for a 
review see Cooper, 1999). Treatment of cells with NO or NO producing reagents has 
been shown to result in ERE-binding (Weiss et al., 1993; Drapier et al., 1993). Treatment 
of cells with hydrogen peroxide leads to activation of RNA-binding activity and 
concomitant loss of cytoplasmic aconitase activity, as would be expected if oxidative 
stress was responsible for cluster disassembly (Martins et al., 1995; Pantopolous and 
Hentze, 1995; Gardner et al., 1995). It is tempting to assume direct chemical attack on 
the iron sulphur cluster of the IRP-1 protein resulting in the reduction of cytoplasmic 
aconitase activity, as has been postulated (Rouault and Klausner, 1996; Hentze, 1996). 
However, there is evidence that suggests ROS may also play a signalling role in the 
induction of IRP-1 (Pantopoulos et al., 1997). Although the level of iron might have 
negligible influence on iron-sulphur cluster disassembly, iron level does determine 
whether the cluster can be assembled and thus will control the transition from apoprotein 
to holoprotein. The holoprotein can function as a sensor of oxidants, while the 
apoprotein can function as a sensor of iron levels. The actual mechanisms of assembly 
and disassembly of the dynamic iron-sulphur clusters are still poorly understood and 
remain to be delineated. In turn, this will provide the understanding of how iron-sulphur 
proteins can serve as sensors of both iron and oxidants (for reviews see Rouault et al., 
1996; Haile, 1999).
3.1.4 The Basis and Objectives o f This Study
In this study we investigate the effects of ALA and UVA on cytoplasmic aconitase 
activity (other consequences of UVA and/or ALA treatment are discussed in previous
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chapters). There is only a sparse amount of data in this particular area, with no data 
existing to the knowledge of this author connecting both ALA and UVA treatment with 
cytoplasmic aconitase activity. In human keratinocytes exposed to UVA, Giordani and 
colleagues demonstrated UVA inactivation of cytoplasmic aconitase activity by UVA 
radiation alone (Giordani et al., 1997), although they were uncertain as to what led to the 
inactivation. Carvalho and colleagues (1997) have shown (in a variety of different cell 
lines) an ALA-induced activation of IRP-1/IRE binding. They propose that ALA alone 
affects the IRP-1 activity and not through other indirect mechanisms such as production 
of ROS or synthesis of PPIX or haem. The concentration range of ALA used in this 
study was between 0.5 and 8mM. Exogenous addition of PPIX to erythroleukemic cells 
has been shown to activate IRP-1 RNA-binding (Coccia et al., 1997). This group 
suggested that PPIX acts through a similar mechanism to that exerted by an iron chelator. 
Our work investigates the effect of UVA on the cytosolic aconitase activity in human 
fibroblasts and keratinocytes. We also study the effects of ALA treatment on the 
cytosolic aconitase activity in the fibroblasts, both before and after UVA irradiation 
(controls are included in the form of haemin and desferal treatment). This assay was 
developed with the intention not only to compliment data obtained using the IRP-1 RNA- 
binding assay, but also to help gain a better understanding of the mechanisms occurring 
during the transition from holoprotein to apoprotein (and vice-versa) after various 
treatments such as UVA irradiation.
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3.1.5 Measurement o f Cytosolic Aconitase Activity
The cytoplasmic aconitase assay has been performed in many different ways 
(documented within references cited in this chapter). All the different variations of this 
assay effectively measure the same thing, which is the activity of the cytoplasmic enzyme 
in response to intracellular iron and oxidant levels. The method used in this study 
(Giordani et al., 1998) measures spectrophotometrically the aconitase activity in the 
cytoplasmic fraction as a function of substrate disappearance/consumption (i.e. cis- 
aconitate) at 240 nm. The addition of the substrate marks the start of the reaction. Cis- 
aconitate acid is the substrate intermediate in the aconitase-catalysed conversion of citrate 
to isocitrate (source: Stryer, 1988):
COO- H COO-
H C— H h20 “OOC—C h2° H—C— OH
-OOC— C— OH ^  ' -OOC—C —^  » 'O O C—C— H
c h 2 c h 2 c h 2
COO- COO- c o o -
Citrate c/s-Aconitate Isocitrate
Subcellular fractionation was achieved using centrifugation and a special method of lysis 
involving the compound digitonin. Digitonin was used to selectively permeablise the 
plasma membrane since it is cholesterol-rich compared to the mitochondrial membrane. 
Digitonin reacts specifically with cholesterol so that the plasma membrane is damaged 
while the mitochondrial membranes remain intact (Zuurendonk and Tager, 1974). The
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quality of the cytosolic fraction was tested for using succinate dehydrogenase as the 
mitochondrial marker enzyme.
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3.2 Methods
3.2.1 Cell Culture
The human lymphoblastoid cell line, TK6, and the primary human fibroblast cell line, 
FEK4, were cultured as described in section 2.2.1. The immortalised human keratinocyte 
cell line HaCaT (Boukamp et al., 1988) was cultured in Dulbecco’s minimal essential 
media high glucose (Gibco, UK), supplemented with 10% FCS, L-glutamine, sodium 
bicarbonate, penicillin and streptomycin. Cells were trypsinised once a week. For all 
experiments HaCaT cells were seeded into plastic culture dishes for 3 days to 
approximately 80% confluency.
3.2.2 Chemical Treatments and Irradiation Conditions
FEK4 cells were treated with ALA as described in section 2.2.3. Positive controls for the 
modulation of the cytoplasmic aconitase activity were prepared for the FEK4 in the form 
of the haem analogue haemin and the iron chelator desferal. Solutions of 50 pM haemin 
or 100 pM desferal (Ciba Geigy, Switzerland) were made using conditioned cell culture 
media. These solutions were added back to the cells, which were incubated at 37°C for 
either 2 h with haemin or 18 h with desferal. Both FEK4 and HaCaT cells were UVA- 
irradiated as described in section 2.2.6.
3.2.3 The Cytoplasmic Aconitase Assay
The cytoplasmic aconitase assay was performed according to Giordani and co-workers 
(1998). After irradiation (or treatment with either haemin or desferal), cells were 
collected. The TK6 cells were centrifuged for 5 min at 1000 rpm, washed with PBS and
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centrifuged again. The FEK4 and HaCaT cells were washed with PBS, then scraped 
from the plates and collected in 3 ml of PBS and centrifuged for 5 min at 1000 rpm. 
Pellets from all cell types were re-suspended in 10 ml of ice-cold buffer containing 0.25- 
M sucrose, 100 mM Hepes and 0.007% digitonin (Bouton et al., 1997). The digitonin 
stock solution was stored in dimethyl sulphoxide (DMSO) at room temperature. Cell 
lysates were centrifuged for 10 min at 1500 g. The supernatant was transferred to a fresh 
tube and centrifuged for 10 min at 12500 g with a Beckman J-25 centrifuge (Ireland). 
Aconitase activity was immediately assayed in the cell-free extracts at 25°C in the 
presence of 0.02% BSA after the final centrifugation using the method described by 
Drapier and Hibbs (1986). The reaction was started with the addition of 0.2mM cis- 
aconitic acid and the disappearance of cis-aconitic acid was measured at 240 nm using 
absorption spectrophotometry with a Kontron Uvikon 922 spectrophotometer 
(Switzerland). A typical reaction measurement is shown below in Fig. 3.1:
Fig. 3.1 A typical aconitase activity measurement using spectrophotometry. This kinetic study shows the 
disappearance of the substrate cw-aconitate measured at 240 nm. Absorbance was set to zero at the start of 
the reaction, which explains the negative absorbance values observed during the reaction as the substrate is 
consumed.
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Both the BSA and cis-aconitic acid stock solutions were made up using the Hepes- 
sucrose buffer described above. A molar absorption coefficient of 3410 cm'1 mJVr1 was 
used for cis-aconitic acid (Henson and Cleland, 1967). Under the experimental 
conditions described here, one unit of IRP-1 aconitase activity is defined as 1 jimol cis- 
aconitate consumed min*1 mg protein'1 (Sigma catalogue). Enzyme activity was 
calculated using the following equation (Segel, 1976):
Activity = (AO.D.W341Q) x (V)
(pg protein) x (t)
Where AO.D.240 is the change in optical density measured at 240 nm, 3410 corresponds 
to the molar absorption coefficient for czj-aconitic acid (cm'1 mM*1), v is volume of the 
reaction mixture (ml), and t is time (min). Protein concentration was determined using 
the method described by Bradford (1976) with the BioRad reagent kit (UK). BSA was 
used for calibration and adsorption measurements were obtained using a microplate 
reader at 595 nm.
3.2.4 Succinate Dehydrogenase Activity - Test fo r Mitochondrial Contamination o f the 
Cytoplasmic Fraction
Succinate dehydrogenase (SDH) activity was assessed by the ability of the cytoplasmic 
fraction and total homogenate to reduce 2-(4-iodophenyl)-3-(4-nitrophenyl)-5-phenyl- 
tetrazolium chloride (INT) in the presence of the electron coupling reagent phenazine 
methosulphate (PMS) (Porteous and Clark, 1965). The incubations (1 ml) contained (in
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pmoles) sodium phosphate, 50; sodium succinate, 10; INT, 0.4; PMS, 0.33; and Triton X- 
100, 0.0001%. The cytoplasmic fraction and the total homogenate were assayed. The 
electron acceptors (INT and PMS) were added after a 6 min pre-incubation at 30°C. 
Absorbance increase was followed at 540 nm (reaction proceeded at 30°C) using a 
Kontron Uvikon 922 spectrophotometer (Switzerland). The reference incubation 
contained 10 pmoles sodium malonate instead of sodium succinate. Mitochondrial 
contamination of the cytoplasmic fraction was expressed as a percentage of the activity of 
SDH in the total homogenate.
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3.3 Results
3.3.1 Basal Cytoplasmic Aconitase Levels
The basal cytoplasmic aconitase activity in the FEK4 primary human fibroblasts and the 
HaCaT immortalised human keratinocytes is shown in Fig 3.2. The fibroblast cell line 
displayed over 2-fold higher basal cytoplasmic aconitase activity compared to the 
keratinocyte cell line (0.825 ± 0.093 and 0.3935 ± 0.054 U/mg protein respectively). 
Mitochondrial contamination of the cytoplasmic fraction was determined by comparing 
the activity of the mitochondrial enzyme succinate dehydrogenase in both the 
cytoplasmic fraction and the total cell homogenate (section 3.2.4). Contamination was 
tested for after all the treatments discussed in this chapter. Succinate dehydrogenase 
activity was never greater than 10% that of the total activity in the cell homogenate.
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Fig. 3.2. Basal cytoplasmic aconitase activity of FEK4 primary human fibroblasts and HaCaT 
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3.3.2 Effects o f UVA Irradiation on the Cytoplasmic Aconitase Activity o f FEK4 
Primary Human Fibroblasts and HaCaT Immortalised Human Keratinocytes 
The cytoplasmic aconitase activity of the FEK4 primary human fibroblasts and HaCaT 
immortalised human keratinocytes in response to graded doses of UVA radiation are 
shown in Tables 3.1 and 3.2 respectively. The response to UVA is similar for both cell 
lines, but the changes observed are greater in the fibroblasts compared with the 
keratinocytes. As the tables show, the cytoplasmic aconitase activity rises steadily up to 
about 250 kJ/m2 UVA where the activity peaks. The activity then decreases between 250 
and 500 kJ/m2 UVA. After a UVA dose of 500kJ/m2, the cytoplasmic aconitase activity 
measured had dropped to below the control levels. Concerning the modulation of 
cytoplasmic aconitase activity by UVA radiation, both the results for the FEK4 
fibroblasts and the HaCaT keratinocytes contrast sharply with those obtained by Giordani 
et al. (1998) with NCTC 2544 keratinocytes.
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Table 3.1. Dose response o f cytoplasmic aconitase activity o f FEK4 primary human fibroblasts exposed to 
UVA radiation. Data represent the mean of 4-6 independent experiments (± S.D.).
Treatment Aconitase Activity 
(U/mg protein)
% Activity (Relative to 
Control)
Sham-irradiated 0.825 ± 0.093 100
50 kJ/m2 UVA 0.867 ± 0.025 105.125 ±3.112
100 kJ/m2 UVA 0.961 ± 0.039* 116.5 ±4.795
250 kJ/m2 UVA 1.2 ±0.051* 145.515 ±6.293
500 kJ/m2 UVA 0.615 ±0.044* 74.6 ± 5.396
Statistical analyses were made using an unpaired t test. *, Significantly different from non-irradiated 
control (p < 0.05 level).
Table 3.2. Dose response o f  cytoplasmic aconitase activity o f HaCaT immortalised human keratinocytes 
exposed to UVA radiation. Data represent the mean o f 3-4 independent experiments (± S.D.).
Treatment Aconitase Activity 
(U/mg protein)
% Activity (Relative to 
Control)
Sham-irradiated 0.3935 ± 0.054 100
50 kJ/m2 UVA 0.399 ±0.0181 101.6 ±4.615
100 kJ/m2 UVA 0.441 ±0.012* 112 ±3.162
250 kJ/m2 UVA 0.506 ±0.0216* 128.68 ± 5.505
500 kJ/m2 UVA 0.339 ± 0.0239* 86.2 ± 6.039
Statistical analyses were made using an unpaired t test. *, Significantly different from non-irradiated 
control (p < 0.05 level).
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3.3.3 Effects o f ALA Treatment and UVA Irradiation on the Cytoplasmic Aconitase 
Activity o f FEK4 Primary Human Fibroblast Cells
The cytoplasmic aconitase activity of FEK4 cells in response to treatment with ALA for 4 
and 18 hours was investigated (Table 3.3). As one can see from the table, after both 
incubation times, the aconitase activity decreases in a dose-dependent manner. The 
maximum decrease in aconitase activity after ALA treatment was approximately 35%, 
and this was observed after a treatment of 200 pM for 4 h. Application of graded doses 
of UVA to the ALA treated populations had a dramatic effect on the cytoplasmic 
aconitase activity in these cells compared to their untreated (without ALA) counterparts 
(Tables 3.1 and 3.2). As Table 3.3 shows, all irradiated ALA treated populations 
expressed a marked increase in cytoplasmic aconitase activity. Interestingly, the 50 
kJ/m2 UVA dose showed an increase in cytoplasmic aconitase activity that correlates 
with an increase in intracellular PPIX concentration (Fig. 2.8). In contrast to this, a 100 
kJ/m2 UVA dose appears to indicate a saturation of the cytoplasmic aconitase activity 
measured, as there is no significant difference between the activities of the samples 
irradiated with this dose. The maximum activity observed under our conditions was just 
over 200% higher that of the untreated control; this was measured after an incubation 
with 200 pM ALA for 18 h followed by a 100 kJ/m2 UVA dose. Mortality of the cells 24 
h after ALA treatment and UVA irradiation are shown in Figs. 2.14 and 2.15.
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Table 3.3. Dose response o f cytoplasmic aconitase activity o f FEK4 primary human fibroblasts exposed to 
ALA and UVA radiation. Data represent the mean o f 4 independent experiments (± S.D.).
Treatment Aconitase Activity 
(U/mg protein)
% Activity (Relative to 
Control)
Non-ALA treated, non-irradiated 0.825 ± 0.093 100
4 h 100 |jM ALA, non-irradiated 0.639 ± 0.068 77.5 ± 8.109
4h 100 (iM ALA50 kJ/m2 UVA 1.237 ±0.198* 150 ±24.055
4 h 100 (iM ALA 100 kJ/m2 UVA 2.345 ±0.197* 284.25 ±23.894
4 h 200 (iM ALA, non-irradiated 0.545 ± 0.055 66.124 ± 6.733
4 h 200 mM ALA 50 kJ/m2 UVA 1.536 ±0.1845* 186.25 ±22.369
4 h 200 pM ALA 100 kJ/m2 UVA 2.369 ± 0.1787* 287.25 ±21.156
18 h 100 pM ALA non-irradiated 0.665 ± 0.0543 80.63 ±6.113
18 h 100 pM ALA 50 kJ/m2 UVA 1.886 ±0.297* 228.641 ± 36.039
' 18 h 100 pM ALA, 100 kJ/m2 UVA 2.43 ±0.189* 295.5 ±23
18 h 200 pM ALA non-irradiated 0.561 ± 0.082 68 ±10
18 h 200 pM ALA 50 kJ/m2 UVA 2.161 ±0.229* 262 ±27.779
18 h 200 pM ALA 100 kJ/m2 UVA 2.602 ± 0.2138* 315.515 ± 25.926
Statistical analyses were made using an unpaired t test. *, Significantly different from non-irradiated 
control (p < 0.05 level).
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3.3.4 The Effects o f Haemin and Desferal on the Cytoplasmic Aconitase Activity o f the 
FEK4 Primary Human Fibroblasts
Positive controls were used to test the efficacy of the cytoplasmic aconitase activity in 
FEK4 cells. Table 3.4 shows the effects of haemin and desferal incubation on the 
cytoplasmic aconitase activity of FEK4 cells. Haemin incubation resulted in an 
approximate 20% increase in activity compared to untreated cells, and desferal 
approximately a 50% decrease.
Table 3.4. Effect o f haemin, and desferal on the cytoplasmic aconitase activity o f FEK4 primary human 
fibroblasts. Data represent the mean o f 3 independent experiments (± S.D.). The activity is expressed as a 
percentage o f a sham-treated control.
Treatment Aconitase Activity % Activity
(U/mg protein)
50 pM Haemin, 2 h 0.995 ± 0.029 120.6 ±3 .6
100 pM Desferal, 18 h 0.402 ± 0.055 48.8 ± 6.7
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3.4 Discussion
The cytoplasmic aconitase assay was developed for this investigation not only to 
compliment data obtained using the IRP-1 RNA-binding assay (and other assays that may 
monitor levels of intracellular iron entities e.g. the calcein assay), but also to gain a better 
understanding of the mechanisms that occur during the transition from IRP-1 holoprotein 
to apoprotein (and vice versa) after various treatments such as UVA irradiation. The 
physiological function of the cytoplasmic aconitase is not clear, although several 
functions have been postulated (section 3.1.2) none have been thoroughly tested. It is 
well accepted and documented that UVA radiation leas to the production of ROS and 
these species are responsible for a variety of modifying and damaging affects (Tyrrell, 
1991). We investigated in this particular study how UVA (and ALA treatment followed 
by UVA) affects iron metabolism in human skin cells through the use of the cytoplasmic 
aconitase assay.
The basal cytoplasmic aconitase activities of FEK4 primary human dermal fibroblasts 
and HaCaT immortalised epidermal keratinocytes are shown in Fig. 3.2. From the graph 
it is clear that the fibroblasts exhibit a much higher activity than the keratinocytes 
(approximately 2-fold higher). This is consistent with measurements of the free iron pool 
using the iron assay and ferritin levels (Chapters 4 and 5). When comparing different 
parameters that are involved in iron regulation between the two cell lines, it is interesting 
to find that the basal HO-1 activity in HaCaT cells is barely detectable compared with the 
FEK4 value. However, the basal HO-2 activity of HaCaT is 2-3-fold higher compared 
with FEK4 (Noel, 1995). Overall HO enzyme activity was found to be approximately
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2.5-fold higher when comparing epidermal keratinocytes to their matched dermal 
fibroblasts (Applegate et al., 1995). Applegate and colleagues (1995) found that the basal 
concentration of ferritin in the keratinocytes was also approximately 2 - 3  times higher 
when compared with the fibroblasts. This is consistent with evidence that levels of 
ferritin are closely linked to HO activity (Applegate, 1995 and references cited therein). 
However, when comparing the fibroblast (FEK4) and the keratinocyte (HaCaT) cell lines, 
we found that the ferritin levels (Chapter5) and iron levels in the keratinocytes, whether 
measured by aconitase activity or the iron assay (Chapter 4), are much lower than in the 
fibroblasts. The reasons for this may to be connected with the expression of H-ferritin 
observed within the keratinocytes. HaCaT cells have been found recently to only express 
the H-ferritin subunit (C. Pourzand, unpublished observation), and it has been 
documented that the expression of this subunit downregulates intracellular ‘free’ iron 
levels because of its ferroxidase activity (Beaumont and Cabantchik, 1999).
Tables 3.1 and 3.2 show the modulation of cytoplasmic aconitase activity by UVA 
radiation in the FEK4 primary human fibroblast cell line and the HaCaT immortalised 
keratinocyte cell lines respectively. In both cell lines we found an increase in 
cytoplasmic aconitase activity in response to UVA irradiation. This increase appeared to 
peak around 250 kJ/m UVA and the activity dropped below the control level at the 
higher dose of 500 kJ/m . In FEK4, the aconitase response correlated with a reciprocal 
decrease in IRP-1 RNA-binding in doses up to 250 kJ/m2 UVA (Pourzand et al., 1999). 
At 500 kJ/m2, like the cytoplasmic aconitase activity, the IRP-1 RNA-binding was lower 
than the control levels suggesting damage to the protein. Under circumstances such as
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these, the advantages of measuring both functions of the IRP-1 protein become obvious. 
The increases observed in cytoplasmic aconitase activity with these two cell lines would 
appear to be due to iron mobilisation as a result of UVA irradiation (Pourzand et al., 
1999; Watkin and Tyrrell, unpublished data). The source of this iron is not completely 
clear, but two possibilities arise from observations made in our laboratories (Pourzand et 
al.,1999; Kvam et al., 1999). It has been postulated that UVA causes oxidative damage 
to lysosomal membranes. In turn this allows leakage of lysosomal proteases into the 
cytosol where the proteolysis of ferritin occurs resulting in the immediate release of ‘free’ 
iron (Pourzand et al., 1999). Another source of iron that is also liberated immediately 
after UVA irradiation is that of haem from microsomal haem proteins (Kvam et al., 
1999). The study of Kvam et al. (1999) demonstrated that haem was released as a result 
of microsomal haem protein degradation in a process that appeared to be mediated by 
cyclooxygenase (COX). The subsequent release of haem leads to the induction of HO-1, 
which in turn causes the release of ‘free’ iron as a result of haem catabolism. Other 
sources of iron may also be responsible for the affects observed on the activity of IRP, 
but they are as yet unidentified. Attempts at elucidating what form of iron the IRP-1 
protein senses has been controversial. Iron may be either sensed directly or indirectly. 
Though it now widely accepted that chelatable iron has a regulatory affect on the IRP, 
there is still uncertainty as to what role, if any, compounds such as haem or haemin (the 
compound most investigated) have on IRP regulation in vivo (Rouault at al., 1993). 
Addition of 50 pM haemin for 2 h led to a 20% increase in the cytoplasmic aconitase 
activity in FEK4 (Table3.4). This increase could have been due to liberation of iron from 
the breakdown of haemin, though it is not definite that this effect was not caused by
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haemin itself. As has been suggested (Kvam, 1999), haem added to cells, or indeed haem 
released from haemproteins, is conceivably chemically distinct from haemin and thus 
may have a different regulatory affect on IRPs in comparison to haemin. If haem 
(released from haemproteins) does directly regulate IRP-1 cytoplasmic aconitase activity, 
then this could explain why there was only partial recovery of the UVA-induced 
reduction of IRP-1 RNA-binding when ferritin degradation was prevented using protease 
inhibitors (Pourzand et al., 1999). Recognition of haem by IRPs may be of benefit to a 
cellular system since this could assist in the prediction of, and help manage, potentially 
harmful changes in the chelatable iron pool.
Previously, it has been documented (Giordani et al, 1998) that UVA radiation leads to the 
inhibition of cytoplasmic aconitase activity in NCTC 2544 human skin keratinocytes. 
Despite using various approaches (including antioxidants and iron chelation), the nature 
or source of this inhibition was not elucidated. In contrast to the findings of Giordani et 
al. (1998) we have observed quite a different response to UVA radiation in the two 
human cell lines, FEK4 primary fibroblasts, and HaCaT immortalised keratinocytes 
(Tables 3.1 and 3.2 respectively). There are a number of factors which may explain why 
our results differ from previous observations (Giordani et al., 1998). These factors 
include differences in the UV source, the dose range, the temperature of irradiation, and 
the exact cell lines used. Unless experimental conditions are identical, it may not be 
appropriate to make direct comparisons. The UVA source used in our study (for spectral 
output see Fig. 2.3) is composed primarily of wavelengths in the UVA I range (340-380 
nm) and also some visible wavelengths up to approximately 420 nm. The source used by
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Giordani et al. contained both UVA I and UVA II (320-340 nm) wavelengths. It is 
possible that these shorter wavelengths may result in the inactivation of the cytoplasmic 
aconitase activity. Determining how UVB, or a combination of UVA and UVB, affect 
cytoplasmic aconitase activity might also help in the understanding of the different results 
observed.
Table 3.3 shows the affect of ALA treatment on the cytoplasmic aconitase activity of 
FEK4 cells, both alone and in combination with UVA radiation. ALA treatment alone 
appears to drive down the aconitase activity to a similar extent after both 4 and 18 hours 
incubation. The treatment of cells with 100 pM desferal for 18 h was considerably more 
effective at reducing the cytoplasmic aconitase activity compared with a similar treatment 
with ALA (Tables 3.4 and Fig. 3.3). One possible explanation is that desferal chelates 
iron from both ‘free’ iron and other sources such as ferritin (Bridges, 1990) effectively 
removing iron for cellular functions and thereby stimulating IRP-1 RNA binding so that 
more TfRs are produced. ALA on the other hand, may lead to an initial sequestration of 
iron by stimulating haem synthesis, however this iron might be recycled through the 
activity of HO thus leading to a less dramatic effect on IRP regulation.
Carvalho and colleagues (1997) postulated that ALA alone is able to regulate IRPs. This 
was based on the observation that adding ALA or allowing its accumulation by adding 
the ALA dehydratase inhibitor succinyl acetone methyl ester (SAME), leads to the 
stimulation of IRP-1 RNA-binding intracellularly. The use of SAME leads to ALA 
accumulation but not haem synthesis suggesting that haem is not important in IRP
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regulation. Carvalho et al. propose that ALA regulates IRP either by direct interaction of 
the ALA enoyl radical with the IRP iron sulphur cluster causing its disassembly, or by 
indirect interaction through ROS generation. This may indicate a role for ALA beyond 
that of an (indirect) iron chelator. However the concentrations of ALA used in the study 
(0.5-8 mM) and those that accumulate intracellularly were very high. When the ALA 
concentration is high, it is cytotoxic (Ortel et al., 1993) and capable of generating ROS 
(Monteiro, 1989; Fraga, 1994). It has also been shown to cause release of iron from 
ferritin (Oteiza et al., 1995), lipid peroxidation (Oteiza and Bechara, 1993), and DNA 
damage induction (Fraga et al., 1994). With such events occurring many factors may 
affect IRPs.
Table 3.3 also shows what happens to the cytoplasmic aconitase activity of FEK4 cells 
that have been treated with ALA (up to 200 jiM) and subsequently irradiated with UVA 
(up to 100 kJ/m2). From the data it clear that induction of PPEX, followed by UVA 
irradiation, has a dramatic affect on stimulating the cytoplasmic aconitase activity in 
FEK4 cells with a peak in activity approximately 200% higher than the control. There 
appears to be a degree of saturation of enzyme activity at the higher UVA dose (100 
kJ/m2), with the lower dose (50 kJ/m2) demonstrating an increase in enzyme activity that 
correlates well with an increase in intracellular PPEX concentration (Fig. 2.8). The effect 
PPEX has in combination with UVA on the cytosolic aconitase activity would appear to 
complement the scenario postulated by Pourzand et al. (1999). PPEX is a hydrophobic 
molecule that locates preferentially deep within lipid membranes (Richelli, 1995). Upon 
photosensitisation by UVA, it is conceivable that membranes containing PPEX will be
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subjected to lipid peroxidation (Girrotti, 1985; Korytowski et al., 1992; Oschner, 1997, 
and refs cited therein; see Chapter 2). Damage to lysosomes and release of acidic 
hydrolases induced by exogenous addition of PPIX followed by UVA irradiation has 
been documented in mouse fibroblasts (Morliere at al., 1987). It is possible that the huge 
increase in cytoplasmic aconitase activity after PPIX induction, followed by UVA 
irradiation, is a result of proteolytic degradation of ferritin. The release of these enzymes 
may be significantly enhanced under these conditions thus leading to a greater 
degradation and liberation of ‘free’ iron. Studies of ferritin in cells that have been treated 
with ALA and exposed to UVA radiation show that ferritin is significantly damaged 
(Chapter 5). It has not been determined if this damage occurs through degradation by 
proteolytic enzymes or directly by ROS. In experiments with horse spleen apoferritin 
(Precigoux et al., 1994; Michaux et al., 1996; Crichton et al., 1997), it has been shown 
that PPIX is able to locate within hydrophobic pockets of ferritin leading to a 
concomitant increase in the UVA-absorbing region (peak 370 nm). Considering the 
photosensitising capacity of PPIX, it is not inconceivable that upon UVA irradiation, 
ROS are generated within the ferritin molecule through the excitation of PPIX. This 
could also be responsible for the liberation of iron from ferritin. An increase in 
cytoplasmic aconitase activity might also occur as a result of ‘free’ haem release from 
microsomes. PPIX may localise in the membranes of microsomes, and upon 
photosensitisation, aid the liberation of haem into the cytoplasm by rupturing microsomal 
membranes. If IRPs do sense haem, this may also explain the huge increase observed 
after PPIX photosensitisation by UVA.
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It is generally accepted that UVA radiation alone, and PPIX upon photosensitisation are 
able to produce singlet oxygen intracellularly (Tyrrell and Pidoux, 1989; Ryter and 
Tyrrell, 1999), along with other ROS. Various ROS and reactive nitrogen species (RNS), 
including H2O2 and NO, have been shown to modulate IRE binding activity and 
dissociate the iron sulphur cluster of the IRP holoprotein (see introduction of this 
chapter). We postulate that the iron release observed under our conditions is more 
effective in dictating the fate of the IRP under moderate doses of UVA (up to 250 kJ/m2) 
than ROS or RNS. This may reflect a defence mechanism that has adapted/evolved to 
help cells cope better under oxidative stress. Maintenance of the integrity of the cluster 
prevents RNA binding and thus allows the synthesis of ferritin, which in turn leads to the 
sequestration of the dangerous ‘free’ iron species. UVA irradiation of cells with altered 
levels of PPEX would also appear to have little or no direct inhibition of cytosolic 
aconitase activity, despite these conditions being highly cytotoxic (under the more severe 
treatments). The inability of the ROS that have been generated by photosensitisation to 
inhibit or inactivate cytoplasmic aconitase activity is conceivably related to the inability 
of PPIX to locate near to (or within) the cytoplasmic aconitase and also to the restricted 
range of action of the ROS generated, particularly singlet oxygen (Moan and Berg, 1991).
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4. Flow cytometry-based method of determining membrane damage and changes in 
the intracellular chelatable iron pool, after ALA treatment and UVA irradiation
4.1 Introduction
The average human body contains about 4 g of iron and because of its low solubility in 
biological mileu, there is a necessity for iron-binding proteins. The functions of these 
proteins are not only to bind iron in a soluble, and in some cases in a form that is can be 
assimilated in cells, but also to prevent the iron from catalysing unwanted, potentially 
cytotoxic reactions intracellularly. Iron that is not bound and kept in a relatively inert 
form, can generate the highly toxic hydroxyl radical (OH) by Fenton and Haber-Weiss 
chemistry:
(Fenton reaction) Fe2+ + H2O2 —> Fe3+ + OH* + OH”
(Haber-Weiss reaction) Fe3+ + O2*” —» Fe2+ + O2
Fe2+ + H?Q, -> OH* + OH~ + Fe3+
Iron catalyst
Net: 0 2*'  + H20 2 -» OH* + OH” + 0 2
(Source: Halliwell and Gutteridge, 1999)
A variety of iron-binding proteins have been identified, with a wide variety of functions. 
These include proteins that are involved in the transport and storage of iron such as 
transferrin and ferritin (discussed in Chapters 3 and 5); iron-containing electron-transfer
102
Chapter 4: Flow cytometry-based method o f determining membrane damage and changes in the
intracellular chelatable iron pool, after ALA treatment and UVA irradiation
proteins of the mitochondrial respiratory chain such as cytochrome c and cytochrome 
oxidase; dioxygenases and mono-oxygenases which incorporate oxygen into substrates or 
use oxygen in hydroxylation reactions such as lipoxygenase and cytochrome P-450 
respectively; catalase and peroxidases such as glutathione peroxidase, enzymes which 
reduce H2O2 to H2O. Many other iron proteins exist, but most possess iron in forms such 
as haem and iron-sulphur clusters that mediate a range of essential biochemical processes 
in the mammalian cell through the versatile co-ordination and redox biochemistry of iron 
(reviewed by Cammack et al., 1990).
4.1.1 The Low Molecular Weight Iron Pool (LMW-Fe Pool)
A small amount of iron not bound to iron binding proteins has been postulated to be 
present in the cytosol. This pool provides the cell with a relatively accessible form of 
iron for incorporation into cytosolic enzymes and proteins. The constituents of this low 
molecular weight iron pool (LMW-Fe pool), are still unclear, but probably consist of both 
Fe2+ and Fe3+ ligands (reviewed by Crichton and Ward, 1992). Early studies (Bartlett, 
1976, Konopka and Szotov, 1972) indicated that this LMW-Fe pool was associated with 
nucleotides such ATP and GTP. Evidence confirming the importance of nucleotides as
9+ligands for the LMW-Fe pool was presented by the finding of receptors for ATP-Fe and 
ATP-Fe3+ on mitochondria (Weaver and Pollock, 1990) which would supply iron for 
haem biosynthesis. Many other ligands have also been suggested as possible components 
of the LMW-Fe pool. These include pyrophosphates, nucleic acids, lipids, glycogen, 
riboflavin, ascorbate, sugars, amino acids, polypeptides, proteins, and uncharged growth 
factors (Crichton and Ward, 1992; and references cited therein), but none of these ligands
103
Chapter 4: Flow cytometry-based method of determining membrane damage and changes in the
intracellular chelatable iron pool, after ALA treatment and UVA irradiation
have been universally accepted as the major ligand for iron in the LMW-Fe pool. In a 
review by Richarson and Ponka (1997), it was observed that many of the studies involved 
in the identification of iron ligands were flawed for a variety of reasons including 
inappropriate and non-physiological conditions, as explained by the authors. More 
recently, using isolated rat liver nuclei, Gurgueira and Meneghini (1996) reported ATP- 
dependent uptake systems for iron-citrate and iron-ATP chelates suggesting that these 
may be of physiological importance.
4.1.2 Determination o f Low Molecular Weight-Fe Pool
Attempts to quantificate and assess the LMW-Fe pool have, in the past, relied on methods 
that homogenise cells and tissues and the iron content is then determined using electron 
paramagnetic resonance (EPR) with iron chelators (Yegorov et al., 1990; Koslov et al., 
1992), or used Mossbauer spectroscopy of chelated iron (St Pierre et al., 1992). All the 
physicochemical methods used, either required cell disruption or relatively large amounts 
of tissue because of the low sensitivity of the method. None of these methods involve 
dynamic measurements of changes in the iron pool (Epsztejn et al., 1997). One method 
designed to assess the LMW-Fe pool involved addition of an iron chelator, nitrobenz- 
furazan-desferrioxamine (NBD-DFO), that was also a fluorescent probe (Lytton et al., 
1992). The method was based on the capacity of NBD-DFO to enter and extract iron 
from cells causing physical disruption. Binding of iron to this fluorescent probe 
quenched its fluorescence, and subsequent removal restored fluorescence which, in turn, 
could be used to provide a quantitative determination of iron content. Problems 
associated with this method, however, were that the probe had a low quantum yield, poor
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of its high affinity for iron (Epsztejn et al., 1997).
It was recently shown recently (Breuer et al., 1995; Breuer et al., 1995a) that calcein 
(CA), a fluorescein molecule with two ethylenediamine diacetate-like moieties (Fig 4.1)
iron. This is because, upon stoichiometric binding (1:1) of an appropriate metal (i.e. 
iron), CA’s fluorescence is quenched. CA, which has a high quantum yield, can be easily 
loaded into cells by its esterified, non-fluorescent analogue, calcein-AM (acetoxymethyl 
ester). Calcein-AM (CA-AM) crosses intact cell membranes and is cleaved by 
intracellular esterases to produce CA, a polar highly fluorescent molecule, that is retained 
in healthy cells, but can leak from cells with damaged membranes (Haugland, 1992).
Fig. 4.1. The chemical structure o f (a) calcein (CA) and (b) salicylaldehyde isonicotinoyl hydrazone (SIH).
By adding a permeant chelator, such as salicylaldehyde isonicotinoyl hydrazone (SIH) 
(Fig.4.1), the concentration of iron that is bound to CA can be revealed (Breuer et al., 
1995; Cabantchik et al., 1996). Changes in fluorescence, evoked by SIH addition,
chelatable iron pool, after ALA treatment and UVA irradiation
cell tolerance, and it was difficult to assess the amount of iron bound to the probe because










provides a basis for the dynamic monitoring of cytosolic iron in living cells using
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spectrofluorimetry (Breuer et al., 1995a). These fluorescence changes can be translated, 
by means of calibration, to provide an estimate of the chelatable iron pool within cells 
(Breuer et al., 1996; Epsztejn et al., 1997) which is also known as the labile iron pool. 
This pool is comprised of all chelatable, rapidly exchangeable forms of iron. The
a  I ^  i
liganded form of iron is in dynamic equilibrium between the Fe and Fe forms, though 
Fe2+ is the only soluble free-form of iron. The levels of LIP can be raised artificially by 
adding iron in different forms, such as diferric transferrin or ferrous ammonium sulphate. 
Conversely, it can be decreased artificially by the addition of iron chelators such as 
desferal. Addition of CA to cells will shift the equilibrium of the LIP to CA-bound forms 
of iron resulting in the quenching of CA fluorescence. CA has two metal binding 
moieties with affinity constants for Fe2+ and Fe3+ identical to EDTA, 1014 and 1024 M*1 
respectively (Breuer et al., 1995a), and it has been deduced (Epsztejn et al., 1997) that the 
Fe2+ bound form of CA is in rapid equilibrium with Fe2+. SIH is a fast (cell) permeating, 
high affinity (tridentate) iron chelator, which can chelate both Fe2+ and Fe3+ forms of iron 
and has a binding constant for Fe3+ of 1029 NT1 (Tsafack et al., 1996). Addition of excess 
SIH to cells rapidly shifts the equilibrium to the chelator bound form. This evokes a rise 
in CA fluorescence and gives a direct reflection of the amount of iron bound to CA.
After the development of this assay a number of different studies were performed to 
assess changes in the chelatable iron pool after various treatments. It was shown in 
human erythroleukemia cells (Breuer et al., 1996) that brief exposure to the Fe2+ salt, 
ferrous ammonium sulphate (FAS), caused a rise in the chelatable iron pool. Oxidative 
treatment in the form of hydrogen peroxide (H2O2), or reductive treatment in the form of 
P-mercaptoethanol (ME), both caused rises in the chelatable iron pool. These rises were
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attributed to reductive iron release from ferritin. Similarly, a different study (Breuer et 
al., 1997) using erythroleukemia cells that were treated with diferric transferrin, and 
subsequently treated with the oxidants f-butyl hydroperoxide (TBHP) or H2O2 , showed 
increases in the chelatable iron pool. The source of this increase of chelatable iron, 
normally undetectable using this assay, was suggested as being Fe3+ tightly bound to 
ligands such as ferritin, nucleotides, or polypetides that may be susceptible to reductive 
release. The viability of cells in these studies was determined using the trypan blue 
exclusion assay, an assay which gives an indication of cell membrane damage.
4.1.3 Calcein as an Indicator o f Membrane Damage
The fluorescent probe CA has recently been used to assess viability in cells exposed to 
aminolevulinic acid (ALA), followed by exposure to light (Campbell et al., 1996). As 
mentioned above, CA-AM added to cells can be converted to fluorescent CA by cells 
with functional intracellular esterases (located on the plasma membrane) and is retained 
in healthy cells with intact membranes. Treatment that causes injury to cells may result 
in a reduction of CA fluorescence of those cells because either a lower quantity is 
produced by damaged esterases, or CA has leaked from the cell through a damaged 
plasma membrane.
4.1.4 Objectives o f this study
In a recent study (Pourzand et al., 1999) it was demonstrated using the calcein assay, that 
treatment of primary human fibroblasts with UVA radiation resulted in an increase in the 
chelatable iron pool. UVA has also been shown to cause membrane damage and reduce 
the survival of cultured human fibroblasts (Gabroriau et al., 1993; Applegate et al.,
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1994). The objective of this present study was to develop a method that could measure 
simultaneously both changes in the intracellular chelatable iron pool, and also a 
parameter of viability, such as membrane damage, of cells that had been treated with 
ALA and/or UVA irradiation. We demonstrate in this study a flow cytometry based 
method that can measure both of these parameters, using the fluorescent probe calcein.
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4.2 Methods
4.2.1 Cell Culture
The primary human fibroblast cell line, FEK4, and the immortalised human keratinocyte 
cell line, HaCaT, were cultured as described in sections 2.2.2 and 3.2.1 respectively.
4.2.2 Chemical Treatment and Irradiation Conditions
FEK4 cells were treated with ALA as described in section 2.2.3. Both FEK4 and HaCaT 
cells were treated with desferal by preparing a 100 pM solution using the appropriate 
conditioned cell culture media. These solutions were then added back to the cells, which 
were incubated for 18 h at 37°C. Prior to irradiation, 80% confluent cells were washed 
with PBS and removed by trypsinsation (0.25%, 10 min). Cells were collected, spun for 
5 min at 1000 rpm, then re-suspended in PBS supplemented with 0.01% Ca2+ and Mg2+ 
(Keyse and Tyrrell, 1989) at a density of 5 x 105 cells/ml. Irradiation conditions are 
described in section 2.2.6. Cell suspensions were UVA irradiated in quartz vessels 
(Scientific Laboratory Supplies, UK) that were agitated on a mixing platform (IKA 
Laboratechnik, Germany). Sham-irradiated cells were treated in the same manner.
4.2.3 Loading o f Cells with Calcein for Analysis using Flow Cytometry 
Immediately after irradiation, cells were collected and centrifuged for 5 min at 1000 rpm. 
The supematent was then removed and cells were re-suspended at a density of 1 x 105 
cells/ml with 0.05 pM calcein-acetoxymethyl ester (CA-AM) (Molecular Probes, USA) 
for 15 min at 37°C in bicarbonate-free, serum-free medium containing 1 mg/ml BSA 
(bovine serum albumin), 20 mM Hepes, pH 7.3 (CA-AM was added from a concentrated
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stock solution in DMSO). After CA-AM incubation, cells were washed of excess CA- 
AM using PBS, re-suspended in CA-AM free loading medium at a density of 5 x 105 
cells/ml, and maintained on ice until flow cytometry analysis.
4.2.4 Analysis o f Calcein-Loaded Cells using Flow Cytometry
For analysis of damage to intracellular esterases and determination of the chelatable iron 
pool within cells using flow cytometry, a specific set-up was designed so that during 
analysis, cells were stirred using a magnetic stirring bar (Merck, UK) whilst maintained
at 37°C (see Fig 4.2).
Fig 4.2. Flow cytometer set-up to keep cells stirred and incubated at 37°C for analysis o f damage to 
intracellular esterases and changes in the chelatable iron pool.
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Immediately prior to measurement, 1 ml of calcein(CA)-loaded cells (5 x 105 cells) were 
centrifuged for 1 min at 3000 rpm, then re-suspended in 1 ml of pre-warmed Hepes 
buffered saline solution (HBS buffer), composed of PBS with 20 mM Hepes and 150 mM 
NaCl, pH 7.3. The cell suspension was placed in flow cytometer tube (Becton Dickinson, 
UK) and cells were analysed using a FACS (fluorescence activated cell sorter) Vantage 
flow cytometer (Becton Dickinson, UK). The flow cytometer used an argon ion laser at 
488 nm (100 mW) for excitation, and measured emission fluorescence at 525 nm with a 
band pass filter (± 30 nm).
4.2.5 Determination o f Intracellular Esterase and Membrane Damage
The mean CA fluorescence of 10000 cells after addition 100 pM of the cell permeant iron 
chelator salicylaldehyde isonicotinoyl hydrazone (SIH) (which was kindly provided by P. 
Ponka, Canada) was obtained for each sample. Membrane damage and intracellular 
esterase inactivation of UVA-irradiated cell populations was determined by comparing 
the fluorescence of these populations to that of the sham-irradiated controls, and 
expressing it as a percentage.
4.2.6 Estimation o f the Intracellular Chelatable Iron Pool
The mean fluorescence of 10000 CA-loaded cells was obtained. The highly cell 
permeant iron, chelator SIH (100 pM), was then added and the increase in fluorescence 
(as SIH de-quenched CA fluorescence by chelating iron bound to CA) was monitored 
until a steady signal was obtained (usually within 2 min). The mean fluorescence of 
10000 cells was obtained once more, and the mean change in fluorescence was
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determined by subtracting the mean fluorescence of the cells pre-SIH treatment from the 
mean fluorescence of the SIH treated population. To convert this fluorescence change to 
a quantitative determination of intracellular chelatable iron, it was necessary to calibrate 
the system using iron. CA-loaded cells were prepared as mentioned above. A stock 
solution of ferrous ammonium sulphate (FAS) was prepared by dissolving the compound 
in Milli-Q water (Millipore, UK) and maintaining the solution under argon to prevent 
oxidation. The liquid was also bubbled with argon before use. By monitoring the 
fluorescence of CA-loaded cells (using flow cytometer, as described above), the 
calibration was performed by first adding 1 pM of the divalent metal ionophore A23187 
(from a concentrated stock solution in DMSO). This substance increases the 
permeability of cell membranes to divalent metal ions and when the metal is added, 
equilibration (of the metal) occurs between the cell and the medium. Sequential additions 
of aliquots of FAS were added to obtain 0.25 pM step increases of metal concentration, 
and the discrete decreases in fluorescence elicited were monitored and recorded. The 
fluorescence recording of 10000 cells was not taken until a stable fluorescence signal was 
obtained after each FAS addition (1-2 min). Addition of 100 pM SIH results in 
restoration of CA fluorescence.
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The data obtained by FAS titration can be fitted by a first order exponential decay 
function (Fig. 4.9) relating the two variables y  and x which are fluorescence and FAS 
concentration respectively:
y  = yo + Ae (x//)
Where yo, A and t are constants. By adding SIH to CA-loaded cells, de-quenching of CA 
fluorescence occurs which is a measure of the amount of iron that was bound to CA. By 
inserting this fluorescence change value into the function described above, an estimation 
of the concentration of chelatable iron pool was derived.
4.2.7 Statistical Analysis
Results are expressed as the mean ± one standard deviation. Significant differences (p< 
0.05) were determined by an unpaired t test.
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4.3 Results
4.3.1 Comparison o f Size and Granularity o f FEK4 Primary Human Fibroblasts and 
HaCaT Immortalised Human Keratinocytes using Flow Cytometry 
Fig 4.3 shows the forward scatter and side scatter of FEK4 and HaCaT cells as 
determined by flow cytometry. A laser beam is directed at a tight stream of fluid 
containing a dispersion of cells. As the laser beam hits the cells, the light is scattered and 
is registered by detectors positioned in front of (forward scatter, FSC), and perpendicular 
(side scatter, SSC) to the flow of cells. Forward scatter gives a measure of size and side 
scatter gives a measure of granularity of cells. Figs. 4.3a and b are dotplots of forward 
scatter verses side scatter of HaCaT and FEK4 respectively. Frequency histograms (and 
their mean values) are also depicted showing the forward scatter (Fig. 4.3c) and side 
scatter (Fig. 4.3d) of the two cell lines (HaCaT histograms are grey and FEK4 histograms 
are black). From this data, it can be concluded that FEK4 is a larger, more granular cell 
than HaCaT. From observation under a light microscope, FEK4 certainly appears larger. 
One thing that should also be noted is, that after trypsinisation, cells sometimes do not 
detach completely from one another (this is particularly noticeable with HaCaT cells). 
Some of the scatter picked up may therefore be from cell aggregates, thus contributing to 
a larger mean scatter value.
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Fig. 4 3 . Flow cytometry dotplots (a and b) and frequency histograms (c and d) o f HaCaT immortalised 
human keratinocytes (a) and FEK4 primary human fibroblasts (b). Data shows the forward scatter (FSC) 
and side scatter (SSC) obtained from these two cell lines, which reflect size and granularity respectively. 
Grey histograms indicate HaCaT data and black histograms indicate FEK4 data. The mean FSC (c) and 
SSC (d) values of the two cell lines are also included.
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4.3.2 Effects o f UVA Irradiation on Cell Size and Granularity
Fig. 4.4 shows forward scatter verses side scatter dotplots of a sham irradiated population 
of FEK4 primary human fibroblasts (Fig. 4.4a), and a population irradiated with 500 
kJ/m UVA radiation (Fig. 4.4b). Figs. 4.4c and d show the forward scatter (Fig. 4.4c) 
and side scatter (4.4d) frequency histograms of both cell populations (sham-irradiated cell 
histograms are black and 500 kJ/m UVA irradiated cell histograms are grey). A 
threshold is normally set on the forward scatter, which means that any cells or particles 
that fall below this threshold size are not recorded. This effectively gates out debris and 
fragmented cells. From this data it is clear that UVA causes the cells to shrink and' 
reduces their granularity. Although this is an extreme example of what happens to cells 
after UVA irradiation, the example is used to clearly show the point. Cells probably 
shrink and express reduced granularity because of damage to the cell membrane, which 
concomitantly results in leakage of intracellular components.
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Fig. 4.4. Flow cytometry dotplots (a and b) and frequency histograms (c and d) FEK4 primary human 
fibroblasts either sham-irradiated (a) or treated with 500 kJ/m2 UVA radiation. Black histograms and 
dotplots indicate sham-irradiated cells and grey histograms and dotplot indicate UVA treated cells data. 
The mean FSC (c) and SSC (d) values of the two cell lines are also included.
o o o -
(b) 2
500 kJ/m2 UVA
—  °  3= °O>«> <D
X
o



































"I |  S 1 1 1 ^  • » ■ * I  •  •  • *  |  ■ ■ ■ ■ I
200 400 600 800 1000
FSC-Height
117
Chapter 4: Flow cytometry-based method o f determining membrane damage and changes in the
intracellular chelatable iron pool, after ALA treatment and UVA irradiation
4.3.3 An Example o f the Effect o f ALA Incubation and UVA Irradiation on the 
Production o f Fluorescent Calcein by Intracellular Esterases
As discussed in the introduction, cells with functional intracellular esterases can convert 
exogenously added CA-AM to fluorescent CA. This CA is retained in healthy cells with 
intact membranes. Treatment of cells that results in inactivation of intracellular esterases 
and damage to cell membranes can affect the ability of cells to produce and retain CA. 
Acquired intracellular fluorescence is probably the most important parameter determined 
by a flow cytometer. In the example shown here (Fig 4.5), cells are treated with either 
ALA alone, or ALA followed by UVA. The two populations are then incubated at 37°C 
for 15 min with CA-AM. This allows cells with functional esterases to cleave CA-AM 
producing fluorescent CA, and in turn, gives an indication of how healthy a population is. 
Intracellular CA fluorescence is measured using flow cytometry and Fig. 4.5 shows an 
example of fluorescence frequency histograms of cells treated with 200 pM ALA alone 
for 18 h (black histogram), and cells treated with ALA followed by a dose of 100 kJ/m2 
UVA (grey histogram). On the diagram, FL-1 is fluorescence intensity detected at 525 
nm (± 30 nm), and calcein fluorescence emission peaks at 535 nm. The higher the FL-1 
value, the greater the intracellular CA fluorescence intensity is. It is clear from the 
example depicted (Fig. 4.5) that ALA incubation (200 pM, 18 h) followed by UVA 
irradiation (100 kJ/m2) results in a marked decrease in the mean fluorescence intensity 
(i.e. CA production and retention).
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Fig. 4.5. Flow cytometry frequency histograms o f FEK4 primary human fibroblasts treated with 200 jiM  
ALA for 18 h and either sham-irradiated (black histogram) or irradiated with a dose of 100 kJ/m2 UVA 
(grey histogram). FL-1 is a measure o f calcein fluorescence intensity of the cells. The mean calcein 
fluorescence of the two cell populations is included.
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4.3.4 Effects o f UVA Irradiation on Calcein Fluorescence in FEK4 Primary Human 
Fibroblasts and HaCaT Immortalised Human Keratinocytes
Fig.4.6 shows the detrimental effect of graded doses of UVA radiation on the CA 
fluorescence in both FEK4 fibroblasts and HaCaT keratinocytes. CA fluorescence of 
UVA treated cells is expressed as a percentage of the CA fluorescence observed in sham- 
irradiated controls. The amount of CA produced intracellularly (after 15 min CA-AM 
incubation) in both cell lines is clearly reduced as a function of UVA dose, suggesting 
either that damage has occurred to intracellular esterases or that CA is lost from the cells 
as a result of damaged plasma membranes. The observed effect appears to be more 
pronounced in the fibroblasts than the keratinocytes, suggesting that the FEK4 are more 
sensitive to UVA-induced damage. All data that was obtained by measuring intracellular 
CA fluorescence reductions as a result of (ALA and/or) UVA treatment was determined 
after the addition of the cell permeable iron chelator, SIH, to the cells being analysed. 
The purpose of this was to remove any artifactual quenching of CA fluorescence by 
intracellular ‘free’ iron (see below for details).
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Fig. 4.6. UVA dose-dependent reduction in calcein fluorescence reduction in FEK4 fibroblasts and HaCaT 
keratinocytes, as a result of intracellular esterase inactivation and loss o f calcein through damaged 
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4.3.5 Effects o f ALA Incubation and UVA Irradiation on the Production o f  
Fluorescent Calcein by Intracellular Esterases in FEK4 Primary Human Fibroblasts 
The effects of either 4 and 18 hours ALA incubation, followed by UVA irradiation (of 
doses up to 100 kJ/m ) on the CA fluorescence in FEK4 cells is shown in Fig. 4.7a and b 
respectively. From the graphs, reduction in intracellular CA fluorescence appears to be 
dose dependent with respect to ALA concentration and UVA dose. The results obtained 
after 4 and 18 hours ALA incubation followed by UVA irradiation are not significant. 
Dark toxicity of ALA was tested and found to have no affect on CA levels detected 
compared to non-treated controls (data not shown).
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Fig. 4.7. UVA dose-dependent reduction of calcein fluorescence in FEK4 fibroblasts treated with ALA for 
either 4 (a) or 18 (b) hours. Data represent the mean of 3-4 experiments (± S.D.).
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4.3.6 Determination o f  the Chelatable *Free' Iron Pool using the Cell Permeable Iron 
Chelator Salicylaldehyde Isonicotinol Hydrazone (SIH)
Calcein not only gives an indication of the state of health of a cell population, it also 
serves as a metallo-sensitive probe. Its fluorescence is quenched due to stoichiometric 
(1:1) binding of iron. Addition of the cell permeable chelator SIH results in the de- 
quenching of CA fluorescence, by the removal of iron, because of SIH has a greater 
affinity for iron than CA. This, in turn, can give an indication of CA-sensitive iron levels 
in the cytosol, which we refer to as chelatable ‘free’ iron levels. Fluorescence changes 
can be monitored using a flow cytometer, thus changes in chelatable ‘free’ iron as a result 
of a specified treatment, such as UVA irradiation, can be estimated using this system. 
Fig.4.8 shows an example of the frequency histograms of CA fluorescence intensity 
produced by HaCaT cells after either sham-irradiation (Fig.4.8a), or after a UVA dose of 
250 kJ/m (Fig.4.8b). The black histograms represent the two cell populations before 
SIH treatment, and the grey histograms represent cells treated with 100 jiM SIH. The 
mean fluorescence of each histogram is also included for clarification. From this data it 
is clear that SIH can de-quench CA fluorescence by chelating iron (seen by the increase 
in CA fluorescence intensity) and that UVA increases this chelatable iron pool.
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Fig. 4.8. Calcein fluorescence frequency histograms o f HaCaT keratinocytes either sham-irradiated (a) or 
have been irradiated with a dose 250 kJ/m2 UVA radiation (b). Black histograms indicate fluorescence 
before SIH treatment and grey histograms indicate fluorescnce after 100 fiM SIH treatment. Mean 
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4.3.7 Estimation o f  Chelatable * Free* Iron Levels
In order to translate the apparent change in fluorescence by the addition of SIH, to a 
quantitative estimate chelatable ‘free’ iron, it was necessary to calibrate CA-loaded cells 
with iron. Fig.4.9 shows an example of a typical calibration of CA-loaded cells (FEK4 
fibroblasts in this example) by titration with ferrous ammonium sulphate. Sequential 
additions of (0.25 juM) FAS added to CA-loaded cells resulted in decreases in 
fluorescence and this was monitored using flow cytometry. The data obtained by the 
titration can be fitted by a first order exponential decay function (see 4.2.5). This 
function, in turn, is used to estimate of the pM concentration of the intracellular ‘free’ 
iron pool (see 4.2.5).
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Fig. 4.9. Typical calibration of calcein-loaded cells (FEK4 primary human fibroblasts) with sequential 
(0,25 pM) aliquots of ferrous ammonium sulphate (FAS). Calcein fluorecence is monitored using flow 
cytometry.
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4.3.8 Effect o f UVA Irradiation on the Concentration o f Chelatable Iron Pool o f FEK4 
Primary Human Fibroblasts and HaCaT Immortalised Human Keratinocytes 
Tables 4.1 and 4.2 show the effects of graded doses on the chelatable iron pool of FEK4 
and HaCaT respectively, measured using flow cytometry. UVA radiation appears to 
cause a dose dependent increase in the chelatable iron pool in both cell lines. Relative 
increases appear lower in FEK4 compared to HaCaT, e.g. after 500 kJ/m2 UVA, FEK4 
showed approximately a 210% increase in the chelatable iron pool when compared to 
non-irradiated controls. A 420% increase was observed in the HaCaT cells after the same 
UVA dose. However, FEK4 possess a chelatable iron pool that is approximately 3 times 
bigger than that of the HaCaT, 0.08024 pM compared to 0.02727 pM. The absolute 
increases in chelatable iron that are observed in the FEK4 and HaCaT after 500 kJ/m 
UVA, are approximately 0.16843 pM and 0.11415 pM respectively (calculation of these 
values is described in 4.2.5). Treatment of both cell lines with the iron chelator desferal 
for 18 h (100 pM) removed all chelatable iron so that there was no change in CA 
fluorescence after 100 pM SIH addition.
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Table 4.1. The concentration o f chelatable iron in the FEK4 primary human fibroblasts after UVA  
irradiation or desferal treatment. Measurements were performed immediately after irradiation. Data 
represent the mean o f 3-4 independent experiments (± S.D.).
Treatm ent Chelatable iron (jliM )
Non-irradiated 0.08024 ±0.01747
100 kJ/m2 UVA 0.11179 ±0.0126*
250 kJ/m2 UVA 0.19903 ±0.01612*
500 kJ/m2 UVA 0.24867 ±0.01629*
18 h Desferal (100 jiM) 0.000 ±  0.000*
Statistical analyses were made using an unpaired t test, 
control ip < 0.05 level).
*, Significantly different from non-irradiated
Fig 4.2. The concentration o f chelatable iron in the HaCaT immortalised human keratinocytes after UVA  
irradiation or desferal treatment. Measurements were performed immediately after irradiation. Data 
represent the mean o f  3-4 independent experiments (± S.D.).
Treatm ent Chelatable iron (jiM )
Non-irradiated 0.02727 ± 0.0645
100 kJ/m2 UVA 0.04717 ±0.01244
250 kJ/m2 UVA 0.09259 ±0.01489*
500 kJ/m2 UVA 0.14142 ±0.02216*
18 h Desferal (100 joM) 0.000 ±  0.000*
Statistical analyses were made using an unpaired t test. *, Significantly different from non-irradiated 
control ip < 0.05 level).
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4.3.9 Effects o f ALA Incubation and UVA Irradiation on the Concentration Chelatable 
Iron Pool o f FEK4 Primary Human Fibroblasts
Table 4.3 shows the effects of incubation with ALA and irradiation with UVA, on the 
concentration of chelatable iron in FEK4 cells, measured using flow cytometry. 
Compared to the non-treated control, incubation with ALA concentrations up to 200 pM, 
for either 4 or 18 hours, led to a reduction in chelatable iron of up to 25%. The longer 
incubation reduced chelatable iron levels more effectively. Cells that were treated with 
100 pM ALA for 4 h, followed by UVA irradiation of either 50 or 100 kJ/m2, showed 
increases of 80% (0.06202 pM) and 130% (0.10124 pM) respectively compared to the 
sham-irradiated control. In contrast, cells treated with 200 pM ALA for the same period 
showed only an increase of approximately 20% (0.01323 pM) after 50 kJ/m2 UVA, and a 
decrease of almost 40% (0.02655 pM) after 100 kJ/m2, compared to the sham-irradiated 
control. The 18 h ALA incubations resulted in similar trends to those observed after 4 h, 
though the changes were less dramatic. For example, the 18h, lOOpM ALA incubation 
resulted in a dose dependent increase in chelatable iron levels up to 70% (0.05 pM) after 
100 kJ/m2 UVA, compared to the non-irradiated control. The 200 pM ALA treatment 
showed an increase of only approximately 8% (0.00485 pM) after 50 kJ/m2 UVA, and a 
decrease of around 12% (0.00697 pM) after 100 kJ/m2. The lowest absolute level of 
chelatable iron measured was after 4h, 200 pM ALA treatment, which resulted in a level 
of 0.04454 pM.
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Fig 4.3. The concentration of chelatable iron in the FEK4 primary human fibroblasts after ALA treatment 
and UVA. Measurements were performed immediately after treatment. Data represent the mean o f 3-5 
independent experiments (± S.D.).
ALA Treatment Chelatable Iron (fiM)
Non ALA-treated, non-irradiated 0.08024 ±0.01747
4 h 100 jiM non-irradiated 0.07736 ±0.01077
4 h 100 nM 50 kJ/m2 UVA 0.13938 ±0.01061*
4 h 100 |iM 100 kJ/m2 UVA 0.1786 ±0.02746*
4 h 200 |iM non-irradiated 0.07109 ±0.00806
4 h 200 nM 50 kJ/m2 UVA 0.08432 ±0.0115
4 h 200 nM 100 kJ/m2 UVA 0.04454 ± 0.009*
18 h 100 jiM  non-irradiated 0.07388 ± 0.00958
18 h 100 nM 50 kJ/m2 UVA 0.103432 ±0.02396*
18 h 100 pM 100 kJ/m2 UVA 0.12389 ±0.00743*
18 h 200 juM non-irradiated 0.05924 ± 0.00457
18 h 200 (J.M 50 kJ/m2 UVA 0.06409 ± 0.00778
18 h 200 jiM 100 kJ/m2 UVA 0.05227 ± 0.00682
Statistical analyses were made using an unpaired t test. *, Significantly different from the corresponding 
non-irradiated control ip  < 0.05 level).
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4.4 Discussion
The purpose of the study presented in this chapter was to provide an assay that could 
measure simultaneously two important parameters that appear to be affected by UVA. 
These parameters are a reduction in the viability of a cell population as reflected by 
damage to the plasma membrane, and changes in intracellular ‘free’ iron levels. We 
initially expected to use a combination of two totally different assays, which use entirely 
different approaches. However, we are able to combine two assay systems that were 
developed independently to provide both pieces of data in a single procedure based on the 
measurement of calcein fluorescence by flow cytometry.
Campbell and co-workers (1996) used an assay involving two fluorescent probes, calcein 
(CA) and ethidium homodimer-1 (EthD-1), that they claimed could measure and 
determine cell survival after treatment with ALA and graded doses of 600-700 nm light 
(i.e. an in vitro method to study the effects of ALA-PDT). These two fluorescent probes 
were part of a kit known as the Live/Dead Eukolite Viability/Cytotoxicity Kit (Molecular 
Probes, USA). The principle behind this kit was that it could provide reciprocal 
(fluorescent) staining of treated cells that could be measured by flow cytometry to 
indicate viability of those cells, i.e. high CA fluorescence and low EthD-1 fluorescence 
indicated a viable (or healthy population), and vice versa. Changes in chelatable iron 
have been performed previously using an assay developed and optimised by Cabantchik 
and co-workers (Epsztejn et al., 1997). This assay, also known as the calcein assay, 
monitored changes in calcein fluorescence in response to changes in chelatable iron as 
measured by spectrofluorimetry.
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By combining various aspects of these two assays and using one fluorescent probe, 
calcein, we have developed an assay that can provide an indication of viability, such as 
membrane damage (following a specified treatment), and concomitantly measure 
changes in the intracellular chelatable iron pool of that population. In showing the 
development stages of this assay (in the results section), the conditions shown in each 
example are varied (i.e. cell line and treatment). This was done mainly to emphasise a 
point more clearly, but all the information, including size (forward scatter, granularity 
(side scatter) and acquired calcein fluorescence is obtained and recorded for each sample 
measured using flow cytometry.
Fig. 4.3 shows the size and granularity of the two cell lines (FEK4 primary human 
fibroblasts, and HaCaT immortalised human keratinocytes) as measured by flow 
cytometry. Consistent with observations made using a light microscope (mentioned in 
the results), HaCaT are approximately 10% smaller than FEK4 (indicated by forward 
scatter), as determined by flow cytometry. The apparent lower granularity of HaCaT 
cells (indicated by side scatter) may also be, to some extent, related to HaCaT being 
smaller a cell. However, side scatter is an indication of specific structures within a cell 
(i.e. granularity), such as organelles, large proteins or anything within the cell that can 
cause the target laser to scatter light perpendicularly to its trajectory. The greater side 
scatter exhibited by FEK4 would suggest that it contains a greater quantity of such 
structures. As an example, FEK4 contains approximately a 4-fold higher level of the iron 
storage protein ferritin (see Chapter 5), which may contribute to side scatter because of 
the iron stored within it.
133
Chapter 4: Flow cytometry-based method o f determining membrane damage and changes in the
intracellular chelatable iron pool, after ALA treatment and UVA irradiation
An example of the effect of UVA radiation (500 kJ/m2) on cell size (FSC) and granularity 
(SSC) is shown in Fig. 4.4. It was observed by light microscopy that cells appear to 
shrink after UVA treatment. This is also clear when comparing the FSC frequency 
histograms of sham-irradiated cells and those irradiated with 500 kJ/m UVA. 
Presumably damage to the plasma membrane as a result of UVA irradiation may cause 
leakage of intracellular contents. From the comparison of the SSC frequency histograms, 
it would appear that intracellular components are also either leaking out of the irradiated 
cells, or are degraded, as reflected by the reduction in SSC. UVA can cause membrane 
damage (reviewed by Tyrrell, 1991). For example, and in a study using human skin 
fibroblasts and lactate dehydrogenase (LDH) release as the marker (Gabroriau et al., 
1993), it was shown that plasma membranes were damaged by UVA irradiation.
It has been mentioned previously in this chapter that injury to cells can reduce the amount 
of fluorescent CA produced by a cell population by either, inactivation of intracellular 
esterases, or by rupturing the cell membrane and thereby allowing the leakage of 
intracellular CA. Fig. 4.5 shows the most extreme treatment used in this study, 200 pM 
ALA treatment for 18 h followed by 100 kJ/m2 UVA irradiation. Also shown is the 
sham-irradiated control. CA fluorescence intensity is denoted FL-1 Height on the 
frequency histogram. It is quite clear in this example that the population (ALA treated, 
then) irradiated have a marked reduction in mean intracellular CA fluorescence. For the 
presentation of our results using intracellular CA levels as an indicator of viability, we 
have not represented decreases in CA fluorescence in terms of percentage survival, as has
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been the case previously (Campbell et al., 1996). The results herein are presented in 
terms of CA fluorescence of treated cells as a percentage CA fluorescence of non-treated 
controls. This represents inactivation of intracellular esterases and membrane damage 
and this can be interpreted as a measure of viability following treatment.
Fig.4.6 shows the effect of UVA alone on the reduction of intracellular CA content in 
both FEK4 fibroblasts and HaCaT keratinocytes. CA content is effectively reduced in a 
UVA dose-dependent manner in both cell lines, but FEK4 appeared to be more sensitive 
to the UVA treatment as compared with the HaCaT keratinocytes. In previous 
experiments with keratinocytes and fibroblasts (Applegate et al., 1995: Leccia et al.,
1998), keratinocytes have been shown to be more resistant to UVA-induced cell 
membrane damage. This has been attributed to higher antioxidant content in these cells 
as compared with fibroblasts (Leccia et al., 1998). In our study, an additional factor that 
may play a role in the HaCaT’s resistance to UVA, is its low iron content. The low 
chelatable iron concentration and also the lower UVA-induced levels of iron release 
observed in the HaCaT cells may limit the damaging affects observed in this cell line 
after UVA irradiation, such as iron-catalysed hydroxyl radical formation and lipid 
peroxidation (Halliwell and Gutteridge, 1999).
Comparison of the CA fluorescence levels as measured after 4 and 18 hours ALA 
incubation, followed by UVA irradiation, reveals that there is not a significant difference 
between the damaging affects observed after the two incubations (Fig. 4.7). This is in 
contrast to the survival studies performed in Chapter 2 (Figs. 2.14 and 2.15) and which
135
Chapter 4: Flow cytometry-based method of determining membrane damage and changes in the
intracellular chelatable iron pool, after ALA treatment and UVA irradiation
was consistent with the possibility that suggest that the 4 h incubation results is a greater 
rate of cytotoxicity after UVA irradiation than 18 h ALA incubation.
It has been previously reported that UVA irradiation of FEK4 fibroblasts results in an 
increase in the chelatable ftee iron pool as measured by the calcein assay and 
spectrofluorimetry (Pourzand et al., 1999). In our study we tested the hypothesis that 
UVA-induced iron release could not only be detected and measured through monitoring 
CA fluorescence by flow cytometry, but that viability measurements could be undertaken 
in the same assay system. This was effectively achieved by adding the cell permeant iron 
chelator (SIH) which had two consequences. Firstly, it removed any iron from CA 
(which quenches its fluorescence), thus removing any artifactual quenching of 
fluorescence for the viability studies. Cells that had high intracellular iron levels after a 
specified treatment would appear to be less healthy then they actually were, if the iron is 
not removed from CA. Secondly, removal of this iron that caused artifactual quenching 
of CA fluorescence, in turn, provides a measure of intracellular chelatable iron in terms 
of a fluorescence increase (Fig. 4.8). The fluorescence increase observed could be 
translated to an estimate of intracellular chelatable iron by calibrating CA-loaded cells 
with FAS (section 4.3.7 and Fig. 4.9). Tables 4.1 and 4.2 show the affects of UVA 
irradiation on the intracellular chelatable iron pool in FEK4 fibroblasts and HaCaT 
keratinocytes respectively. Both cell lines show a dose dependent increase in chelatable 
iron levels as a function of UVA irradition, with FEK4 releasing a greater amount of iron 
compared to the HaCaT at the same dose. FEK4, on the other hand, has a chelatable iron 
pool around 3 times larger than the HaCaT cells. This difference, including a greater iron
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release after UVA, observed in FEK4 compared to HaCaT, was also evident in aconitase 
measurements (see Chapter 3). FEK4 cells also possess a much higher ferritin content 
(see Chapter 5). In a previous study (Pourzand et al., 1999), the author postulated that 
ferritin is a major source of this chelatable iron increase. In Chapter 5, the results are 
consistent with the conclusion that UVA leads to ferritin degradation, particularly in the 
FEK4 cells and this provides an explanation as to why there is a greater increase in 
chelatable iron observed in FEK4 as compared with HaCaT.
Incubation of FEK4 fibroblasts with ALA appears to have a modest effect on the 
reduction of the level of chelatable iron (Table 4.3). Stimulating the biosynthesis of 
PPIX may cause ALA to exert a chelative effect because the penultimate step in the 
production of haem is the insertion of iron into the tetrapyrrole ring of PPIX. This, in 
turn, could contribute to the lowering of the chelatable iron pool. Addition of the iron 
chelator desferal (100 juM, 18 h) effectively abolished the chelatabe iron pool in FEK4 
(Table 4.1), suggesting that the effect exerted by ALA as an iron chelator is minor 
compared to that of desferal. A decrease in aconitase activity was also observed after an 
identical ALA incubation (Chapter 3), as was a concomitant reduction in ferritin levels.
PPEX has been shown to locate within the ferritin molecule (Precigoux et al., 1994; 
Michaux et al., 1996) and it is also known to localise in hydophobic environments, 
particularly cell membranes (Ricchelli, 1995). Therefore, it is conceivable that UVA 
irradiation of PPIX in either of these locations could induce photosensitisation and 
aggravate damage to ferritin, resulting in concomitant iron release. PPIX located in
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ferritin could cause direct damage to the protein shell upon photosensitisation, or it could 
damage lysosomal membranes causing hydrolytic enzymes to spill out into the cytosol, 
which in turn, could degrade ferritin (Pourzand et al., 1999). We intended to show in this 
study whether or not ALA-induced PPIX could induce, or exacerbate the release of 
chelatable iron after UVA irradiation.
ALA treatment of cells followed by UVA irradiation appeared to result in two different 
phenomena depending on the concentration of ALA administered. UVA dose-dependent 
increases in the chelatable iron levels were observed with 100 pM ALA after both 4 and 
18 hours incubation. The absolute increases were higher after 4 h incubation, suggesting 
that the longer incubation had diminished the source of chelatable iron increase to some 
degree. In contrast, the 200 pM ALA incubation after both incubations showed a slight 
increase in the chelatable iron pool after 50 kJ/m2 UVA, but a decrease (below non- 
irradiated controls) after 100 kJ/m UVA irradiation. This would suggest that iron bound 
to CA is able to leak from cells with damaged plasma membranes, and that PPIX 
produced after incubation with ALA may contribute to this effect. The level of reduction 
of intracellular CA fluorescence after the higher ALA dose and irradiation with UVA 
(Fig. 4.8) would appear to support this hypothesis. In order to confirm this, extracellular 
CA levels would need to be determined, along with the bound iron. This could be done 
by performing similar spectrofluorimetric measurements on the supernatants of these 
cells after CA-AM incubation.
We report here that the flow cytometer can be used to detect changes in the chelatable 
iron pool of a population of cells, and concomitantly provide an indication of viability (as
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assessed by membrane damage) using the fluorescent probe calcein. This assay has an 
added advantage over the calcein assay because it can measure changes in intracellular 
‘free’ iron levels (similar to the calcein assay) and viability in the same procedure. The 
flow cytometer determines intracellular fluorescence, so loss of CA from cells provides 
part of the basis of determining membrane damage. The reduction in CA fluorescence, 
through inactivation of esterases, is also another indication of cell damage. With the 
calcein assay, this method of determining ‘viability’ is not possible as it measures both 
intracellular and extracellular fluorescence (i.e. total fluorescence). CA loss from cells 
with damaged membranes would therefore not be detected. To combat this, an anti- 
calcein fluorescence quenching antibody has been used with this method (Breuer et al., 
1995), which is intended to quench the fluorescence of any CA leaking from cells. 
However, in the same study it was shown that addition of this antibody to cells with 
permeabilised membranes resulted in 90% quenching in total CA fluorescence. The 
disadvantage of flow cytometry in only being able to detect intracellular fluorescence is 
manifested when chelatable iron measurements are made with cells that have damaged 
membranes. If iron bound to calcein leaks from these cells (which does appear to happen 
under certain conditions, see Table 4.3), then quantification of the total increase in 
chelatable iron by this method is not possible. However, this problem may be overcome 
using spectrofluorimetry, by either measuring extracellular CA loss and the iron bound to 
it, or by performing the iron measurements using the calcein assay.
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5. Study of the effects of ALA incubation and UVA irradiation on ferritin in human 
cells
5.1 Introduction
Iron is an essential nutritional element for most organisms and it plays a critical role in 
cellular processes such as electron transport and respiration, cell proliferation and 
differentiation, DNA synthesis and the regulation of gene expression. These major 
functions of iron rely on its ability to catalyse oxidation and reduction reactions by virtue 
of its ability to change valence states. Most iron present in organisms is complexed in 
proteins although some may also be present in a soluble pool of low molecular weight 
complexes such as ferric citrate and Fe3+ ATP (Weaver and Pollock, 1989). Despite iron 
being an essential element, excess ‘free’ iron can be toxic as in the presence of 
superoxide and hydrogen peroxide it can catalyse the formation of the highly reactive 
hydroxyl radical through the Fenton and Haber-Weiss reactions (Halliwell and 
Gutteridge, 1999). In turn, the hydroxyl radical can cause damage to a variety of 
biomolecules, and in particular, cause lipid peroxidation (see Chapter 1). Thus it is 
crucial for organisms to be able to protect against the toxic effects of iron and this is 
achieved be the sequestration of iron by two highly specialised iron-binding proteins, the 
extracellular transferrin and the intracellular ferritin (both binding iron in a relatively safe 
Fe3+ form). Potentially, iron can have a very damaging effect intracellularly, so the 
regulation of iron trafficking and iron storage is of major importance (discussed in 
Chapter 3).
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5.1.1 Ferritin
The ferritin molecule is a cytosolic hollow protein shell made up of 24 polypeptide chains 
(subunits) of two types, H (heavy) and L (light), with slightly different molecular weights 
of 21,000 and 19,000 respectively (for most animal species). The ferritin molecule is 
capable of storing up to 4500 Fe3+ atoms in a cavity as an inorganic complex where its 
weight can vary from approximately 450,000 (depending on H- and L- subunit 
composition) to approximately 900,000 depending on iron content. All ferritin molecules 
contain approximately an 8 nm iron-storage cavity within which an iron-core structure 
composed of an insoluble structure known as hydrated ferric oxide or ferrihydrite 5 Fe2 0 3  
• 9 H2O is formed (Towe, 1981). Normally, ferritin is only about 20% iron-saturated 
(Reif, 1992). There is a wide variation of the number of ferritin genes found between 
different species. The human genome, for example, contains 15 H-copies and 5-L-copies 
of the ferritin genes. The rat genome, in contrast, contains more than 20 L-copies and 
only 5 H-copies. Most copies are processed pseudogenes and it has been concluded that 
there is probably only one expressed copy of each type in both genomes (Munro, 1993). 
Various vertebrate ferritin amino acid sequences have been extensively characterised 
including those from human, horse, sheep, pig, rabbit, rat, mouse, chicken, and tadpole. 
The mammalian H- and L-ferritin polypeptide chain sequences show about 54% identity 
and approximately 90% of H-chain residues, and 85% of L-chains, are identical amongst 
mammals (Harrison and Arosio, 1996). Ferritins isolated from mammalian tissues 
consist of a mixture of isoferritins that range in iron content and subunit composition 
(Arosio et al, 1978). Twenty-five possible isoferritin compositions have been defined, 
made up of variations in subunit rations of H- and L-polypeptide chains. Generally,
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organs that store iron (liver and spleen) tend to be rich in L-rich ferritins that usually have 
a relatively high average iron content of 1500 Fe atoms/molecule or more (Harrison and 
Arosio, 1996). H-rich ferritins have a relatively low iron content of less than 100 Fe 
atoms/molecule and are more characteristic of organs such as the brain and heart.
The ferritin three-dimensional structures are more highly conserved than their primary 
structures. Each of the 24 subunits consists of a bundle of 4 long helical segments and 
one short helical segment that confer rigidity, with the remainder of the subunit 
consisting of non-helical segments connecting the helices. Apoferritin (ferritin devoid of 
iron) is assembled from 24 structurally equivalent subunits. In heteropolymers (mixed 
subunit molecules), H- and L-subunits have the same conformations enabling the 
formation of heteropolymers with a complete range of subunit compositions because 
there are many similar or identical residues in the subunits. It has been proposed that like 
chains cluster preferentially within the polymer (Luzzago et al., 1986). The large number 
of intra- and inter-subunit bonds (salt bridges and H-bonds) contributes to the apparent 
stability of apoferritin to heat. In the assembled apoferritin molecule, the 24 subunits are 
related by a 4-, 3-, and 2-fold symmetry axes. Subunits pack tightly together except, at 
the 3-fold axes where there are narrow channels traversing the shell. It has been 
proposed that these 3-fold channels are the main entry route of iron and are also Fe2+ 
oxidation sites (Wardwska et al., 1986; Stefanini et al.,1989;Yablonski et al., 1992; 
Teffry et al, 1993).
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5.1.2 Iron Storage Processes
When a dose of 59Fe (as labelled ferric ammonium citrate or iron dextran) is injected into 
a rat, part of the dose will be found in the liver as soluble cytosolic ferritin (Drysdale and 
Munro, 1966; Kohgo et al., 1980; Bomford et al., 1981; Treffry et al., 1984). The steps 
by which this occurs have not been fully elucidated though it is known that transferrin 
delivers much of this iron by receptor mediated endocytosis (reviewed by Richardson and 
Ponka, 1997). After iron is liberated from transferrin into in the cytosol, the fate of iron 
is less clear. It is not known what the intracellular donor is in vivo, or the chemical form 
in which iron is delivered to ferritin. It is however known, that storage involves gradual 
accumulation by binding of iron to ferritin iron-core particles (Treffry and Harrison, 
1984). Ferric citrate is probably one of the low molecular weight iron complexes of the 
cytosol. However, attempts to load apoferritin with this compound (or other Fe3+ 
compounds) in vitro have been unsuccessful (Treffry and Harrision, 1979) unless a 
reductant such as ascorbate is present (Lauhere and Briat, 1993).
Though not fully understood, there appears to be a generally accepted mechanism by 
which Fe becomes oxidised and deposited within ferritin (reviewed by Harrison and 
Arosio, 1996 and refs, cited therein). It would appear that Fe2+ is first bound and
<5-1
oxidised at catalytic centres on the protein. Fe then migrates to form clusters in the 
cavity of ferritin yielding stable nuclei (or iron-cores) of crystalline structure 
(ferrihydrite). Finally, the nuclei that are formed provide a secondary growing surface
04-onto which Fe can be deposited and oxidised, nucleated molecules are able to deposit
o  I
iron faster than those devoid of nuclei. When adding Fe to apoferritin, most of the iron
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is found on the protein and little in iron-core clusters. However, as more iron is added 
and becomes oxidised by ferritin, the Fe3+ greatly favours attachment to the iron-core 
compared to the protein. After the early production of Fe3+ clusters the rate of Fe3+ 
deposition greatly increases.
Much attention was paid to the oxidation of Fe by apoferritin and some of the work 
undertaken used recombinant ferritins composed of only one subunit type. This led to the 
discovery that the catalytic ferroxidase activity of ferritin (i.e. oxidation of Fe2+ to Fe3+) 
was associated with H-chains and not L-chains. Additionally, a metal centre was 
identified in human H-chain homopolymers that was not found in L-ferritin. Mutational 
studies indicated that removal of these metal centres could remove ferroxidase activity in 
H-chains. This opens the question as to what function do L-chains have in ferritin and 
iron storage, and why have heteropolymers at all? Horse spleen ferritin has a high 
average percentage of L-chain (85%), it also has a relatively high iron (average 2700 Fe 
atoms/molecule), yet the L-chain fraction extracted from horse spleen ferritin was found 
to be devoid of iron (Ishitani and Listowsky, 1975). Despite L-chains being unable to 
take up a significant amount of iron in vivo themselves as subunits, there is clearly an 
important function of the L-chain when in heteropolymers.
Human L-chain homopolymers are able to produce iron-cores using Fe2+ and this led to 
the suggestion that L-chains may possess an alternative Fe2+ oxidation site (Levi et al., 
1992). However, this does not happen as quickly or efficiently as the H-chain 
homopolymer. H-ferritins, on the other hand, are comparatively poor iron-core-formers
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(Levi et al., 1992; Levi et al., 1994). The L-chain iron-cores of homopolymers and native 
heteropolymers have been found to be more regular and slightly larger than those of the 
H-chain homopolymers, which has led to the view that L-chains may be more efficient at 
ferrihydrite nucleation (Wade et al., 1991; Levi et al., 1992). It would thus seem that H- 
chains are essential for rapid Fe2+ oxidation and thus removal of potentially toxic iron. L- 
chains appear to be efficient in nucleation and iron-core formation, hence provide the iron 
storage capacity of ferritin. This would explain why tissues that store iron tend to be rich 
in L-ferritin. It is therefore advantageous for ferritin molecules to be composed of both H 
and L-subunits because of functional and complimentary differences.
5.1.3 Liberation o f Iron from Ferritin
Mechanisms by which iron is liberated from ferritin for intracellular use are also poorly 
understood. Experimentally, iron stored within ferritin can be mobilised by the use of 
iron chelators such as desferal. This has been demonstrated in perfused rat liver (Baker et 
al., 1980) and in cultured rat hepatocytes (Laub et al., 1985). In vitro, iron can be readily 
mobilised from ferritin by small reductants such as ascorbate, cysteine and glutathione, 
assisted by an Fe2+ chelator such as ferrozine (Boyer et al., 1988). A variety of 
physiological reducing agents have been found to be effective, or at least partially 
effective in releasing iron from ferritin. Reduced flavins such as riboflavin, FMNH2 and 
FADH2 were found to be very effective (Sirivech et al., 1974), with superoxide found to 
be partially effective (see below). Dognin and Crichton (1975) tested in vitro a wide 
variety of biological reductants for possible mobilisation of iron from ferritin. Some of 
the more effective reductants included cysteine, ascorbate and glutathione, however all
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were very slow compared to reduced flavins and none of these agents has been clearly 
implicated in iron mobilisation from ferritin in vivo. From experiments performed using 
liver homogenates (Topham et al., 1989), it was proposed that xanthine and NAD(P)H- 
dependent ferriductase activity promotes the mobilisation of ferritin iron (and transferrin 
iron within the endosome) using a reduced flavin nucleotide (FAD or FMN) to apparently 
shuttle electrons from reduced enzymes to the iron contained within the ferritin molecule 
(Topham et al, 1989). In rat hepatocytes, iron has been shown to be mobilised as a 
consequence of the uptake of extracellular ferritin and subsequent degradation by 
lysosomes (Sibille et al., 1989). Ferritin is known to be degraded in secondary lysosomes 
and this is usually preceeded by ferritin aggregation and auotphagic engulfment by 
vacuoles. These vacuoles fuse with secondary lysosomes where ferritin is slowly 
degraded to a non-specific complex containing iron, partially degraded protein, and lipid 
(Bridges, 1990; Harrison and Arosio, 1996)). This material is known a haemosiderin and 
is very prominent in cells heavily loaded with iron. Iron is released by controlled 
interactions with enzyme generated reducing agents, where presumably it is available to 
enter the cytosol for intracellular use. However, little is known about the mechanisms by 
which this occurs (Bridges, 1990).
5.1.4 Ferritin and Oxidative Iron Mobilisation
In addition to the iron storage role of ferritin, it has long been considered that ferritins are 
also able to detoxify iron. This toxicity is mainly related to ability of ‘free’ iron to induce 
the formation of ROS, which in turn, causes oxidative damage (Halliwell and Gutteridge,
1999). Whilst stored in ferritin, iron is relatively inert as a promoter of ROS formation,
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however it becomes active as a catalyst when it is released by reducing agents. 
Superoxide, a physiological reductant, is produced intracellularly from a number of 
different sources including enzymes like peroxidases and xanthine oxidase and by haem 
proteins as well as through auto-oxidation of various biomolecules (Halliwell and 
Gutteridge, 1999). UVA radiation of NADH and NADPH also produces superoxide 
(Czochralska et al., 1984;Cunningham et al., 1985). In 1974, Williams and co-workers 
reported that superoxide (generated by xanthine/xanthine oxidase) in vitro was capable of 
mobilising iron from ferritin. Since that report, the list of free radicals and toxicants also 
capable of releasing iron from ferritin has increased (reviewed by Reif, 1992) and will be 
briefly discussed. The efficiency of superoxide-dependent iron mobilisation that has 
been reported has been variable. In general, the release of iron by the xanthine oxidase is 
around a range of 5%. The amount released has been shown to decrease after repeated 
cycles of the xanthine/xanthine oxidase reaction (Bolann and Ulvik, 1990). In contrast to 
the xanthine oxidase method used to induce iron release from ferritin, Reif and colleagues 
(1988) showed that repeated bursts of superoxide generated radiolytically (using 137Cs y 
radiation) could release up to approximately 70% of iron from ferritin. It is not known 
why the two systems of producing superoxide vary so greatly in the relative efficiency of 
releasing iron from ferritin, although factors such as size and age of the ferritin iron cores 
used in these experiments seem to have some bearing on the amount that is released 
(Bolann and Ulvik, 1990). Despite the small amount of iron release from ferritin using 
the xanthine oxidase method of producing superoxide, the amount has been shown to be 
sufficient to promote lipid peroxidation of phospholipid liposomes (Thomas et al., 1985).
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The reduction potential of a compound appears to be the primary indicator of the ability 
of that compound to reductively mobilise iron from ferritin. Toxicant xenobiotics with 
redox cycling capacities such as paraquat (lung toxicant), adriamycin (heart toxicant) and 
alloxan (pancreatic toxicant), have high reduction potentials and have been shown to 
mobilise ferritin iron which, in turn, stimulates lipid peroxidation (Thomas and Aust, 
1986; Vile and Winterboum, 1988; Reif et al., 1989). Iron is mobilised by these 
xenobiotics either indirectly by the production of superoxide, or directly by the free 
radical form of these agents. Other mechanisms of iron release from ferritin have also 
been documented, particularly that of photoreduction. It is well known that some Fe3+ 
complexes can be photoreduced by UV light. Aubailly and colleagues (1991) 
demonstrated that in vitro UVA (and visible) radiation could photoreduce (thus release) 
approximately 4% of the ferric ions stored in ferritin. Laulhere and colleagues (1990) 
also demonstrated iron release from pea seed ferritin using UVA and visible wavelengths. 
They showed that it was the iron-core that was the site of photoreduction. It has also 
been demonstrated in vitro that ALA can cause the release of iron from ferritin and 
concomitantly initiate liposome lipid peroxidation (Oteiza et al, 1995).
5.1.5 The Objectives o f this Study
Recently, it was demonstrated in this laboratory (Pourzand et al., 1999) that UVA 
irradiation of cultured primary fibroblasts could result in an increase in the intracellular 
‘free’ iron pool as determined by assays based on IRP/IRE binding, cytoplasmic 
aconitase activity, and calcein fluorescence. It was proposed that the release of
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proteolytic enzymes from UVA-damaged lysosomes resulted in ferritin degradation 
(measured by immunoprecipitation) and the concomitant immediate release of ‘free’ iron. 
Previously, Cairo and colleagues (1995) had also shown intracellular iron release by 
adding the glutathione-depleting drug Phorone. This was similarly attributed to ferritin 
degradation.
The objective of our study was to quantitatively determine the level of ferritin after 
specified treatments using a polyclonal (anti-ferritin) enzyme-linked immunosorbent 
assay kit known as the Enzymun-Test® Ferritin kit (Roche, UK). The basic principles of 
this method are depicted in Fig. 5.1. In brief, a cytosolic extract is prepared which is 
added to a streptavidin tube along with biotinylated anti-ferritin antibodies and 
peroxidase (POD)-labelled anti-ferritin antibodies (the incubation solution). The 
antibodies bind to specific ferritin epitopes present on ferritin and the biotin part of the 
biotinylated antibody binds to streptavidin, thus anchoring the ferritin/antibody 
complexes to the tube. Excess antibodies are removed by washing them with the 
substrate-chromogen solution, ABTS® (di-ammonium 2, 2’-azino bis (3- 
ethylbenzothiazoline-6-sulphonate), is added. ABTS® is a peroxidase substrate and is 
cleaved by the peroxidase to produce a characteristic green coloured product, which is 
measured spectrophotometrically. This is intended to provide a quantitative 
determination of ferritin present in the sample extract.
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Fig. 5.1. Enzyme-immunoassay for the quantitative determination o f ferritin in vitro (Source: Enzymun- 
Test® Ferritin fact sheet provided with the kit)
Test principle: ELISA/1 -step sandwich assay using streptavidin technology
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It was the intention of our study to determine ferritin content in FEK4 primary human 
skin fibroblasts and HaCaT human immortalised epidermal keratinocytes after UVA 
irradiation. Previous unpublished data, using the cytoplasmic aconitase assay (see 
Chapter 3), suggests that there is a large increase in detectable iron levels after ALA 
treatment followed by UVA irradiation. It has been previously reported that PPIX can 
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(Precigoux et al., 1994; Michaux et al., 1996; Crichton et al., 1997). PPIX is known to be 
a potent photosensitiser (see Chapter 2). Using the enzyme-immunoassay kit, the 
hypothesis that ALA treatment followed by UVA irradiation could cause ferritin 
degradation in FEK4 cells was tested. In turn, ferritin degradation would result in the 
concomitant release of iron release in these cells. This may occur by either rupturing 
lysosomal membranes allowing proteolytic enzymes to spill into the cytosol, in turn 
degrading ferritin, or by PPIX causing direct damage to the ferritin shell itself.
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5.2 Methods
5.2.1 Cell Culture
The primary human fibroblast cell line, FEK4, and the immortalised human keratinocyte 
cell line, HaCaT, were cultured as described in sections 2.2.2 and 3.2.1 respectively.
5.2.2 Chemical Treatment and Irradiation Conditions
FEK4 cells were treated ALA as described in section 2.2.3. Positive controls for the 
modulation of ferritin levels were prepared for both FEK4 and HaCaT cells. Solutions of 
50 pM haemin or 100 pM desferal (Ciba Geigy, Switzerland) were prepared using the 
appropriate conditioned cell culture media. These solutions were added back to the cells, 
which were incubated for 18 h at 37°C. Preparation and irradiation conditions of both 
FEK4 and HaCaT cells are described in section 2.2.6.
5.2.3 Preparation o f Cytoplasmic Extracts fo r Ferritin Analysis
Immediately after treatment, plates were placed on ice. Media was removed and cells 
were washed with ice-cold PBS. Ice-cold PBS containing 1 mM EDTA (Merck, UK) and 
the protease inhibitors Pefabloc® at a concentration of 50 pg/ml (Roche, UK), 
chymostatin at a concentration of 50 pg/ml (Roche, UK), and leupeptin at a concentration 
of 20 pg/ml(Roche, UK), was added and cells were scraped using a rubber policeman. 
Cells were collected and centrifuged at 4°C for 5 min at 1500 rpm. The supernatant was 
removed and cells re-suspended in 1 ml of the fresh ice-cold buffer containing the 
protease inhibitors. Cells were counted and centrifuged as before. The supematent was 
aspirated and the cells were re-suspended in ice-cold (lx) Munroe lysis buffer containing
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10 mM Hepes (pH 7.5), 3 mM MgCfe, 40 mM KC1 and 5% glycerol. The buffer also 
contained 50 pg/ml Pefabloc®, 50 pg/ml chymostatin, 20 pg/ml leupeptih, 0.3% Nonidet 
P-40 (Merck, UK), and 1 mM phenylmethlsulphonylfluoride (PMSF) (Sigma, UK). 
These were added to the lysis buffer just before use. Cell pellets were re-suspended and 
lysed on ice, using 250 pi per 1 x 107 cells of the buffer. Lysates were centrifuged at 4°C 
for 7 min at 2500 rpm. The cell extract (supematent) was removed and placed in a 1.5 ml 
tube then flash frozen in a dry ice/95% ethanol mixture. Extracts were stored at -70°C.
5.2.4 Determination o f Ferritin Content in Cell Extracts
Cell extracts were prepared for the measurement of ferritin content using a polyclonal 
enzyme-linked immunosorbent assay (ELISA) known as the Enzymun-Test® Ferritin Kit 
(Roche, UK). All components of this kit were brought to room temperature before use. 
The extracts were thawed and protein concentration was determined using the method 
described by Bradford (1976) with the BioRad reagent kit (UK). Bovine serum albumin 
(BSA) was used for calibration and absorption measurements were obtained using a 
microplate reader at 595 nm. Ferritin standards and cell extracts, to be measured, were 
added to separate streptavidin-coated tubes. Incubation buffer (containing the anti­
ferritin antibodies) was added to each tube and incubated at room temperature for 30 min. 
The tube contents were aspirated, washing solution was added, then the tubes were 
incubated for a further 30 min. The washing solution was aspirated then the chromogen- 
substrate solution was added to each tube. The tubes were incubated for 15 min at room 
temperature and the absorbance was determined immediately at 420 nm using a 
spectrophotometer. The concentration of ferritin protein in each extract was determined
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against the ferritin standards. This value was then normalised using total protein content 
obtained from the Bradford assay and expressed as nanograms (ng) of ferritin per 
milligrams (mg) of protein.
5.2.5 Statistical Analysis
Results are expressed as the mean ± one standard deviation. Significant differences (p< 
0.05) were determined by an unpaired t test.
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5.3 Results
5.3.1 Effects o f either UVA Irradiation, Haemin, or Desferal Treatment on the Ferritin 
Content o f the HaCaT Immortalised Human Keratinocytes
The ferritin content of HaCaT keratinocytes, in response to graded doses of UVA 
radiation, is shown in Table 5.1. Immediately after irradiation, cell extracts were 
prepared for the measurement of cytosolic ferritin content using a polyclonal enzyme 
linked immunosorbent assay (ELISA) kit (see section 5.2.3). After 100 kJ/m2 UVA there 
was approximately a 1.25-fold increase in the ferritin content. Increasing the dose of 
UVA led to a drop in the ferritin content. After 250 kJ/m2 UVA the ferritin level was not 
significantly different to that of the control. After 500 kJ/m2 UVA the ferritin level 
appeared to drop slightly below that of the control (5-10%), though this was, again, not 
significant. Positive controls, desferal and haemin, were used to test the efficacy of the 
ELISA kit (Table 5.1). Incubation of HaCaT cells with the iron chelator desferal (18 h, 
100 pM) resulted in a 5-6-fold decrease in ferritin compared to control levels. 
Incubation with haemin (18 h, 50 pM), on the other hand, resulted in a 10—11-fold- 
increase in ferritin.
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Fig.5.1. Effect o f various treatments on the ferritin content o f HaCaT cells. Ferritin levels were measured 
using an enzyme-linked polyclonal immunosorbent assay kit. Data represent the mean o f 4-6 independent 
experiments (± S.D.).
Treatment Ferritin Content (ng mg protein'1)
Non-irradiated 26.45 ±2.082
100kJ/m2UVA 32.96 ± 1.357*
250 kJ/m2 UVA 27.2 ± 0.989
500 kJ/m2 UVA 24.715 ±1.414
18 h Desferal (100 gM) 4.682 ± 0.350*
18 h Haemin (50 juM) 278.8 ± 7.636*
Statistical analyses were made using an unpaired t test. *, Significantly different from non-irradiated 
control ( p , 0.05 level).
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5.3.2 Effects o f either UVA Irradiation, Haemin, or Desferal Treatment on the Ferritin 
Content o f the FEK4 Primary Human Fibroblasts
Table 5.2 shows the effect of graded doses of UVA radiation on the ferritin content of the 
FEK4 fibroblasts. After irradiation with a UVA dose of 100 kJ/m2, the level of ferritin 
appears to rise to almost 1.2-fold above that of the control level. The ferritin level 
appears to peak around 250 kJ/m2, approximately 1.4-fold above the control. After a 
UVA dose of 500 kJ/m , the ferritin content had dropped to approximately 1.5-fold below 
that of the control level. The significance of this result, and how it compares with data 
from immunoprecipitation studies of ferritin after the same treatment (Pourzand et al., 
1999), is detailed in the discussion of this chapter. Positive controls, desferal and 
haemin, were also used for FEK4 (Table 5.2). Incubation with desferal for 18 h (100 
pM) resulted in approximately a 5-fold decrease in ferritin compared to control levels. 
Haemin treatment (50 pM, 18 h) resulted in approximately a 6-fold increase in ferritin 
levels. Compared to the HaCaT cells (Table 5.1), FEK4 possess a 3.5-4-fold higher 
basal content of ferritin.
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Fig.5.2. Ferritin content in FEK4 cells after various treatments measured using an enzyme-linked 
polyclonal immunosorbent assay kit. Data represent the mean o f 4-6 independent experiments (± S.D.).
Treatment Ferritin Content (ng mg protein'1)
Non-irradiated 99.828 ± 7.63
100kJ/m2UVA 117.95 ±7.141*
250 kJ/m2 UVA 140.69 ±22.641*
500 kJ/m2 UVA 65.646 ± 1.578*
18 h Desferal (1G0 gM) 19.605 ±2.623*
18 h Haemin (50 nM) 572.43 ± 13.534*
Statistical analyses were made using an unpaired t test. *, Significantly different from non-irradiated 
control ( p , 0.05 level).
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5.3.3 Effects o f ALA Incubation and UVA Irradiation on the Ferritin Content o f the 
FEK4 Primary Human Fibroblasts
Table 5.3 shows the effects of ALA treatment (4 and 18 hours) and UVA irradiation on 
the ferritin content of the FEK4 fibroblasts. Treatment of cells with 100 or 200 pM ALA 
for 4 h resulted in a decrease in intracellular ferritin content of 1.035- and 1.25-fold 
respectively, compared to the non-treated control. When these ALA-treated cells were 
irradiated with UVA, increases of 3 -  3.5-fold in ferritin content were detected compared 
to the non-irradiated controls (Table 5.3). After irradiation, ferritin levels were higher in 
the 100 pM ALA treated sample compared to those of the 200 pM treatment (Table 5.3).
Treatment of cells with ALA for 18 h resulted in a decrease in ferritin content of 
approximately 2.5 -  3-fold, with both 100 and 200 pM concentrations (the effect was not 
significantly different comparing the two concentrations). Irradiation of these ALA- 
treated cells led to increases in ferritin levels compared to the non-irradiated controls. 
The irradiated 100 pM and 200 pM ALA treated populations showed approximate 
increases in detectable ferritin over the non-irradiated controls of 1.2 -  1.4-fold and 1.6 -  
1.7-fold respectively. Comparison of the 50 kJ/m2 and 100 kJ/m2 UVA doses, shows 
there is no significant difference between the two, after incubation with either 100 or 200 
pM ALA.
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Fig.5.3. Ferritin content in FEK4 cells treatments with ALA then exposed to UVA radiation. Ferritin 
content was measured using an enzyme-linked polyclonal immunosorbent assay kit. Data represent the 
mean o f  4-6 independent experiments (± S.D.).
ALA Treatment Ferritin Content (ng mg protein'1)
Non ALA-treated/non-irradiated 99.828 ± 7.63
4 h 100 jiM non-irradiated 96.475 ± 8.308
4 h 100 (jM  50 kJ/m2 UVA 313 ±18.129*
4 h 100 nM 100 kJ/m2 UVA 307.2 ±14.119*
4 h 200 jiM non-irradiated 78.685 ± 4.546
4 h 200 |iM 50 kJ/m2 UVA 274.1 ±24.748*
4 h 200 nM 100 kJ/m2 UVA 232.75 ± 19.771*
18 h 100 fiM non-irradiated 36.355 ±5.154
18 h 100 |iM 50 kJ/m2 UVA 46.11 ± 1.569*
18 h 100 nM 100 kJ/m2 UVA 48.91 ±3.493*
18 h 200 fiM non-irradiated 33.68 ± 1.244
18 h 200 fiM 50 kJ/m2 UVA 55.49 ±2.135*
18 h 200 |liM 100 kJ/m2 UVA 54.1 ±3.818*
Statistical analyses were made using an unpaired t test. *, Significantly different from non-irradiated 
control ( p , 0.05 level).
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5.4 Discussion
The basis of this study was the data produced in this laboratory by Pourzand and 
colleagues (1999) who demonstrated that UVA treatment of FEK4 fibroblasts resulted in 
an increase in the intracellular ‘free’ iron pool. One of the possible sources of this iron 
was postulated to be ferritin. In the Pourzand et al. study it was shown using 
immunoprecipitation that ferritin degradation occurred and that the level of degradation 
was a function of UVA dose. At least some of this degradation appeared to be a result of 
the release of proteolytic enzymes from lysosomes whose membranes had been damaged 
by UVA radiation. Quantification of ferritin degradation is difficult using 
immunoprecipitation, so the purpose of this study was to quantify this apparent ferritin 
degradation in FEK4 fibroblasts using a polyclonal enzyme-linked immunosorbent assay 
kit (Roche, UK). This method was also used to assess ferritin content in FEK4 
fibroblasts treated with ALA and UVA radiation, and in HaCaT immortalised human 
keratinocytes exposed to UVA radiation.
Analysis of the basal ferritin content of FEK4 fibroblasts and HaCaT keratinocytes 
(Tables 5.1 and 5.2) reveals that the basal content of ferritin in FEK4 cells is 
approximately 3.5 -  4-fold that of HaCaT cells. This is in contrast to previous results 
with primary fibroblasts and primary keratinocytes. Applegate and co-workers (1995) 
showed that ferritin levels were 2 -  3-fold higher in keratinocytes compared with 
matching fibroblasts (i.e. from the same biopsy). The difference between these two 
studies was that our study involved a comparison of a primary fibroblast cell line, FEK4, 
with the fast growing immortalised keratinocyte cell line, HaCaT. Primary keratinocytes
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grow slower than primary fibroblast cell lines. Recently it has been observed (C. 
Pourzand, unpublished data, this laboratory) that HaCaT cells possess little or no 
detectable L-ferritin as measured by immunoprecipitation. Detection of the ferritin that 
was present (i.e. H-ferritin) was difficult to detect because of the low levels.
In previous chapters, it has been reported that irradiation of FEK4, and to a lesser extent 
HaCaT cells, results in an increase in the intracellular ‘free’ iron pool. Quantification of 
ferritin content in HaCaT cells, in response to UVA radiation (Table 5.1), suggests that 
UVA has little or no effect on the ferritin content of these cells. With a dose of 100 kJ/m2 
UVA, there appears to be an increase in ferritin levels of approximately 1.25-fold. Doses 
above 100 kJ/m2 result in a decrease in ferritin levels to just below the control level (after 
500 kJ/m2 UVA), but this is not significant. In HaCaT cells, the response observed in 
ferritin levels as a result of UVA-irradiation is not significant.
When FEK4 cells were irradiated with graded doses of UVA, an apparent increase in the 
level of ferritin (Table 5.2) was observed up to a dose of 250 kJ/m2, where it peaks at 
approximately 1.4-fold above that of the control level. Between 250 and 500 kJ/m2 UVA 
the level of ferritin decreases. After 500 kJ/m UVA the ferritin level is approximately 
1.5-fold below that of the control. This would appear to contradict the result seen with 
the UVA-mediated degradation of ferritin as measured using immunoprecipitation 
(Pourzand et al., 1999). In the study by Pourzand et al. (1999) it was shown that UVA 
irradiation resulted in degradation of ferritin in a dose-dependent manner. However, 
ferritin levels measured in both our study and the study by Pourzand et al. (1999)
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employed cell extracts that were prepared immediately after irradiation (and both used a 
mouse polyclonal antibody to detect ferritin). This means that it is unlikely that the cell 
is capable of synthesising new ferritin. The reason and the significance of the different 
responses observed using the two methods may be explained. For analysis of ferritin 
using immunoprecipitation, cell extracts are subjected to a number of freeze-thaw cycles 
to dissociate (radioactively labelled) ferritin into its H and L subunits. The purpose of 
this procedure is so that H- and L-ferritin subunits are seen as discrete bands (21,000 and 
19,000 Da respectively) when run on a Western gel, as revealed by autoradiography. 
UVA-induced degradation of these subunits results in the disappearance of these distinct 
bands, presumably because the degradation products are random and varied so that 
discrete bands are not formed when run on a gel. The ferritin assay (ELISA kit method), 
on the other hand, does not employ the deliberate dissociation of ferritin into its subunits. 
This, in part, may explain why an increase in the apparent level of ferritin (in FEK4 cells) 
is observed after UVA irradiation using the ferritin assay. Allen and colleagues (1997 
and 1999) have documented, using an anti-ferritin mouse polyclonal antibody and atomic 
force microscopy, that ferritin possesses many antibody-antigen binding sites, i.e. it is 
polyepitopic. We believe that the some of the apparent increases observed in ferritin 
levels after UVA irradiation, measured using the ferritin assay, may occur as a result of 
fragmentation of the ferritin molecule into its subunits. Some of the increases may also 
be due to degradation of subunits, which in turn, might liberate more detectable epitopes. 
After a dose of 500 kJ/m2 UVA, the level of ferritin that can be measured by the ferritin 
assay drops to below that of the control (Table 5.2). This presumably occurs because so
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much damage has occurred to the protein that, either fragments are produced that contain 
one epitope or less, or the epitopes are no longer recognisable by the antibody.
To directly compare data from immunoprecipitation and the ferritin assay, the extracts 
prepared for the ferritin assay would have to be subjected to freeze thaw cycles to 
dissociate the subunits before analysis. This would remove any apparent increases in 
ferritin levels measured due to the ferritin molecule breaking up into its subunits as 
function of UVA radiation. Any changes in ferritin levels detected after this procedure 
must be due to changes other than subunit dissociation. Changes in ferritin levels that are 
then observed after UVA irradiation, as measured using the ferritin assay, could be 
interpreted in one of two ways. If the levels of ferritin decrease after UVA treatment, this 
might be interpreted as degradation of the ferritin subunits. This would be convenient as 
quantitative measurements of ferritin subunits could be made, which could be compared 
with the immunoprecipitation data. The results would have to be expressed as ng of 
ferritin subunits per mg of protein rather then ng of ferritin per mg protein (as the ferritin 
kit specifies). On the other hand, if the apparent level of ferritin increases after UVA 
treatment, it is possible that degradation of ferritin subunits is occurring, but is liberating 
more detectable epitopes in the process (or more fragments that contain two or more 
epitopes). The quantitative measurement under this scenario would have to be defined as 
number of ferritin epitopes recognised per mg of protein. One very important point does 
need to be addressed however, and that is certain experimental treatments might cause 
ferritin damage that results in subunits to dissociate from the ferritin molecule. This 
would probably induce iron release, as iron-cores may be exposed to the cytosol (and
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thus a reducing environment), but may not necessarily require significant damage to the 
subunits, just breaking of intermolecular bonds. Therefore, iron release from ferritin 
could occur, but a method that involves dissociating subunits in order to analyse them 
(i.e. immunoprecipitation) would not detect this form of damage, which in turn could 
prevent the identification of ferritin as the source of iron release. Under such 
circumstances, dissociating ferritin into its subunits for analysis would be inappropriate 
and exemplifies one advantage the ferritin assay may have over immunoprecipitation (if 
freeze-thaw cycles are not used).
One option may be to perform both assays as originally described i.e. dissociation of 
subunits with immunoprecipitation, but not with the ferritin assay. If a reduction in 
ferritin subunits is observed after immunoprecipitation, then an increase observed in the 
ferritin assay would indicate that subunits are being degraded, but are exposing more 
epitopes in the process (or more fragments with two or more epitopes). Under this 
circumstance, a quantitative measurement could be made with the ferritin assay, but 
would have to be expressed in arbitrary units as the number of epitopes recognised by the 
anti-ferritin antibody per mg of protein, which otherwise, may not reflect the true level of 
ferritin. This emphasises the importance of using both techniques, as without the 
knowledge of the degradation of ferritin, as observed with immunoprecipitation, an 
incorrect interpretation may be made of results obtained using the ferritin kit. 
Alternatively, the ferritin assay may measure increases in ferritin levels that occur 
through the production of more protein e.g. by haemin treatment (Table 5.2). Again, this 
could be confirmed by performing immunoprecipitation ferritin. The hypothesis that
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treatment causes fragmentation of ferritin and the increased recognition of epitopes, could 
be an explanation for the increased ferritin levels observed in HaCaT cells after UVA 
irradiation. Because there is a much lower basal level of ferritin in the HaCaT cells, the 
response to UVA was less than that with the FEK4 cells.
Desferal (an iron chelator), and haemin (ferric haem) treatments were used in this study 
as controls to show modulation of ferritin levels. HaCaT and FEK4 cells showed a 5 -  6- 
and 5-fold reduction in the ferritin level respectively in response to desferal treatment 
(lOOfiM, 18 h), and 10-11- and 5 -  6-fold increase respectively in response to haemin 
treatment (50 pM, 18 h). The desferal treatment and resultant ferritin down-regulation 
indicates iron starvation within the cell and the apparent lack of need for iron storage, as 
expected. After the haemin treatment, on the other hand, the large up-regulation of 
ferritin protein suggests a protective response by the cell that enables the cell to sequester 
and store the potentially hazardous influx of iron absorbed in the form of haemin.
Treatment of FEK4 cells with ALA for 4 and 18 hours resulted in a decrease in ferritin 
levels, as measured using the ferritin assay (Table 5.3). The effect observed was much 
greater for the longer incubation time (see below). This decrease in ferritin levels would 
appear to occur as a result of the iron chelator properties ALA-induced PPEX. The 
penultimate step of haem biosynthesis is catalysed by the enzyme ferrochelatase. This 
event involves insertion of iron into the tetrapyrrole ring of PPIX producing haem and 
effectively chelating iron at the same time. The reduction in ferritin content by ALA 
would suggest that iron could be mobilised from ferritin to produce haem. Cells treated
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with ALA show reductions in the ‘free’ iron pool and aconitase activity, supporting the 
hypothesis that ALA-induced PPEX can function as an iron chelator (see Chapters 4 and 2 
respectively).
Irradiation of ALA-treated cells with UVA resulted in an increase in the detectable 
number of ferritin epitopes (Table 5.3). Irradiation of cells after 4 h ALA incubation 
caused a huge increase in the detectable number of ferritin epitopes (between 3 -  3.5-fold 
above that of the non-irradiated control). This increase far exceeded that observed by 
UVA alone, suggesting that ALA treatment, followed by UVA irradiation may be more 
effective in damaging ferritin and act by a different mechanism. The fold increase in the 
number of ferritin epitopes measured after 4 h, 100 and 200 pM ALA treatment, are 
comparable after UVA irradiation. However, the number of epitopes detected after the 
200 pM treatment, followed by irradiation, is lower compared with that of the 100 pM 
ALA treatment. This is consistent with the observation that the higher ALA 
concentration results in greater ferritin depletion. The number of epitopes detected after 
4 h ALA treatment appeared to go down after the larger dose of 100 kJ/m UVA 
compared to the 50kJ/m2 dose. This would suggest that the degree of damage caused to 
the ferritin is more severe.
After incubation of cells with ALA for 18 h (100 and 200 pM), the ferritin content of 
FEK4 cells had decreased by 2.5 -  3-fold below that of the control level (Table 5.3). 
This was a much greater decrease than that observed after treatment with ALA for 4 h. 
Cells that were treated with ALA for 18 h followed by irradiation showed an apparent
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increase in ferritin levels as observed for the 4 h treatment, but the fold increases in the 
number of ferritin epitopes detected were much lower. The fold increases after 
irradiation, compared to non-irradiated controls, ranged from 1.2 -  1.7-fold depending on 
the concentration of ALA treatment and the dose of UVA administered (Table 5.3). This 
low level of ferritin modulation is consistent with the level of ferritin originally present.
The results presented in this study that involved treatment of cells with ALA and UVA 
would appear to support the hypothesis that ALA-induced PPIX can exacerbate 
degradation of ferritin by virtue of a photosensitisation mechanism. Whether this 
degradation process occurs as a result of proteolytic enzymes from damage to lysosomes, 
as proposed by Pourzand and colleagues (1999), or whether it is due to direct 
photosensitisation of the ferritin molecule by PPIX, is not clear from this study. As 
mentioned in the introduction, PPIX has been shown to locate within ferritin (Precigoux 
et al., 1994; Michaux et al., 1996). If PPIX located within the ferritin molecule is 
exposed to UVA during irradiation, this could result in direct photosensitised damage to 
the ferritin protein shell. Clarifying the precise mechanisms involved may be difficult. 
PPIX added to cells and then irradiated has been shown to damage lysosomes and result 
in the spillage of proteolytic enzymes into the cytosol (Morliere et al, 1987). Thus, it 
would seem reasonable to expect proteolytic enzyme spillage from lysosomes (as a result 
of ALA treatment and UVA irradiation) to be responsible for at least some ferritin 
degradation. However, if PPIX is located within the ferritin molecule and is able to cause 
direct photosensitised damage, then this would probably occur before any protease could
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reach the ferritin molecule. The action of proteases may be a secondary event, but would 
still be important.
In conclusion, this study supports the hypothesis that UVA irradiation of human cells 
results in damage to the ferritin protein. This, in turn, causes an increase in the ‘free’ iron 
pool. Treatment of cells with ALA reduces the basal level of ferritin. UVA irradiation of 
these ALA-treated cells would appear, under the appropriate conditions, to exacerbate 
damage caused to ferritin.
169
Chapter 6: Conclusions and Future Work
6. Conclusions and Future Work
This project was divided into two areas. One was to determine the importance of PPIX 
as an intracellular chromophore in UVA-mediated damage and a second to establish a 
clearer understanding of the fate of intracellular iron after UVA irradiation. The latter 
part of the project was investigated using three techniques. These included the direct 
measurement of intracellular iron by the flow cytometry-based iron assay, indirect 
measurement of intracellular iron by the cytoplasmic aconitase assay, and measurement 
of the iron storage protein ferritin as measured by the ferritin assay.
One of the main purposes of this project was to test the hypothesis that the basal content 
of PPIX may be critical in the UVA-mediated inactivation of human cells. To examine 
this, PPIX levels were modulated in the human lymphoblastoid cell line, TK6, and the 
primary human fibroblast cell line, FEK4, by incubation with ALA for 4 and 18 hours. 
At known intracellular PPIX concentrations (measured by spectrofluorimetry), cells were 
irradiated with graded doses of UVA radiation to produce dose response curves. The 
slope of each dose response curve provides the rate of inactivation of a cell population at 
each particular intracellular PPIX concentration. By examining the relationship between 
inactivation rate constants at different intracellular PPIX concentrations, an estimate of 
the basal content of PPIX necessary to lead to significant cell death following UVA 
irradiation was made (see Chapter 2). From this study it was deduced that the basal 
content of PPIX in TK6 cells was insufficient to make a significant contribution to UVA- 
mediated inactivation. In contrast, the basal content of FEK4 cells appears to be critical 
in the UVA-mediated inactivation of these cells. PPIX therefore, may be an important
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UVA absorbing chromophore responsible for inactivation of certain cell types, but not 
others. This theory would have to be tested further by performing similar studies on 
other cell lines such as keratinocytes. Other information derived from this study was that 
the MTS reagent-based assay is an unsuitable method for determining viability after 
treatment with ALA as we have documented a reaction between the MTS tetrazolium salt 
with ALA producing a coloured formazan product (Fig. 2.10)
The results measuring the different parameters of intracellular iron including aconitase 
activity, free iron levels and ferritin levels, all showed that FEK4 cells possess greater 
intracellular iron levels and ferritin levels than HaCaT cells. It has been observed that 
HaCaT cells only possess H-ferritin (C. Pourzand, unpublished observation, this 
laboratory). A recent publication showed that the level of H-ferritin, which possesses 
ferroxidase activity, appears to have an inverse relationship with the level of intracellular 
free iron (Beaumont et al., 1999). This may suggest why low free iron levels are 
observed in HaCaT cells. The lower levels of as membrane damage measured by flow 
cytometry and calcein fluorescence could be a reflection of the fact that, after UVA 
irradiation, as lower basal ‘free’ iron concentration and iron release in HaCaT cells could 
limit the degree of lipid peroxidation and membrane damage observed in these cells 
(Fig.4.6). A future study in this area would be to determine whether a correlation exists 
between intracellular ‘free’ iron levels of different cell types, and UVA-induced 
membrane damage. Other factors also need to be considered such as intracellular 
antioxidant concentration, as this can vary and may affect the results obtained in such a 
study (Leccia et al., 1998).
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UVA irradiation of the two cell lines FEK4 and HaCaT generally resulted in similar 
trends in the responses measured by the cytoplasmic aconitase assay, the iron assay, and 
the ferritin assay. The difference between the two cell lines was mainly that the response 
observed by the FEK4 cells was much greater, in all respects, compared to the HaCaT 
cells. The results did not provide conclusive evidence that there was a change in ferritin 
levels of HaCaT cells after UVA irradiation, as measured by ferritin assay.
Treatment of FEK4 cells with ALA reduced the ‘free’ iron pool as measured by aconitase 
activity, the iron assay and the ferritin assay. Irradiation of ALA-treated cells produced 
some very significant results using these three assays. There was a huge increase 
measured by aconitase activity, much larger than UVA alone (see Chapter 3). Using the 
ferritin assay, as described herein, there appeared to be fragmentation of ferritin (see 
below and Chapter 5), but on a considerably greater scale than UVA irradiation alone. 
The iron assay showed increases in chelatable iron after less severe treatments with ALA 
and UVA. Treatment of cells with higher ALA concentrations and UVA doses resulted 
in comparatively lower levels of measurable chelatable ‘free’ of iron (accompanied by 
greater increases in membrane damage) and in some cases these levels were below 
control levels (Chapter 4 and see below). Taking the results together, we speculate that 
ALA treatment of cells followed by UVA irradiation results in severe damage to ferritin 
and other cellular targets. This, in turn, results in a huge release of intracellular iron, 
which is detected by the decrease in binding activity of the IRP and concomitant increase 
in cytoplasmic aconitase activity. However, the level of damage can be so severe (with 
the more detrimental experimental conditions) that the cell membrane is damaged
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allowing the leakage of cytosolic components including iron and iron bound to CA. This 
is evident by the damage to the plasma membrane and the drop in iron levels, as 
measured by the flow cytometry-based iron assay (Chapter 4). The reason why the 
aconitase activity does not also drop after the more severe treatments that result in loss of 
iron from the cell is not clear. It is possible that the way the assay is designed does not 
allow enough time for the IRP to respond to the loss of iron from the cells. Alternatively, 
there may an additional source of iron such as ‘free’ haem or another form of iron that is 
released into the cytosol after treatment that might be recognised by the IRP but not 
bound by calcein. It is possible that the IRP is responding to forms of iron in the cell that 
the iron assay cannot detect and that this causes this large change in response in aconitase 
activity after treatment of cells with ALA followed by UVA irradiation. Future work in 
this area may lead to the identification of a form of iron that is liberated after oxidative 
stress and is recognised by the IRP, but not detected by the iron assay.
Concerning the effects of UVA irradiation on the modulation of cytoplasmic aconitase 
activity of the two cell lines, FEK4 fibroblasts, and HaCaT keratinocytes (Chapter 3), it 
was observed that these results sharply contrast with those documented in another study 
that measured the effect of UVA irradiation on the cytoplasmic aconitase activity of 
NCTC 2544 cultured human keratinocytes (Giordani et al., 1998). The cytoplasmic 
aconitase activity in the study by Giordani et al. (1998) showed a dose-dependent 
decrease after UVA irradiation. In contrast to this, both of the cell lines used in our study 
showed an increase in cytoplasmic aconitase activity up to 250 kJ/m UVA irradiation. 
Between 250 and 500 kJ/m2 UVA the aconitase activity decreased. The UVA source
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used in our experiments doe not emit the UVA II (320-340 nm) part of the UV spectrum 
(fig. 2.3), which could be crucial in explaining the differences between the results 
obtained in our study and the results obtained by Giordani et al. (1998) as the UVA 
source used by Giordani et al. (1998) emitted the more powerful UVA II wavelengths. 
Future studies in this area should focus on more discrete wavelength bands of UV 
radiation and their application to cultured cells to determine if the affect of UV on 
aconitase activity is wavelength dependent. Similar studies using the flow cytometry- 
based iron assay should also be run in parallel to confirm if iron release is induced.
The polyclonal (anti-ferritin) enzyme-linked immunosorbent assay (the ferritin assay) 
was originally employed to quantify ferritin levels after UVA irradiation because 
quantification of ferritin using immunoprecipitation is difficult. Using 
immunoprecipitation Pourzand et al. (1999) showed that ferritin was degraded by UVA 
irradiation in a dose-dependent manner. We have shown using the ferritin assay that an 
apparent increase in the level of ferritin occurs after UVA irradiation. The significance 
and explanation for this (see Chapter 5 for detailed discussion) is that the ferritin protein 
is polyepitopic and when exposed to UVA radiation degradation occurs resulting in the 
exposure of more epitopes. This appears as an increase in ferritin protein as measured by 
the ferritin assay.
It is clear that both immunoprecipitation and the ferritin assay need to be employed to 
assess ferritin status. The ferritin assay can provide a quantifiable method of determining 
ferritin levels, however, the method of expressing the result may need to be modified
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depending on the treatment applied to the cells. For example, the kit specifies that 
measurements made using this method should be expressed as ng of ferritin per mg 
protein, which is acceptable if treatments that induce the production of ferritin (such as 
haemin treatment) are used. However, treatments that result in the degradation of ferritin 
(which should be initially investigated using immunoprecipitation) should be expressed 
as number of epitopes recognised per mg of protein. This may go up initially as the 
protein is degraded (and more epitopes are exposed), but may also decrease if treatment 
results in the destruction of epitopes or the degradation and production of fragments 
containing one or no epitopes. Future studies in this area, using the ferritin assay, should 
ideally concentrate on the initial elucidation of what increase in epitopes measured is 
contributed by dissociation of ferritin into its subunits, and what increase in epitopes 
measured is contributed by the degradation of subunits into smaller fragments. This can 
be done by freeze-thawing extracts, which dissociates ferritin into its subunits. The 
purpose of this step would be to determine what level of dissociation of subunits is 
induced by a particular treatment before subunits are themselves degraded. This may 
provide information on the release of iron from ferritin that is induced by subunit 
dissociation, but that is not detected by immunoprecipitation.
The mechanisms that result in such large increases in ferritin epitopes as measured by the 
ferritin assay after treatment of cells with ALA followed by UVA irradiation should be 
investigated. It would appear that damage caused to ferritin by UVA irradiation of cells 
with altered PPIX levels does not occur in an identical way to that in cells that are treated 
with UVA alone. Release of proteolytic enzymes into the cytosol from cells with UVA-
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damaged lysosomes has been demonstrated by Pourzand et al. (1999) which were 
proposed to be responsible for the degradation of ferritin. Release of these proteolytic 
enzymes should be investigated after treatment of cells with ALA and UVA irradiation in 
order to determine if there is any difference after this treatment, compared with treatment 
of cells with UVA alone. If a large increase in the release of these enzymes was 
observed, this may be correlated with the damage observed to ferritin after such a 
treatment. If, however, such an increase was not observed after ALA treatment and UVA 
irradiation, then it would appear that the increase in epitopes observed using the ferritin 
assay would be attributable to an alternative mechanism, possibly by direct 
photosensitised damage of the ferritin molecule by PPIX.
The iron assay, detailed in Chapter 4, represents the development of a method that can 
measure both intracellular chelatable iron and membrane damage in the same assay 
system based on the fluorescence measurements of calcein by flow cytometry. The 
method is not complete, as a procedure of evaluating CA bound iron loss through 
damaged membranes needs to be established because the flow cytometer is only capable 
of measuring intracellular fluorescence. This procedure would probably involve the use 
of a technique such as the calcein assay (Epsztejn et al., 1997), which uses 
spectrofluorimetry to obtain fluorescence measurements. As described in Chapter 4, the 
iron assay has been used to estimate values of the chelatable iron pool. There is however, 
a more accurate process of obtaining the intracellular ‘free’ iron concentration that could 
be employed in this system. This more accurate method also includes the determination 
of chelatable iron that is not bound to CA. Previously Epsztejn et al. (1997) have
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described this method for the calcein assay. To obtain the total chelatable ‘free’ iron 
concentration using our system, some additional measurements are required. The total 
intracellular CA concentration needs to be determined by calibrating the cell system with 
known concentrations of CA. The concentration of iron bound to calcein, [CA-Fe], is 
also needed. This is obtained by the measuring the change in fluorescence evoked by 
adding the fast permeating iron chelator, SIH, which is then translated into a CA 
concentration using the CA calibration. CA binds Fe stoichiometrically (1:1) so this 
reveals the concentration of Fe bound to CA. The ‘free’ cell iron concentration [Fe2+] 
that is not bound to CA, but is chelatable, can be derived from experimentally determined
^  i
values of CA-Fe dissociation constant {Kj) in the particular cell lines used. The Kj  is 
obtained by titrating CA-loaded cells with Fe2+ (i.e. FAS) and measuring the concomitant 
fluorescence changes. The [Fe] value is calculated from application of the mass law 
equation using the experimentally derived Kj  value of [CA-Fe], the [CA-Fe] value and 
the intracellular CA concentration:
Kd = [C A] • [Fe]/[C A-Fe]
The total intracellular chelatable ‘free’ iron is defined as the sum of [CA- Fe] and [Fe]. 
Derivation of this value is the next step in the development and refinement of the iron 
assay.
In conclusion, we provide evidence in this study to implicate PPIX as an important UVA 
absorbing chromophore that may be crucial in the UVA-mediated inactivation of certain 
cell types. We also document the development of a flow-cytometry-based fluorescence
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assay system that is capable of determining membrane damage and intracellular ‘free’ 
iron levels. Using this system and also measuring cytoplasmic aconitase activity, we 
show that UVA radiation induces an increase in intracellular ‘free’ iron levels which is 
augmented by ALA treatment prior to irradiation. We also show using the ferritin assay 
that UVA irradiation results in the degradation of the iron storage protein ferritin (which 
is also augmented by ALA pre-treatment), providing evidence that ferritin is a major 
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